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Snake venoms are a rich source of pharmacologically active proteins and 
polypeptides, targeting a variety of receptors, which includes several potent and 
lethal neurotoxins. This family contains several types of neurotoxins that interact 
with different subtypes of nicotinic and muscarinic receptors involved in central 
and peripheral cholinergic transmission. They are being potentially used by the 
researchers as molecular probes to characterize different subtypes of cholinergic 
receptors. 
In this study, we report the purification, structural and functional characterization 
of a novel non-covalent homodimeric neurotoxin, haditoxin, from the venom of 
Ophiophagus hannah (king cobra). This protein was first identified in a cDNA 
library from the venom gland mRNA of O. hannah. Haditoxin was purified to 
homogeneity from the venom using a two-step chromatography approach. The 
protein consists of 65 amino acid residues with four intramolecular disulfide 
bonds. From the cysteine scaffold it was concluded that this protein belong to the 
three-finger toxin family of snake venom proteins.  
Haditoxin produced a potent postsynaptic neuromuscular blockade on avian and 
mammalian muscle preparations and the reversibility of the blockade was species-
specific. In the elctrophysiological studies with expressed human nicotinic 
receptors haditoxin exhibited novel pharmacology with antagonism towards 
muscle (αβγδ) and neuronal (α7, α3β2 and α4β2) nicotinic acetylcholine receptors 
(nAChRs), with highest affinity for α7-nAChRs. The high resolution (1.55 Å) 
xiii 
 
crystal structure revealed haditoxin as a non-covalent dimer with two identical 
subunits in a three-finger protein fold, which correlates well with the biophysical 
studies. Each of the monomer adapted a structure similar to the short-chain α-
neurotoxins, with four intramolecular disulfide bridges, such as- erabutoxin, 
which interacts specifically with muscle (αβγδ) nAChRs. However, the 
quaternary structure is similar to that of κ-neurotoxins such as κ-bungarotoxin, 
which interact specifically with neuronal (α3β2 and α4β2) nAChRs. Clearly 
haditoxin shows unique structural and functional profiles. Haditoxin is the first 
dimeric neurotoxin to interact with the muscle nAChR as well as the first short-
chain α-neurotoxin to interact with neuronal α7-nAChR with nanomolar affinity. 
Interestingly however, haditoxin lacked the helix-like segment cyclized by the 
fifth disulfide bridge at the tip of loop II of long-chain α-neurotoxins, hitherto 
considered critical for binding to neuronal α7-receptors. It is therefore likely that 
haditoxin, which shares a common tertiary fold with α-neurotoxins and κ-
neurotoxins may have other functional determinants for recognizing neuronal α7-
receptors. 
Finally, we have successfully expressed recombinant haditoxin which had also 
exhibited potent neuromuscular blockade. Further structure-function relationship 
studies are in progress. Delineating the structure-function relationship of this 
protein will help us to understand in great detail how a dimeric neurotoxin interacts 
with muscle nicotinic receptors as well as to identify the novel structural elements 
responsible for binding of a neurotoxin with neuronal nicotinic receptors. Thus, the 
novel ligand, haditoxin can lead to opening of new avenues for future studies that 
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1.1   Poisons to potions 
Poisonous or venomous organisms are usually associated with fascination, fear and 
myths for mankind throughout history. These organisms are widely spread throughout 
the animal kingdom, comprising more than 100,000 species distributed among all 
major phyla, such as chordates (reptiles, fishes, amphibians, mammals), echinoderms 
(starfishes, sea urchins), mollusks (cone snails, octopi), annelids (leeches), nemertines, 
arthropods (arachnids, insects, myriapods) and cnidarians (sea anemones, jellyfish, 
corals) (Calvete et al, 2009). To survive in a competitive environment nature herself 
has provided some solutions by way of evolutionary peptide engineering in venom 
glands of these animals. Poisons or venoms have evolved with the main purpose, to 
help the venomous animals to subdue, immobilize and kill their prey or to defend 
themselves through chemical means. Thus, venom represents an adaptive trait and an 
example of convergent evolution (Fry et al, 2006, Fry et al, 2008; Fry et al, 2009). 
Venoms are a deadly mixture of proteins and peptide originated by natural selection 
process. These proteins and polypeptides aim a wide range of physiological targets in 
the prey affecting the major organ systems and thereby death. Hence, venoms are a 
rich and abundant source of pharmacologically active proteins and peptides which are 
also known as toxins. Therefore, the chances of finding bioactive components are 
extremely high in venoms compared to any other tissue or organ where the proteins 




secrete out and exert the function somewhere else (Kini, 2010). Although primary 
research on venoms and toxins have focused mainly to find ways and means to 
neutralize the toxicity and adverse effects of envenomation, but the medicinal value of 
venoms and toxins are well documented since ancient times (Harvey et al, 1998; Koh 
et al, 2006). However, extensive research on venom toxins has only been performed 
for the last few decades with an aim to develop therapeutic agents and molecular 
probes. This was motivated after the isolation of a bradykinin-potentiating peptide 
from the venom of the Brazilian viper Bothrops jararaca (this was further developed 
to the antihypertensive drug captopril) in 1950’s (Rocha e Silva et al, 1949; Fernandez 
et al, 2004) as well as in the early 1960’s the discovery of the curaremimetic 
neurotoxin α-bungarotoxin from the venom of the banded krait (Bungarus 
multicinctus) (Chang and Lee, 1963), which pioneered the identification and isolation 
of the nicotinic acetylcholine receptor, the first and most well characterized receptors 
till today (Langley, 1907 Katz  and Thesleff , 1957; Changeux, 1990). Hereafter, 
research on venoms and toxins has also been carried out to determine the mode and 
mechanism of action of the toxins, to develop specific research tools that are useful in 
understanding normal physiological processes at both cellular and molecular levels as 
well as to develop prototypes of pharmaceutical agents based on the structure-function 
relationship of the toxins. 
Venoms represent an enormous and unexplored pool of pharmacologically active 
components. This reservoir is spread among the 700 or so known species of Conus, the 





ca. 37,000 known species of spiders, from which one can have a knowledge of the 
huge cornucopia of the bioactive molecules accumulated by nature (Calvete et al, 
2009). Because of the high selectivity and affinity of venom peptides towards the 
molecular targets modulating various physiological processes they form ideal 
candidates as lead molecules for drug design and development. There are many 
success stories where deadly toxins have been fashioned into lifesaving drugs (Harvey 
et al. 1998; Ménez, 2002; Ménez et al, 2006). Starting from the antihypertensive drug 
captopril, an angiotensin converting enzyme (ACE) inhibitor (from the Brazilian pit 
viper, Bothrops jararaca) to the recently developed, potent analgesic ziconotide (from 
the marine cone snail Conus magus), several drugs have had humble origins from the 
pharmacopoeia present in animal venoms. Moreover, these naturally occurring 
biomolecules have provided useful probes in deciphering the molecular details of 
normal physiological processes and hence contributed to several aspects of life. 
Furthermore, they have also provided excellent insight into the evolution of different 
families of venom proteins and protein-protein interactions in general, which open up 
yet other appealing and important fields of study. Clearly, rather than the intended 
offensive and defensive purposes of the toxins, they go a long way for the benefit of 




Thus the contributions of toxins deserve much more credit than we give them! 





1.2   The enigmatic serpents: Snakes 
Snakes and their venom have been of great interest historically representing love and 
hatred, good and evil, life and death, medicine and poison. According to the modern 
taxonomic system, snakes belong to the class Reptilia, order Squamata and sub-order 
Serpentes. They have evolved from either burrowing or aquatic lizards probably 
during the Cretaceous age (100 to 120 million years ago) (Mc Dowell, 1972; Harris, 
1991; Durand, 2004). During the Miocene period (less than 30 million years ago) in 
response to the rapid shift in prevailing environmental conditions snakes evolved the 
strategy of rapid locomotion and passive immobilization (Savitzky, 1980). The first 
venom producing apparatus known as, Duvernoy’s gland was evolved during this 
period. Subsequently, during the course of evolution these glands were converted to 
the specialized and advanced venom glands associated with the venom delivery 
apparatus like the fangs in the venomous snakes. Living snakes are found on every 
continent except for Antarctica and few islands such as Ireland, Iceland, and New 
Zealand (Conant and Collins, 1991). Fifteen families are currently recognized, 
comprising 456 genera and over 2,900 species (Serpentes, ITIS, 2008; TIGR Reptile 
Database, 2008), of which 1300 species are known to be venomous (Phelps, 1981; 
Hider et al, 1991; Gold et al, 2002). All of the venomous snakes belong to the 
superfamily Colubroidea (Lawson et al, 2005; Pyron et al, 2011). These venomous 
colubroids are responsible for approximately 20,000–94,000 human fatalities every 
year (Kasturiratne et al, 2008). The superfamily Colubroidea consists of seven families, 
which are- Colubridae, Elapidae, Homalopsidae, Lamprophiidae, Pareatidae, 




2009; Pyron et al, 2011). The Colubridae includes the rat snakes, garter snakes, and 
other common snakes. Members of this family can be found in all parts of the world 
(Savitzky, 1980). Colubrids produce small volumes of venom and their venom 
delivery apparatus is poorly developed (White, 1998; Cogger, 2000; O'Shea, 2005). 
The Elapidae includes two subfamilies- the Elapinae (cobras, mambas, kraits, coral 
snakes) and the Hydrophiinae (sea snakes). Elapids are well represented in parts of 
Asia, Africa, America, Australia, Indian and Pacific oceans (Shine, 1998). They 
possess short, fixed fangs in the front of the mouth (Fairley, 1929a,b; O'Shea, 2005). 
The Viperidae includes three subfamilies- Azemiopinae (which include only the Fea's 
viper), Crotalinae (rattlesnakes, cottonmouths, mostly New World vipers), and 
Viperinae (which includes most of the Old World vipers). Species belonging to the 
Viperidae family can be found in parts of Africa, Europe, Asia, North America and 
South America (Harris, 1991). The venom delivery apparatus of the viperids is very 
advanced with retractable fangs (Fairley, 1929a; O'Shea, 2005). 
 
1.2.1    Ophiophagus hannah: King of the serpents 
This study involves the characterization of novel proteins isolated from the venom of 
Ophiophagus hannah, an elapid snake. It is also known as king cobra because of its 
size, it is the longest venomous snake in the world, growing to a maximum length of 
18 feet (Figure 1.1 A and B). King cobra has a relatively long average lifespan of up 
to 25 years (Veto et al, 2007).  These snakes are widely distributed in the dense rain 










Figure 1.1: Ophiophagus hannah (king cobra) and its geographical distribution. 
 
(A) An adult king cobra showing its hood, photo provided by Michael D. Kern 
(www.thegardensofeden.org), CA, USA, (B) A juvenile king cobra, photo provided by 
Mr. Peter Mirtschin, Venom Supplies Pty. Ltd., Australia.  (C) Map showing the 









(Tan and Saifuddin, 1989) (Fig 1.1 C). The snake preferentially feeds on other 
venomous and non-venomous snakes, hence it is named as Ophiophagus (in Latin, 
‘Ophis’ meaning ‘snake’ and ‘phagein’ meaning ‘eat’) (Coborn, 1991). 
King cobra is regarded as one of the deadliest snakes in the world. It can deliver a 
large quantity of venom in one bite (420 mg dry weight per milking) (Ganthavorn, 
1969). The LD50 of the crude venom of O. hannah in mice is 1.5 to 2.18 mg/kg via 
subcutaneous injection (Broad et al, 1979) and 1.28 mg/kg via intravenous injection 
(Ganthavorn, 1969). The lethality of O. hannah venom is relatively low when 
compared to some of the other elapids (0.025 to 1.2 mg/kg) and sea snakes (0.09 to 
0.71 mg/kg) (Ganthavorn, 1969; Broad et al, 1979) which is compensated by the large 
volume. However, in a recent toxicology study the LD50 of Chinese king cobra venom 
was found to be 0.34 mg/kg (Gopalakrishnakone and Chou, 1990).  
The king cobra can be highly aggressive if provoked. There have been several well 
reported O. hannah envenomation cases (Ganthavorn, 1971; Wetzel and Christy, 
1989; Pe et al, 1995; Gold and Pyle, 1998; Veto et al., 2007). One third of the reported 
35 cases of O. hannah envenomation have been fatal (Gold and Pyle, 1998). The 
venom of the king cobra consists of neurotoxins primarily, but it also contains 
cytotoxic compounds. The initial symptoms observed upon envenomation are 
drowsiness, nausea, headache, abdominal pain, hypotension and occasionally shock 
followed by massive swelling of bite areas and extensive tissue necrosis is observed 






1.3   Snake venom: The complex mixture 
Snake venom is highly modified saliva that is secreted from the venom glands of 
snakes. It is a complex mixture of pharmacologically active proteins and polypeptides. 
Peptides and proteins constitute over 90% of the dry weight of venom. Apart from 
proteins, snake venoms also contain non-protein low molecular weight compounds 
which include metal ions, lipids, nucleic acids, amino acids, carbohydrates and 
biological amines (Hider et al, 1991). The most common metal ions found in snake 
venoms are magnesium, calcium and zinc, while copper has been detected in certain 
venoms (Friederich and Tu, 1971). These metal ions are mainly associated with the 
proteins components and probably they serve the role of enzyme cofactors. 
Additionally, some venom, like that of the mamba contains high levels of bioactive 
amines like- acetylcholine and 5-hydroxytrypamine, which most likely play a 
defensive role as a potent algesic agent (Welsh, 1967). Another important non-protein 
constituent of several snake venoms is citrate, presumably serving a self-protective 
role by inhibiting the deleterious activity of venom enzymes within the venom gland 
(Freitas et al, 1992; Odell et al, 1999). Although the functional role of non-protein 
venom constituents should not be neglected; however, from the perspective of a 
venom scientist, the protein components are of major interest. They constitute of a 
highly evolved and organized arsenal of proteins acting on diverse molecular targets 
involving the vital processes of a normal physiological systems. Venom proteins 
mainly exert cytotoxic, neurotoxic or hemotoxic effects. Moreover, these proteins bind 
to their targets with high selectivity and affinity. Therefore, snake venom acts as a 




interests (Dufton, 1993; Harvey, 2002; Pal et al, 2002; Lewis and Garcia, 2003; Bogin, 
2005; Koh et al, 2006; Calvete et al, 2009; Kini, 2010). Single snake venoms may 
contain more than hundred of different proteins. However, most of the proteins belong 
to a small number of structural superfamilies (Menez 1998; Kordis and Gubensek, 
2000). A superfamily is defined as a collection of proteins, in which all members have 
a similar three-dimensional structure, but may differ from each other with respect to 
their physiological targets and pharmacological effects. In a broader spectrum snake 
venom protein families are divided into enzymatic (Table 1.1 and Fig. 1.2) and non-
enzymatic (Table 1.2 and Fig. 1.3) superfamilies. Snake venoms are rich in enzymatic 
proteins. More than 20 different enzymes are known to be present in snake venoms. 
Venoms of the viperids and crotalids are primarily enzymatic (80-95%) whereas, 
elapids contain relatively lower amounts (25-70%) followed by hydrophid venoms 
with lowest amounts of enzymatic proteins (~20%) (Hider et al, 1991). The 
pharmacological effects of these enzymes are listed in Table 1.1. The major 
components of the enzymatic venom proteins are: phospholipases A2 (PLA2s), L-
amino acid oxidase (LAO), serine proteases, snake venom metalloproteases (SVMPs), 
acetylcholinesterases (AChEs), Venom factors (VFs) and phosphodiesterases (PDEs) 
(for reviews, see Iwanaga and Suzuki, 1979; Bailey, 1998). The non-enzymatic venom 
proteins are relatively smaller in size than the enzymatic ones. The predominant non-
enzymatic venom proteins include- three-finger toxins (3FTXs), C-type lectin-related 
proteins (CLPs), serine proteinase inhibitors (SPIs), disintegrins, helveprins/CRISPs, 





Phospholipase A2 (PLA2) Abundant in elapidae, hydrophidae,
viperidae and crotalidae venoms
Esterolytic enzymes hydrolyzing 3-sn-phosphoglycerides. They are composed of ~130 amino
acid residues with 7 disulfide bridges. Unlike mammalian PLA2, snake PLA2 enzymes induce
various pharmacological effects like pre- and postsynaptic neurotoxicity, myotoxicity,
cardiotoxicity, hemolytic activity, anticoagulant activity, antiplatelet activity, hypotension,
hemorrhage and edema.
L-amino acid oxidase (LAO) Found widely in elapidae, viperidae and
crotalidae venoms
Flavo enzymes catalyzing the conversion of L-amino acid substrates to α-keto acids. LAOs from
snake venoms also induce pharmacological effects like induction or inhibition of platelet
aggregation, association with mammalian epithelial cells and induction of apoptosis and anti
bacterial activity. They are composed of ~500 residues with 2 subunits.
Serine Proteinases Found widely in elapidae and viperidae
venoms
Snake venom serine proteinases, in addition to their contribution to the digestion of prey, affect
various physiological functions. They affect platelet aggregation, blood coagulation, fibrinolysis,
the complement system, blood pressure and the nervous system. They are made up of 240 amino
acid residues with 6 disulfide bridges.
Metalloproteinases Found widely in elapidae and viperidae
venoms
Snake venom metalloproteinases are endoproteolytic enzymes. Their catalytic activity is
dependent on Zn2+ ions. In addition to their role in the digestion of prey, they exhibit several
biological effects, including haemorrhagic, pro-coagulant, anticoagulant and antiplatelet effects.
They consists of ~200 residues with 3-4 disulfide bridges.
Acetylcholinesterases Primarily in elapidae venoms The venoms of most Elapidae snakes contain large amounts of a highly active non-amphiphilic
monomeric AChE. They regulate the cholinergic transmission in the prey. They are made up of
~550 residues and 5 disulfide bridges, they can exist as monomer, dimer or tetramer.
Venom factors Primarily in elapidae venoms Venom factors activates the complement system . They consist of three  polypeptide chains each 
with 1200 residues and 13 disulfide bridges.
Phosphodiesterases Ubiquitously present in all venoms Snake venom phosphodiesterase shares a number of mechanistic features in common with the
nucleotidyl transferases. All of these enzymes contain zinc, are activated by magnesium, and
catalyze α-β phosphoryl bond cleavage.
Table 1.1: Enzymatic proteins from snake venoms
                  

















Figure 1.2: Representative examples of major families of enzymatic snake venom proteins. 
 
(A) phospholipase A2: notexin (1AE7), (B) serine proteinase: TSV-PA (1BQY), (C) 
metalloproteinase: atrolysin (1ATL), (D) model of acetylcholinesterase from Bungarus candidus 
(Q92035) built based on acetylcholinesterase from Torpedo californica (2ACE), (E) model of L-
amino oxidase from Notechis scutatus (AAY89681), (F) model of Austrelaps superbus venom 
factor (AY903291) built base on human complement component C3 (2A73). The protein data 
bank and/or GenBank accession numbers are given in parentheses. The structures are α-carbon 







Abundant in elapidae and hydrophidae venoms Members show similar molecular scaffold but varying functions like neurotoxicity, cardiotoxicity, 
anticoagulant activity and antiplatelet aggregation activity. Similar structures are found in a wide 
range of species from plants to mammals.
C-type Lectin-related 
proteins
Mostly found in viperidae and crotalidae venoms These anticoagulant proteins inhibit prothrombin activation by non-enzymatic mechanisms.
Serine proteinase
inhibitors
Distributed widely in many snake venoms They range in size from ~ 5000 Da to ~ 6000 Da and has  three disulphide bridges, and belong to 
the Kunitz pancreatic trypsin-inhibitor family. As all the proteinases in blood coagulation and 
fibrinolysis are serine proteinases, these group polypeptides are thought to be potential 
anticoagulants.
Disintegrins Abundant in viperidae venoms Bind to integrins through the RGD motif and prevent platelet aggregation.
Helveprins/CRISP Identified in all families of snake venoms Cyeteine-rich secretory proteins (CRISPs) or helothermine-related venom proteins are proteins 
with 16 conserved Cys residues. They are known to modulate the activity of various ion channels.
Waprins Isolated from elapidae snakes Oxyuranus
microlepidotus and Naja nigricollis
Whey acidic proteins related proteins (waprins) have 8 conserved Cys residues forming 4 disulfide 
bonds. Omwaprin shows anti-bacterial activity.
Vespryns First identified from Ophiophagus hannah venom. 
Also found in other elapidae and viperidae venoms 
Ohanin shows potent hypolocomotion and hyperalgesia in animals.
Bradykinin-
potentiating peptides
Reported from viperidae and crotalidae venoms only They are 9 to 13 residues long which are rich in Pro residues. They induce hypotension by acting 
on smooth muscles. 
Natriuretic peptides Reported from the venoms of Dendroaspis 
angusticeps, Micrurus corallinus, Pseudechis 
australis and Trimeresurus gramineus
Potent hypotensive and vasorelaxant properties.
Sarafotoxins Isolated from the venom of Atractaspis engaddensis These isopeptides are structurally and functionally related to mammalian endothelins. They are 
potent vacoconstrictors acting on cardiac muscles and brain.
Nerve growth factors 
(NGF)
First identified from the venom of Agkistrodon
piscivorus (cottonmouth, water moccasin). Later 
isolated from venoms of viperidae, crotalidae and 
elapidae.
Divided into four groups, they range in size from ~ 25,000 Da to ~ 35,000 Da and may exist as 
homodimer and contain carbohydrate moiety. The exact role of these molecules in venoms is 
unknown. However, some suggest that they may act as carriers of other molecules like neurotoxins 
to the CNS.
Table 1.2: Non-enzymatic proteins from snake venoms 






            
            
   
 
Figure 1.3: Representative examples of major families of non-enzymatic snake venom  
                    proteins. 
 
(A) 3FTXs: α-cobratoxin (2CTX), (B) C-type lectin related proteins: factor IX binding 
protein (1IOD), (C) serine-proteinase inhibitors: dendrotoxins (1DTX), (D) disintegrins: 
echistatin (2ECH), (E) Sarafotoxins: SRTX-b (1SRB), (F) helveprins / CRISPs:  triflin 
(1WVR), (G) waprins: nawaprin (1UDK), (H) vespryns: model of ohanin built base on 
PRY/SPRY domain (2FBE) . The protein data bank accession numbers are given in 
parentheses. The structures are α-carbon solid ribbon representation and presented with the 




peptides (BPPs) and natriuretic peptides (NPs) (Harvey, 1991; Kini, 2002; Torres et al, 2003). 
A brief description of these venom protein superfamilies is compiled in the Table 1.2. The scope 
of this thesis limits this review to just a description of the three-finger toxin family, because the 
protein being characterized belongs to this family. 
 
1.4   Three-finger toxin (3FTX) family 
Three-finger toxins (3FTXs) are the largest group of non-enzymatic snake venom proteins 
(Dufton and Hider, 1988; Harvey, 1991; Kini, 2002; Kini and Doley, 2010). These proteins 
consist of 60-75 amino acids residues (Tsetlin, 1999). They are most commonly and abundantly 
found in the venoms of elapid and hydrophiid snakes. Recently, our laboratory has also 
demonstrated the presence of 3FTXs in colubrid venoms (Pawlak et al, 2006; Pawlak et al, 
2009) and 3FTX transcripts have also been found in the venom gland transcriptome of viperid 
snakes (Pahari et al, 2007; Junqueira-de-Azevedo et al, 2006; Jiang et al, 1987). The proteins in 
this family of toxins share a common structural scaffold of three β-sheeted loops emerging from 
a central core (Fig. 1.4) (Kini, 2002; Nirthanan and Gwee, 2004; Tsetlin, 1999; Kini and Doley, 
2010). Because of this appearance, they resembles the three outstretched fingers of the hand 
hence, this family of proteins is referred as the three-finger toxin family. There are no α-helical 
segments in three-finger toxins and a multistranded β-structure is the predominant feature of 
these molecules (Tsetlin, 1999). Each toxin is essentially a flat “leaf-like” molecule with a slight 
concavity, the plane being determined by the extensive β-sheet (Tsetlin, 1999; Servent; Menez, 
2001).  
Despite the overall similarity in structure, these proteins have diverse functional properties (Fig. 




1990; Grant and Chiappinelli, 1985; Jerusalinsky and Harvey, 1994; Tsetlin, 1999) 
cytotoxins/cardiotoxins interacting with the cell membranes (Louw and Visser, 1978; Kumar et 
al, 1997; Bilwes et al, 1994), calciseptine and related toxins that block the L-type Ca2+ channels 
(de Weille et al, 1991; Albrand et al, 1995), dendroaspins, which are antagonists of various cell-
adhesion processes (McDowell et al, 1992), fasciculins that inhibit the enzyme, 
acetylcholinesterase (Cervenansky et al, 1991), and β-cardiotoxin  antagonizing the β-
adrenoceptors (Rajagopalan et al, 2007). The subtle variations in their structures, such as the 
presence of extra disulfide bonds, number of β-sheets present, differences in size and overall 
conformation (twists and turns) of the loops and longer C-terminal and/or N-terminal extensions 
(Ricciardi et al, 2000), may contribute to the observed functional diversity as well as specificity 
of these toxins (Ohno et al, 1998).  
However, there are a number of “orphan groups” of 3FTXs whose molecular target in the victim 
and hence their functional roles in the snake venoms are not yet known (Fry et al, 2003). Hence, 
every new 3FTX isolated from the snake venom should be considered as a new challenge, as it 






























  Figure 1.4: Three-dimensional structural similarity among 3FTXs from snake venoms. 
 
(A) Erabutoxin a (1QKD), (B) α-bungarotoxin (2ABX), (C) cardiotoxin V4 (1CDT), (D) κ-
bungarotoxin (1KBA), inset, dimer, (E) candoxin (1JGK), (F) fasciculin 2 (1FAS), (G) 
muscarinic toxin MT-2 (1FF4), (H) FS2 toxin (1TFS), (I) dendroaspin (1DRS). The protein 
data bank codes are stated in parentheses. All 3FTXs share a common fold: three finger-like 
loops emerging from the core at the top of the molecules, which contains four conserved 
disulphide bridges (shown in yellow). Some toxins, such as α-bungarotoxin (B) and κ-
bungarotoxin (D) have the fifth disulphide bridge in loop II. In contrast candoxin (E) has the 
fifth disulphide bridge in loop I. Three β-sheeted loops numbered right to left as loop I, II and 
III respectively. The β-sheet structure is shown in blue. Figures were adapted from Kini, 2002 


















Figure 1.5: Functional diversity of three-finger toxins. 
 
Six different functional sites elaborated on a common three-finger motif of three-finger toxins: 
(A) neurotoxic site of erabutoxin-a; (B) cytolytic site of cardiotoxin; (C) acetylcholine 
esterase (AChE) inhibitory site of fasciculin; (D) hypotensive site of calciseptine; (E) 
analgesic site of hannalgesin; (F) antiplatelet site of mambin.  The functional site(s) are shown 
in red on the green α-carbon back structure of the respective toxins. All structures are shown 






1.5   The ubiquitous three-finger fold 
Interestingly, the three-finger fold is not only restricted with snake venom toxins. This fold has 
been associated with protein from mammalian and non-mammalian organisms. It is observed 
that many non-toxic proteins have adopted this three-finger fold like- mammalian Ly-6 family 
of cell-surface accessory proteins expressed in immune system cells (Fleming et al, 1993; 
Kieffer et al, 1994; Gumley et al, 1995). This fold has also been utilized by the extracellular 
domain of the human complement regulatory protein CD59 (Fletcher et al, 1994), a domain of 
the receptor for the urokinase-type plasminogen activator (Ploug and Ellis 1994; Llinas et al, 
2005), epidermal neuromodulators SLURP-1 & SLURP-2 (Chimienti et al, 2003; Arredondo et 
al, 2006), bone morphogenetic protein IA (Kirsch et al, 2000), type II activin receptor 
(Greenwald et al, 1999), xenoxins from frog (Xenopus laevis) skin secretions (Kolbe et al, 
1993) pheromones like Plethodontid Modulating Factor (PMF) in salamander (Palmer et al, 
2007), plasma protein like trout toxin 1 in rainbow trout (Gumley et al, 1995) and HEP21 from 
hen egg white (Nau et al, 2003). A few plant lectins like wheat germ agglutinin (Drenth et al, 
1980) and hevein (Gidrol et al, 1994) is also known to possess the unique three-finger fold. 
Interestingly, lynx1 (Miwa et al, 1999 and Ibanez-Tallon et al, 2002) and lynx2 genes (Dessaud 
et al, 2006) encodes for two non-toxic three-finger proteins, which are highly expressed in 
murine nervous system. They have been found to act as novel modulators of neuronal nicotinic 
acetylcholine receptors in vitro (Miwa et al, 1999). The protein lynx1 was found to co-localize 
with both, α4β2- and α7-subtypes of nicotinic receptors. Further, it was also found to increase the 
effective concentration of acetylcholine required for activation of these receptors as well as slow 
their recovery from desensitization (Ibañez-Tallon et al, 2002). Of particular interest, this is the 




nicotinic receptor function. Moreover, these proteins as well as the Ly-6 family of proteins 
share the common structural patters (with respect to the cysteine bonding) with the non-
conventional three-finger toxins. Furthermore, all these family of proteins share a common gene 
organization, which raises the possibility of their evolutionary relationship. An ancestral gene 
encoding for the three-finger fold proteins might have been duplicated during evolution and 
recruited to the venom gland (Fry, 2005). Further the descendents of this gene has undergone 
accelerated evolution via extensive gene duplications in the protein-coding regions (Nakashima 
et al, 1993; Nakashima et al, 1995; Nobuhisa et al, 1996; Kini and Chan 1999; Fujimi et al, 
2003; Doley et al, 2009; Kini and Doley, 2010), leaving only parts essential for the integrity of 
the three-finger fold, at the same time manipulating the functional residues. 
 
1.6   Three-finger toxins interacting with the cholinergic systems 
Snake venoms are rich in toxins that are well known to interfere with cholinergic transmission 
(Chang and Lee, 1963; Karlsson 1966; Lee, 1972; Chang, 1979; Karlsson, 1979) in the central 
and peripheral nervous systems. Snake venom toxins targeting the cholinergic system can be 
subdivided into three major classes- Muscarinic toxins, Fasciculins and Neurotoxins. 
 
1.6.1  Muscarinic toxins 
Muscarinic toxins were originally isolated from African mamba snake, Dendroaspis 
angusticeps (Adem et al, 1988) and are predominantly found in mamba venoms (Bradley, 2000; 
Servent and Fruchart-Gaillard, 2009). They are the first protein ligands to interact with the 
muscarinic acetylcholine receptors (mAChRs). Hence, they were named as muscarinic toxins 




superfamily, which comprises of seven transmembrane helices with extra- and intra-cellular 
loops. As the name suggests, GPCRs act through GTP binding proteins (G proteins) to stimulate 
or inhibit intracellular effector systems (Segalas et al, 1995, Karlsson et al, 2000; Jerusalinsky 
and Harvey, 1994). There are five subtypes of mAChRs (M1 to M5), depending on their 
different G protein coupling properties (Caulfield and Birdsall 1998), which control a large 
number of physiological processes (Segalas et al., 1995; Karlsson et al., 2000).  mAChRs have 
been implicated as important drug targets in disorders like schizophrenia, depression, drug 
addiction, Parkinson’s and Alzheimer’s diseases (Segalas et al, 1995; Bradley, 2000; Scarr and 
Dean 2008; Langmead et al, 2008). Although currently there are many conventional small 
molecular ligands available for these receptors, but all of these bind non-specifically with more 
than one subtype of mAChR (Bradley, 2000; Lee et al, 2001). As a result of this, it was difficult 
to assess the functional role of the individual subtypes of mAChRs in different tissues as more 
than one subtype of the receptor may exist simultaneously in many organs (Jerusalinsky and 
Harvey, 1994, Karlsson et al., 2000; Adem and Karlsson, 1997) as well as to develop specific 
drugs against a disease involving a particular subtype of mAChRs without affecting the normal 
activity of the others. The only ligands to show subtype specificity for these receptors are the 
naturally occurring snake venom muscarinic toxins (Fig. 1.6). 
MTs belong to the snake venom three-finger toxin family. About 10 different MTs have been 
isolated from the venom of either Dendroaspis angusticeps or Dendroaspis polylepis. The 
sequence of the MTs vary in length, each containing 65–66 residues, eight cysteine residues 




Name Organism Accession #
Loop I Loop III
Loop II
MT1  D. angusticeps  AAB31994  LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYR-DVINCCGTDKCNK 65 
MT2  D. angusticeps  P18328    LTCVTTKSIGGVTTEDCPAGQNVCFKRWHYVTPKNYDIIKGCAATCPKVDNN-DPIRCCGTDKCND 65 
MT3  D. angusticeps  P81031    LTCVTKNTIFGITTENCPAGQNLCFKRWHYVIPRYTEITRGCAATCPIPENY-DSIHCCKTDKCNE 65 
MT4  D. angusticeps  Q9PSN1    LTCVTSKSIFGITTENCPDGQNLCFKKWYYIVPRYSDITWGCAATCPKPTNVRETIHCCETDKCNE 66 
MT7  D. angusticeps  Q8QGR0    LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYR-DVINCCGTDKCNK 65 




Consensus sequence  
 
LTCV----I---T-E-CP-GQN-CFK---Y----------GC-ATCP-------I-CC-TDKCN- 
Figure 1.6: Muscarinic toxins from mamba venom. 
(A) Muscarinic toxins from Dendroaspis angusticeps
(green mamba) and D. Polylepis (black mamba) venoms.
The consensus sequences are highlighted in black, the
disulfide bridges are shown in black lines and the loop
regions are indicated by black solid arrows. (B) Structure
of muscarinic toxin 2 (MT2) isolated from Dendroaspis























The three dimensional structure of MTs along with the highly conserved sequences are shown 
in figure 1.6. Despite of the similarity in their primary and tertiary structures, MTs exhibit clear 
functional differences and display distinct interaction profiles with the different subtypes of 
muscarinic receptors (Karlsson et al., 2000). Moreover, MTs have a variety of functional 
characteristics, with the competitive antagonistic effect, they can also act as allosteric modulator 
or agonist (Servent; Fruchart-Gaillard, 2009). This has made them invaluable scientific tools for 
therapeutic applications.  
 
1.6.2  Fasciculins 
Fasciculins do not interact with any cholinergic receptors but they inhibit the enzyme, 
acetylcholine esterase (AChE). Like MTs, fasciculins were also isolated from the venom of 
mambas. The first one was isolated from the venom of Dendroaspis angusticeps (Viljoen and 
Botes, 1973; Karlsson et al, 1984) which was followed by other closely related proteins from 
Dendroaspis polylepis and Dendroaspis viridis (le Du et al, 1996). Fasciculins are composed of 
about 61 amino acid residues with four disulfide bridges and similar to other 3FTXs composed 
of predominantly β-sheet structure (Fig. 1.7 A). Fasciculins are potent inhibitors of the enzyme 
acetylcholinesterase (AChE) and they bind with a 1:1 stoichiometry to the peripheral anionic 
site of the enzyme (le Du et al, 1996). AChE is a synaptic enzyme whose principal role is the 
termination of impulse transmission at cholinergic synapses by the rapid hydrolysis of the 
neurotransmitter acetylcholine. By inhibiting this enzyme, fasciculins cause severe, generalized 
and long-lasting fasciculation of skeletal muscles due to the accumulation of acetylcholine in 

















Figure 1.7: Fasciculins from snake venom 
 
(A) Structure of Fasciculin 1 from the green mamba Dendroaspis angusticeps (1FAS). The important residues involved in interactions 
with the target molecule (AChE) are shown in red (CPK representation) and the conserved cysteines are represented in as sticks (B) 





Torpedo californica (Pacific electric ray) and fasciculin-II  (FAS-II)  from  D. angusticeps  
(eastern green mamba)  shows a stoichiometric complex with one molecule of FAS-II bound to 
each AChE subunit (Fig. 1.7 B). FAS-II binds to the peripheral anionic site of the enzyme and 
seals the narrow gorge leading to the active site. The structures of the two partners in the 
complex appear similar to their monomeric structures showing that there are no conformational 
changes associated with complex formation. The high affinity of FAS-II for AChE (Ki ~ 0.1 
nM) is due to a remarkable surface complementarity involving a large contact area (~ 2000 Å2) 
(Harel et al, 1995). Most of the residues involved in important contacts with the target enzyme 
are located on the first and second loops of the toxin (Fig. 1.7 A).  
 
1.6.3  Neurotoxins 
Neurotoxins are extremely important components of snake venom as they are useful in the 
effective capture of prey. They cause rapid paralysis of the voluntary muscles and, hence, 
inhibit movement and respiration followed by death. Depending on the site of action snake 
neurotoxins are generally classified as either postsynaptic or presynaptic. The three-finger 
neurotoxins are mainly postsynaptic toxins. They are widely referred to as 'curare-mimetic 
toxins' due to their similarity in action to the arrow poison curare which is a competitive 
nicotinic acetylcholine receptor (nAChR) antagonist (Endo & Tamiya, 1991). These 
neurotoxins bind with high affinity and specificity to acetylcholine binding sites on skeletal 
muscle nicotinic receptors (Changeux et al, 1970). Over the years, more than 100 α-neurotoxins 
have been isolated from snake venom which contributed significantly to isolation and 




Depending on the target receptors as well as primary structures, these neurotoxins can be 
broadly divided into various groups such as- Curaremimetic or α-neurotoxins, κ-neurotoxins 
and non-conventional or weak toxins. The α-neurotoxins can be subdivided into short-chain and 
long-chain α-neurotoxins depending on the primary structural features (amino acid residues and 
number of disulfide bridges). Short-chain α-neurotoxins are composed of 60-62 amino acid 
residues with four conserved disulfide bonds (Fig. 1.8 A) and long-chain α-neurotoxins are 
composed of 66-74 amino acid residues and four conserved disulfide bonds with an additional 
disulfide bond in the tip of loop II (Fig. 1.8 B and C) (Endo and Tamiya, 1991; Servent and 
Menez, 2001). Both short-chain and long-chain α-neurotoxins target muscle (αβγδ or α1 
subtype) nAChRs (Nirthanan and Gwee, 2004; Tsetlin, 1999; Changeux, 1990). Functional 
difference lies in the kinetics of association and dissociation between the two types of α-
neurotoxins with the skeletal muscle nicotinic receptor (Tsetlin, 1999). It was shown that short-
chain neurotoxins tend to associate about 6-7 folds faster with the receptor and dissociate 5-9 
fold faster than long-chain neurotoxins (Chicheportiche et al, 1975). In addition, long-chain 
neurotoxins, but not short-chain neurotoxins, also target neuronal α7-nAChRs associated with 
neurotransmission in the brain (Servent et al, 1997; Servent et al, 2000). While lacking the extra 
disulfide bridge, Laticauda colubrina toxins (Lc-a and Lc-b) is considered to be a long-chain 
neurotoxin based on high sequence homology with other long-chain aneurotoxins (Endo & 
Tamiya, 1991; Servent et al, 1997). However, functionally they behave as short-chain 
neurotoxins, showing high affinity towards muscle receptors and poor affinity towards neuronal 








Figure 1.8: Snake toxins that interact with nicotinic acetylcholine receptors. 
 
Representative examples of: (A) erabutoxin-a (5EBX): short-chain α-neurotoxin (monomer); 
(B) α-bungarotoxin (1IDI): long-chain α-neurotoxin (monomer); (C) α-cobratoxin (2CTX): 
long-chain α-neurotoxin (monomer); (D) candoxin (1JGK): non-conventional toxin from 
elapid snake (monomer); (E) κ-bungarotoxin (1KBA): κ-neurotoxin (non-covalent 
homodimer), (F) irditoxin (2H7Z): non-conventional toxin from colubrid snake (covalent 
heterodimer). The protein data bank accession codes are stated in parenthesis. All toxins share 
a common three-finger scaffold that includes a core region cross-linked by four conserved 
disulfide bridges (shown in yellow). β-sheets are shown in cyan. The structures are α-carbon 






κ-Neurotoxins are first 3FTX reported to exist as a homodimeric complex (Fig. 1.8 E) (Dewan 
et al, 1994). These molecules are structurally similar to long-chain α-neurotoxins with five 
disulfide bonds (the additional one is in the tip of loop II). However, they have a shorter C-
terminal tail like the short α-neurotoxins, and intermediate number of (66) amino acid residues 
(Grant and Chiappinelli 1985; Fiordalisi et al, 1994). The κ-neurotoxins, such as κ-
bungarotoxin (Bungarus multicinctus), show specificity for other neuronal subtypes, α3β2- and 
α4β2-nAChRs (Grant and Chiappinelli, 1985; Wolf et al, 1988).   
Non-conventional toxins are not so well characterized class of 3FTXs. They consist of 62-68 
amino acid residues and five disulfide linkages. However, unlike the long-chain α-neurotoxins 
and κ-neurotoxins, the fifth disulfide linkage is present in the loop 1 (Fig. 1.8 D). The non-
conventional toxins showed low lethality (LD50 ~ 5–80 mg/kg) compared to the highly lethal α-
neurotoxins (LD50 ~0.04–0.3 mg/kg). Thus, this group of toxins has also been referred to as 
‘weak toxins’ (Utkin et al. 2001). However, this convention does not hold true for a few cases 
like γ-bungarotoxin and candoxin isolated from the venom of Bungarus multicinctus (Antil et al, 
1999; Nirthanan et al, 2002). Candoxin produced a potent neuromuscular blockade, but unlike 
α-neurotoxins this blockade was readily reversible. Additionally, candoxin also interacted with 
α7-nAChRs and the affinity is in nanomolar range (Nirthanan et al, 2002). 
All neurotoxins characterized to date exist as monomers with the exception of κ-neurotoxins 
from Bungarus sp. (Chiappinelli and Lee, 1985; Chiappinelli and Wolf, 1989), which are  non-
covalently linked homodimers that binds neuronal (α3β2 and α4β2), but not muscle 
(αβγδ) nAChRs. More recently, an article was published which was the first report of a covalent 
heterodimeric neurotoxin, irditoxin (Fig. 1.8 F) from the venom of Boiga irregularis, which 




study is the first to report the existence of a novel homodimeric short neurotoxin that interacts 
with nAChRs. 
 
1.7   Nicotinic Acetylcholine Receptors 
Nicotinic acetylcholine receptors (nAChRs) are member of the pentameric “Cys-loop” 
superfamily of Ligand-Gated Ion Channels (LGICs), also referred to as ionotropic receptors. 
These receptors are a group of intrinsic transmembrane ion channels which open in response to 
binding of a chemical messenger, referred as ligands. LGICs are divided into three 
superfamilies based on their structural organization (Fig. 1.9) (Le Novere and Changeux, 1999)- 
trimeric - made up with 3 homologous subunits, each with 2 transmembrane segments (eg. ATP 
gated channels); tetrameric - made up with 4 homologous subunits, each with 3 transmembrane 
segments (eg. glutamate activated cationic channels such as- NMDA receptors) and pentameric 
- made up with 5 homologous subunits, each with 4 transmembrane segments (eg. Cys loop 
superfamily such as- nAChRs, 5-HT3 receptors, GABAA receptors, glycine receptors).  
Nicotinic receptors are transmembrane, allosteric glycoproteins of molecular weight ~290 kDa, 
involved in fast ionic responses to acetylcholine (Grutter and Changeux, 2001; Karlin, 2002). 
They are composed of 5 homologous subunits arranged symmetrically around the ion channel 
perpendicular to the membrane (Fig 1.10 and 1.11). These subunits can be divided into α and 
non-α types. The principal component of the ligand binding site is formed by α-subunits. The 
non-α subunits constitute the complementary component of binding site or sometimes they 
provide structural integrity (Changeux and Edelstein, 1998; Corringer, et al, 2000; Itier and 
Bertrand, 2001) (Fig. 1.10 B). Each subunit can be divided into four domains: a large N-









Figure 1.9: Schematic representation of superfamilies of ligand-gated ion channels. 
 
A) trimeric receptors - ATP gated channels superfamily B) tetrameric - glutamate activated 






























                    Figure 1.10: Structure of the nicotinic acetylcholine receptors. 
 
(A) Schematic representation of the threading pattern of receptor subunits through the cell 
membrane. (B) A schematic representation of the quaternary structure, showing the 
arrangement of the subunits in the muscle-type receptor, the location of the two acetylcholine 
binding sites (between an α- and a γ-subunit, and an α- and a δ- subunit), and the axial cation-
conducting channel. (C) A cross-section through the 4.6 Å structure of the receptor 
determined by electron microscopy of tubular crystals of Torpedo membrane embedded in ice. 
Dashed line indicates proposed path to binding site. Figure was adapted from Karlin, 2002 and 











Figure 1.11 Schematic representations of nicotinic receptor and its subtypes. 
 
A) Drawing of the single α-subunit of nAChR. The glycosylation sites are represented in red 
and the intracellular phosphorylation sites are represented by pink diamond with P letter. The 
four transmembrane domains are named MI to M IV. The MII domains of all five subunits 
line the ionic pore. ACh symbol represents the biding site for the ligand acetylcholine B) 
nAChR, composed of 5 homologous subunits. The model represents muscle receptor with the 
stoichiometry (α1)2βγδ, but for clarity δ subunit is not shown. The ACh binding site is 
localized at the interface between two subunits. C) The subunit composition of various 
subtypes of nAChRs and respective ACh binding sites. Starting from left: 1) muscle or 
electric organ nAChR 2) heteropentameric neuronal nAChR with two types of subunits (α2, 
α3, α4, α6 and β2, β4) 3) neuronal homopentameric nAChR (α7, α8, α9) 4) ganglionic 
receptor 5) neuronal heteropentameric (four types of subunits) β3 can be replaced by α5 6) 




spanning pore composed of four trans-membrane helices (MI, MII, MIII, MIV), a large 
cytoplasmic loop between MIII and MIV and a smaller extracellular C-terminal domain, giving 
it a total length of about 160 Ǻ normal to the membrane plane (Fig. 1.10 A and 1.11 A). The N-
terminal domain is composed of 210-220 amino acid residues, which contains the characteristic 
“Cys-loop” consisting of 13 residues between Cys128-Cys141 (all numbering is according to 
Torpedo muscular receptor). This domain contains ligand binding site as well as glycosylation 
sites important for expression and secretion of the receptor (Ramanathan and Hall, 1999). In 
some species (e.g. mongoose (Barchan et al, 1992)) the glycosylation also offers resistance to α-
neurotoxins (Kreienkamp et al, 1994). The transmembrane domain is composed of 70 residues 
long hydrophobic region divided into 3 transmembrane segments of 19-27 amino acid residues 
called: MI, MII and MIII. MI segment is required for the assembling of subunits and a 
heterodimeric ligand-binding site formation (Wang et al, 1996). The ion channel pore is formed 
by the contribution of MII domains of all five subunits. The pore has a diameter of ~6.5 Å in the 
narrowest part and is ~3-6 Å long. It possesses 3 rings (extracellular, intermediate and 
intracellular) of negatively charged residues and one central ring of polar residues. These rings 
attract cations into the channel and also act as selectivity filers for them (Fig. 1.15 B) (Ashcroft, 
2000). The cytoplasmic domain contains phosphorylation sites. They are key mechanism in 
complex regulation of ion channel activity. It has been shown that a balance between kinases 
and phosphatases regulates tyrosine phosphorylation of the receptors at the cell surface in order 








1.8   Subtypes of nAChRs 
In vertebrates, huge variety of alpha and non-alpha subunit subtypes and combinatorial 
assembly of homo- and heteropentamers generates a wide diversity of receptor types (Fig. 1.11 
C). Very broadly, nicotinic receptors can be divided into two main families: the muscle and 
neuronal nAChRs (Corringer et al, 2000). 
 
1.8.1  Muscular type of nAChR 
The muscle type nicotinic receptor is well-characterized. It was discovered in Torpedo and 
Electrophorus in 1970 (Fig. 1.12). α-Bungarotoxin enabled purification of the receptor and its 
characterization further (Chang and Lee, 1963; Changeux et al, 1970).  Muscle nAChR consists 
of a combination of α, β, δ and γ or ε subunits in the stoichiometry of (α)2βγδ or (α)2βεδ in the 
embryonic or adult receptor, respectively (Fig. 1.12) (Mishina et al, 1986). Muscle nAChRs are 
densely distributed on the postsynaptic membrane of the neuromuscular junction and they are 
involved in the neuromuscular transmission (Fig. 1.13). The muscle-type with stoichiometry 
(α)2βγδ is also found in abundance in the electric organ of the electric ray Torpedo sp.  
 
Neurotransmission in neuromuscular junction 
The neuromuscular junction is the well-studied synapse (reviewed in Durant, 1984; Pollard, 
1994; Feldman, 1996; Naguib et al, 2002). It is referred as the point of contact between the axon 
terminal of a motor nerve fibre and the associated skeletal muscle fibre. The presynaptic 




synaptic cleft of ~20-30 nm (Fig. 1.13). The transmission of an electrical impulse involves a 
series of events involving the neurotransmitter ACh, leading to the ultimate muscle contraction. 
ACh is synthesized in the cytoplasm of the presynaptic bouton of nerve terminal (Fig. 1.13). 
During an action potential induced membrane depolarization, there is a sharp increase in the 
intracellular calcium concentration. This increase in calcium level triggers the fusion of the 
synaptic vesicle containing ACh is fused with the presynaptic membrane followed by ACh 
released to synaptic cleft (Fig. 1.13). A single nerve impulse may release between 100 – 300 
vesicles of ACh. The postsynaptic membrane contains densely populated nAChRs. Binding of 
ACh to the receptors causes the opening of the cation channel and provoke the entrance of 
sodium ions on the muscle fiber. This ion influx leads to local depolarization of the postsynaptic 
membrane (from the resting value of -50 mV to +10 mV) and finally muscle contraction. The 
action of acetylcholine is terminated as a result of hydrolysis into choline and acetate by the 
enzyme, acetylcholinesterase.  
 
1.8.2  Neuronal type of nAChRs 
Neuronal nAChRs are localized in the central and peripheral nervous system. Neuronal nAChRs 
are pentamers consisting of subunits alpha and beta (Fig. 1.14). 
Till date, 12 subunits including nine α (α2-α10) and four β (β2-β5) have been cloned (McGehee 
and Role, 1995). Different combinations of those subunits give rise to a great diversification of 
neuronal nAChRs accompanied by different pharmacological profiles and physiological 
properties. The most common heteropentameric arrangement consists of two identical α-
subunits and three identical β-subunits. Subunits α2, α3, α4 and α6 can form functional 




Functional heteropentamers can also be created by subunits α7/α8 and α9/α10. Homopentamers 
can be assembled by α7, α8 and α9 subunits (McGehee and Role, 1995). The different subunit 
organizational patterns lead to different functional effects of neuronal nicotinic receptors (Fig 
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Figure 1.12: Structure of Torpedo marmorata (marbled electric ray) nAChR at 4 Å obtained by cryo-electron microscopy    
                     (2BG9) (Unwin, 2005). 
 
(A) Ribbon diagrams of the whole receptor, as viewed from the synaptic cleft. For clarity, only the ligand-binding domain is 
highlighted. Subunits are shown in colors: α, red; β, green; γ, blue; δ, light blue. B) Ribbon diagrams of the whole receptor, viewed 
parallel with the membrane plane. For clarity only the front two subunits are highlighted. Also shown are the locations of Trp149 
(yellow), the main immunogenic region (MIR), the membrane (horizontal grey bars)and the ligand binding or extracellular, 
transmembrane and intracellular domain by solid black arrows. C) Ribbon diagrams of a single subunit viewed parallel with the 
membrane plane, in orientations such that the central axis of the pentamer (vertical line) is at the back. The α-helices are in yellow; the 
β-strands composing the β-sandwich are in blue (inner) and red (outer). Locations of the N and C termini, Trp149, Val46, the Cys loop 















Figure 1.13: Signal transmission at the neuromuscular junction (the synapse). 
 
A schematic diagram representing the structure of the mammalian neuromuscular junction. 
The presynaptic membrane of the nerve terminus is separated from the postsynaptic 
membrane of the skeletal muscle by the synaptic cleft (30-50 nm), shown by black solid 
arrow. The postsynaptic membrane is characterized by numerous junctional folds and is 
densely populated with muscle-type nicotinic acetylcholine receptors. These receptors are 
congregated specially at region of the junctional folds. Acetylcholine containing synaptic 
vesicles are present in large numbers in the nerve terminal, specifically at the active zones 
that face the openings of the junctional folds of the postsynaptic membrane. The figure was 





















































Figure 1.14: Molecular model of mammalian (rat) α7 nicotinic receptor 
 
The model was developed based on sequence alignment with the cryoelectron microscopy 
structure of the T. marmorata nAChR as indicated in Gay et al. (2007). The α-helices are 
shown in red and the β-strands in blue, (A) a side view of the pentameric α7 receptor model, 
the ligand binding or extracellular, transmembrane and intracellular domain are indicated by 
solid black arrows. (C) a top-down view of the α7 receptor model. (B) The extracellular ligand 
binding domain is shown close up in. The ligand binding site is composed of a cluster of 
aromatic residues from both the principal and complementary subunits and is capped by the 
C-loop. The transition domain consists of several loops including: Cys-loop, β1-β2 linker, β8-





The anatomical distribution of the variety of neuronal receptors is less well understood. In the 
rat brain, a wide distribution of the α7 subunit as well as α4 and α2 subunits suggested that α7 
and α4β2 nAChRs represent the major subtypes present in the vertebrate brain (Seguela et al, 
1993; McGehee and Role, 1995). Minimal cognitive deficits was observed with knockout mice 
lacking α4 and α2 subunits implying that brain nAChRs may not be crucial for the survival of 
the animal, but may play a more subtle role in brain functions such as learning, memory and 
attention (Picciotto et al, 1995). The α9 homopentamaric receptor is expressed in vertebrate 
cochlear hair cells as part of a cholinergic efferent innervation (Chen and Patrick, 1997). 
nAChRs affects both excitatory and inhibitory nerve activity. At the cellular level, neuronal 
these receptors have been shown to modulate the release of several neurotransmitters and to 
depolarize and generate action potentials in various types of neuronal cells (Wonnacott, 1997). 
Neuronal nAChRs are known to be involved in nicotine addiction in smokers as well as the 
positive effects of nicotine on cognition, memory and attention are also mediated by them. They 
are also known to be involved in several pathological conditions including schizophrenia, 
Alzheimer's disease, Parkinson's disease and certain forms of epilepsy (Lindstrom, 1997; Lena 
and Changeux, 1997; Paterson and Nordberg, 2000). Another major central function in which 
nicotinic transmission appears to be involved is pain processing and nociception (Pan et al, 
1999). Many nicotinic receptor agonists (e.g. epibatidine) are reported to exert potent 
antinociceptive action (Meyer et al, 2000) probably by a selective action at α4β2 receptors 
(Tassonyi et al, 2002). 
In the autonomic ganglia of peripheral nervous system, α3β4 receptors, represent the main 
receptor type at postsynaptic sties and are responsible for fast synaptic transmission. Knockout 




role of this receptor in autonomic ganglia (Xu et al, 1999a; 1999b). Nicotinic autoreceptors, 
presumably of the α3β2 and α7 subtypes, have been described in the membranes of motor nerve 
terminals (Tsuneki et al, 1995) and postulated to be involved in process of transmitter release in 
response to rapid nerve stimulation. 
 
1.9   The ligand-binding domain of nAChRs 
The extracellular N-terminal domains of nAChRs are 210-220 amino acid residues long and 
contain binding site for ligands (agonists and competitive antagonists). The ligand binding site 
is located at the interface between two subunits with contributions from both counterparts (Fig. 
1.15 A) (Corringer et al, 2000; Arias, 2000; Yakel, 2010). Affinity labelling of the ACh-binding 
site led to the first identification of a receptor subunit, the electrocyte ACh receptor α-subunit 
(Reiter et al, 1972). The affinity-labelled residues were a pair of adjacent cysteines, αCys192 
(bp187) and αCys193 (bp188) (Kao et al, 1984), (numbers of the residues correspond to the 
mature Torpedo α-subunit and are followed by the numbers of the aligned residues in 
acetylcholine binding protein (AChBP), preceded by ‘bp’, for details on AChBP see below 
section 1.10), which are characteristic of all ACh receptor α-subunits. Subsequently, four widely 
spaced aromatic residues in the α-subunit such as- αTyr93 (bpTyr89), αTrp149 (bpTrp143), 
αTyr190 (bpTyr185) and αTyr198 (bpTyr192), were also found to be affinity labeled (Galzi et 
al, 1990; Middleton and Cohen, 1991). Alike the cysteines, these aromatic residues are also 
conserved in all ACh receptor α-subunits (except in neuronal α5, Tyr190 is replaced by Asp190). 
The involvement of the cysteines pair and the aromatic residues in ligand binding was also 
proven by further mutagenesis studies (for a review see, Karlin, 2002). Labelling and cross-




between subunits. In an experiment using dTC the aligned pairs γTrp53 (bpTrp53) and δTrp55, 
and γTyr111 (bpVal106) and δArg113, as well as γTyr117 (bpLeu112) were specifically 
photolabelled. Using another inhibitor, benzoylbenzoylcholine, the aligned pairs γLeu109 
(bpArg104) and δLeu111 were also found to be photolabelled (Wang et al, 2000). Therefore, 
from all these experiments it was inferred that the principal component of the binding pocket is 
formed by the α-subunit and the complementary component of the binding pocket is formed by 
the non α-subunits. Amino acid residues from the α-subunit contributes to the formation of 
loops A, B and C, which are the principle components, whereas the neighbouring subunit (δ, γ 
or ε in muscle and α or β subtypes in neuronal receptors) residues contribute to loops D, E and F 
that form the complementary component of the binding pocket (Fig. 1.15) (Changeux and 
Edelstein, 1998; Corringer et al, 2000; Arias, 2000; Itier and Bertrand, 2001). Thus, the muscle 
nAChR contains two different ligand binding sites (α/δ and α/γ) with distinct affinities for 
nicotinic antagonists (Corringer et al, 2000), whereas the homopentameric α7 receptor offers 
five identical ligand binding sites (Fig. 1.14) (Palma et al, 1996; Itier and Bertrand, 2001; Yakel, 
2010). 
 
1.10   Acetylcholine binding protein (AChBP) 
The isolation and characterization of an acetylcholine binding protein (AChBP) from the marine 
and fresh water snails Lymnaea stagnalis and Aplysia californica (Smit et al, 2001; Brejc et al, 
2001; Hansen et al, 2004) has provided an excellent insight into the structure-function 
relationship of nAChRs. AChBP is a homopentameric, soluble protein that is secreted by snail 
glial cells into cholinergic synapses, where it interacts with acetylcholine to modulate 





                  
        
 
            
                       Figure 1.15: Representation of the ligand binding site and the ion channel of the nicotinic receptors 
 
(A) The ligand binding site of nAChRs, as viewed from the exterior of the receptor along the plane of the membrane. Residues 
identified by affinity labeling and site-directed mutagenesis are indicated in the primary site present on α-type subunits and the 
complementary site present on γ or δ subunits of muscle receptor, or on α subunits of homopentameric neuronal receptors or β 
subunits of heteromeric neuronal receptors (B) The ion channel of nAChRs. Residues from M2 and the cytoplasmic loop component 





which each subunit consists of 210 amino acid residues (Fig. 1.16). It binds to the agonists and 
competitive antagonists of the nicotinic ACh receptor, including the small molecular ligands 
such as- ACh, nicotine, epibatidine, (+)-tubocurarine as well as protein ligands such as- 
conotoxins and snake venom α-neurotoxins. The spectrum of binding affinities resembles that 
of homomeric neuronal nicotinic receptors that are composed of α7- or α9-subunits. This 
soluble protein is a homologue of the N-terminal ligand binding domain of nAChRs, 
particularly α-subunits, but it lacks the transmembrane and intracellular domains. The amino 
acid sequence of AChBP and the N-terminal domain for nAChR are highly conserved, 
including those that are relevant for ligand binding (discussed above in section 1.9). The 
sequence identity of AChBP to the human α7 subunit is about 26% (Smit et al, 2001) and this 
value reaches up to ~ 60% when considering only the functional loop (A-F) regions (Fruchart-
Gaillard et al, 2002). The high resolution crystal structure of AChBP (Fig. 1.16) revealed the 
predominantly β-sheeted structure, which correlates well with the structure of Torpedo nAChR 
(Fig. 1.12) predicted by cryo-electron microscopy (Miyazawa et al, 1999; Unwin 2005). As for 
the AChBP, nearly all the residues of the agonist-binding site of the α7 receptor that were 
previously identified by photoaffinity labeling and mutagenesis experiments (reviewed in 
Grutter and Changeux, 2001; Karlin, 2002), are located in a small cavity of about 10-12 Å 
diameter. This cavity is primarily formed by aromatic residues that are contributed by both, the 
principle and complementary sides of two adjacent subunits. All ligands of the ACh receptor 
have at least one quaternary ammonium group or a protonated tertiary ammonium group. The 
aromatic side chains present in the principle and complementary binding sides are proposed to 
make cationic- pi interactions (a non-covalent interaction between a cation and the face of an 
















Figure 1.16: The acetylcholine binding protein (119B) from Lymnaea stagnalis. 
(A) Top view of the 2.7 Å resolution crystal structure of the acetylcholine binding protein (AChBP) homopentamer from Lymnaea 
stagnalis glial cells (Brejc et al, 2001). The AChBP coloured to show the five subunits constituting the pentameric structure. Each 
AChBP subunit is a single domain protein. With the exception of the amino-terminal region of each subunit which consists of a short 
α-helix segment, β-sheet sandwich structure predominates (shown in ribbon diagram). The five equivalent dimer interfaces serve as 
the only links between the subunits. The interface buries a large surface area of 2,700 Å2. The cavity/pocket at each interface between 
the subunits are lined by residues which were biochemically shown to be involved in ligand binding in nicotinic acetylcholine 
receptors and therefore likely constitute the ligand binding site. (B) The AChBP viewed perpendicular to the five-fold axis. It forms a 
62 Å-high cylinder with a diameter of 80 Å. The N- and C- termini are located at 'top' and 'bottom' of the pentamer, respectively. The 
ligand-binding pockets are roughly equatorially positioned, about 30 Å away from the C termini conforming to the expected location 


























Figure 1.17: Three dimensional structure of the α-cobratoxin (Cbtx)-AChBP complex. 
 
The 4.2 Å crystal structure of AChBP from Lymnaea stagnalis (1YI5) colored to show five 
subunits complex with Cbtx. The Cbtx molecule bound at this subunit interface is shown in 
red. The pentameric complex is viewed (A) along and (B) perpendicular to the AChBP five-

















Figure 1.18: Close up view of a single AChBP subunit and the Cbtx molecule bound at this subunit interface (1YI5). 
 
(A) A single subunit of AChBP (shown in magenta). The structural elements are predominantly β-sheet, except a small α-helical 
segment at the N-terminal, (B) AChBP subunits B (cyan) and C (magenta), which respectively contribute to the principal and the 
complementary faces of the interface and Cbtx molecule (red) bound at subunits interface. The residues involved in the complex 






Table 1.3: Intermolecular interactions between α-cobratoxin and AChBP


























the crystal structure of AChBP complexed with α-cobratoxin (Bourne et al, 2005) both beautiful 
and enlightening. It revealed that the toxin/ligand binding site is located in a cleft at a subunit 
interface (Fig. 1.17 and 1.18), formed by the series of loops from the principal face of one 
subunit (loops A, B and C) and another series of loops from the complementary face of an 
adjacent subunit (loops D, E and F). The residues involved in the interaction for both cobratoxin 
and AChBP is listed in table 1.3. The AChBP-toxin complex structure correlates well with 
affinity labelling and mutational binding studies to nAChRs (Fruchart- Gaillard et al. 2002; 
Karlin, 2002). Recently, many structures of AChBP complexes with various ligands and α-
conotoxins have been solved (Celie et al, 2004; Hansen et al, 2005; Ulens et al, 2006), which 
are greatly contributing to the understanding of nAChR-ligand interactions. 
 
1.11  Nicotinic acetylcholine receptors: Allosteric properties 
Acetylcholine receptors are allosteric, in that they are oligomeric, contain multiple agonist-
binding sites, and gates that interact at a distance (away from the ligand binging sites) through 
changes in the quaternary structure of the receptor (Karlin, 2002). Specifically, the binding of an 
agonist to the ligand-binding site of the receptor induces allosteric interactions between subunits, 
resulting numerous conformational transitions which lead to the rapid opening of the 
transmembrane cation channel and ultimate membrane depolarization followed by muscle 
contraction (reviewed in Changeux and Edelstein, 1998; 2001; Karlin, 2002). Three functional 
states have been described for nicotinic receptors, basal or resting (closed), active (open), or 
desensitized (closed) (Changeux and Edelstein, 1998). The resting state is the most stable state 
in the absence of agonist. The equilibrium between the various conformational states of 




antagonists, and also the noncompetitive allosteric modulators. Indeed, the ligands will stabilize 
the states for which they display the highest affinity. In particular, agonists exhibit a higher 
affinity for the active (open) than for the basal (closed) state, therefore causing the opening of 
the channel. The continued presence of an agonist leads to receptor desensitization and ion 
channel closure. In the desensitized state, the receptor is refractory to activation although it 
displays higher affinity for agonist binding. In contrast, snake toxins block the receptor by 
stabilizing the basal (closed) state (Fruchart-Gaillard et al, 2002). Other competitive antagonists 
such as dTC also preferentially stabilize the receptor in the closed state, either the basal or 
desensitized configuration (Changeux and Edelstein, 1998). 
 
1.12  The scope for nicotinic acetylcholine receptor ligands 
Despite the growing library of the nicotinic ligands, there is still a lack of subtype-specific 
ligands, agonists and antagonists, especially directed towards the less abundant neuronal 
nicotinic receptor subtypes. Several ligands with this degree of specificity have been isolated 
from natural sources, animal venoms in particular. Starting from α-bungarotoxin which played a 
pivotal role in the early characterization of the acetylcholine receptor, till the wide variety of 
conotoxins with specificity for different interfaces of the receptor, venom peptides have 
provided some of the most useful molecular probes known to date. The discovery or design of 
more subtype-specific ligands will greatly facilitate the elucidation of the physiological and 
pathological roles of the different neuronal subtypes and thereby discovering the therapeutic 
potential of individual neuronal receptors. Moreover, the venom peptides possess immense 
potential to provide the structural insights of the ligand binding domain of nicotinic receptors as 




influence of nicotinic receptors on central and peripheral nervous system activities, the target-
oriented search for venom peptides will no doubt continue. 
 
1.13   Aim and scope of the thesis 
Snake venoms have been a natural source of bioactive proteins. These molecules have long been 
useful in research as molecular probes to identify novel targets and in drug discovery as lead 
compounds to develop therapeutic molecules. Till date, many of the highly abundant venom 
proteins have been well-characterized, but the minor venom components are poorly understood. 
The usefulness of these molecules are not only restricted to their unique pharmacological 
properties, but also on the structural and functional characterization of these molecules. 
Understanding the structure-function relationship of these proteins will help us to explore its 
scientific potential in the pharmaceutical industry.  
In search for novel toxins Rajagopalan et al (2007) has constructed a cDNA library from the 
venom gland of O. hannah. Few novel sequences were identified in the cDNA library, among 
them one, β-cardiotoxin, has been characterized (Rajagopalan et al, 2007) with novel β-
adrenergic receptor blocking activity. The current study was aimed to isolate and characterize 
another novel protein from cDNA library of the venom gland of O. hannah. Specifically, the 
objectives of the study were: 
 
1.      To isolate and purify to homogeneity the protein of interest from the crude venom of O.  
         hannah, confirm the identity and compare the homology of its primary structure to other  






2.     To carry out a detailed pharmacological characterization of the protein of interest in several  
         isolated smooth muscle and skeletal muscle preparations 
 
3.    To investigate the effects of the protein on acetylcholine currents in oocyte expressed  
       muscle (αβγδ) and neuronal (α7, α3β2 and α4β2) nicotinic acetylcholine receptors using  
      electrophysiological techniques. 
 
4.      To investigate the existence of oligomeric species for the protein of interest in solution. 
 
5.     To solve the three-dimensional structure of the protein and to carry out a detailed structure- 
        function analysis with respect to the homologous proteins from the same family. 
 
6.    To understand the structure-function relationship of the protein by co-crystallization and  



















Isolation and purification of haditoxin 
 
2.1 INTRODUCTION 
Snake venoms are a blend of bioactive proteins and polypeptides. More than 90% 
of the venom's dry weight constitutes of proteins. The venom from each snake is a 
complex mixture showing up to 200 different proteins and polypeptides (Harvey, 
1991; Birrell et al, 2007) and this composition can vary depending on the 
evolutionary diversities. Approximately 20% of the total snake population in the 
world is venomous and their venoms form a goldmine of proteins and 
polypeptides for researchers. The venom components must achieve their effects at 
very low concentrations because of the minute amount of venom reaching the 
bloodstream during envenomation. Thus purification of these proteins to 
homogeneity from the crude snake venom is a redoubtable challenge for scientists. 
In the past, most research have focused on the isolation and characterization of the 
highly abundant or/and highly toxic proteins from venoms, but recently with more 
advanced and sophisticated proteomics tools, it is possible now to identify low-
abundance venom proteins present in minute amounts (Kini, 2002; Rajagopalan et 
al, 2007; Omprova et al, 2010; Chatrath et al, 2011).  
 
This chapter details the isolation and purification of haditoxin. Haditoxin was first 
identified as MTLP-3 homolog in the cDNA library of the venom gland tissue of 
O. hannah along with four other novel proteins (Rajagopalan et al, 2007). Liquid 




previously in our lab (Pung et al, 2005) showed the presence of four (DQ902574, 
DQ902575, DQ902576 and AY354198) out of the five newly identified proteins 
in the venom. We describe a two step chromatographic approach for the isolation 
of these proteins from the crude venom of O. hannah. The procedure involved 
size exclusion chromatography as the initial step and reverse phase-high 
performance liquid chromatography (RP-HPLC) as the second step. Size 
exclusion chromatography which is also known as gel filtration chromatography 
separates the protein based on their molecular size. The porous gel matrix acts as 
a molecular sieve which allows different degrees of access to the analyte 
molecules (smaller molecules have greater access and larger molecules less). This 
method is widely used as an initial step for venom protein purification because of 
its simple and mild nature. As this method offers group separation that is the 
components of a sample are separated into two/more major groups according to 
the size, so it is generally combined with other chromatographic techniques. For 
example, in the case of several elapid venoms gel filtration offers a separation of 
three major groups, >40 kDa (mainly enzymes), 11-25 kDa (phospholipases, 
ohanin etc.) and 6-8 kDa (three-finger toxins, proteinase inhibitors, etc.). 
Therefore, during the purification of haditoxin, we have used RP-HPLC as a 
second step of purification where the proteins are separated based on their 
hydrophobicity. RP-HPLC is not extensively used for protein purification because 
of the use of higher concentration of organic solvents in mobile phase which can 
cause protein denaturation with loss of activity. Fortunately, the robust disulfide-
linked three-finger fold of the 3FTXs makes them fairly resistant to denaturation. 




room temperature instead of 4 °C, because of the resistance of 3FTXs to thermal 
degradation due to proteolysis. Use of RP-HPLC as a final step also allows us to 
purify the protein in a desalted form, ready to be lyophilized. 
The lyophilized purified protein was subjected to N-terminal sequencing by 
Edman degradation to confirm its identity. It is also vital to ensure that the 
purified protein does not contain any contaminants that could mask and/or 
interfere in its biological activity. Therefore, the homogeneity of the purified 
protein was confirmed by capillary electrophoresis where separation is based on 
the size to charge ratio of the analytes. Capillary electrophoresis offers an accurate 
estimation of the homogeneity because of its high sensitivity and resolution. 
Circular dichroism (CD) was used to determine the secondary structure of the 
purified protein. CD spectroscopy measures differences in the absorption of left-
handed polarized light versus right-handed polarized light which arise due to 














2.2 MATERIALS AND METHODS 
2.2.1 Materials 
Lyophilized O. hannah venom was obtained from PT Venom Indo Persada 
(Jakarta, Indonesia) and Kentucky Reptile Zoo (Slade, KY, USA). Reagents for 
N-terminal sequencing by Edman degradation are from Applied Biosystems 
(Foster City, CA, USA). Acetonitrile (ACN) and trifluoroacetic acid (TFA) were 
from Merck KGaA, Darmstadt, Germany. Superdex 30 Hiload (16/60) column 
and Jupiter C18 (5 µ, 300 Å, 4.6 mm x 250 mm) were purchased from GE 
Healthcare Life Sciences (Piscataway, NJ, USA) and Phenomenex (Torrance, CA, 
USA) respectively. All the reagents were of the highest purity grade. Water was 
purified using a MilliQ system (Millipore, Billerica, MA, USA).  
 
2.2.2     Sequence Analysis 
Sequence analysis was carried out using the BLAST program against the non-
redundant database of NCBI (www.ncbi.nlm.nih.gov) and ExPASy proteomics 
tools (www.expasy.ch). Sequence alignments were carried out using the online 
server ClustalW (www.ebi.ac.uk) followed by manual adjustments to obtain the 
best possible alignment. 
 
2.2.3   Protein purification from crude venom 
Haditoxin was purified from the venom of O. hannah crude venom using a two-
step chromatographic approach. Crude venom (100 mg) was dissolved in 1 ml of 
deionized water, centrifuged at 14,000 rpm for 15 min and the supernantant was 




30 (1.6 x 60 cm) gel filtration column, equilibrated with 50 mM Tris-
hydrochloride (HCl) buffer; pH 7.4 and eluted with the same buffer at a flow rate 
of 1 ml/min using an ÄKTA purifier system (GE Healthcare Life Sciences, 
Piscataway, NJ, USA) and fractions of 2 ml were collected. Pooled fractions 
containing the toxin of interest were further sub-fractionated by reverse phase-
high performance liquid chromatography (RP-HPLC) using a Jupiter C18 column, 
equilibrated with 0.1% (v/v) TFA and eluted with a linear gradient of 80% (v/v) 
ACN in 0.1% (v/v) TFA at 1 ml/min flow rate. Elution was monitored at 280 and 
215 nm. Fractions were directly injected into an API-300 LC/MS/MS system 
(PerkinElmer Life Sciences, Wellesley, MA, USA) to determine the mass and 
homogeneity of the protein. Fractions showing the expected molecular mass were 
pooled and lyophilized. 
 
2.2.4 Molecular mass determination 
The mass and homogeneity of the novel proteins were determined by electrospray 
ionization mass spectrometry (ESI-MS) using an API-300 liquid 
chromatography/tandem mass spectrometry system (PerkinElmer Life 
Sciences,Wellesley, MA, USA). RP-HPLC fractions were directly used for the 
analysis. Ion spray, orifice, and ring voltages were set at 4600, 50, and 350 V, 
respectively. Nitrogen was used as the nebulizer and curtain gas. A Shimadzu LC-
10AD pump was used for solvent delivery (50% acetonitrile in 0.1% formic acid) 
at a flow rate of 40 µl/min. Data was acquired in a positive ion mode. Nitrogen 
was used as curtain gas with a flow rate of 0.6 L/min and as nebulizer gas with a 




1000 to 2000 m/z with step size of 0.1 Da. Analyte software (PerkinElmer Life 
Sciences, Wellesley, MA, USA) was used to analyze and deconvolute the raw 
mass data.   
 
2.2.5 N-terminal sequencing 
N-terminal sequencing of the native protein was performed by automated Edman 
degradation using a Procise 494 pulsed-liquid-phase protein sequencer (Applied 
Biosystems, Foster City, CA, USA) with an on-line 785A phenylthiohydantion 
(PTH)-derivative analyzer. The PTH amino acids were sequentially identified by 
mapping the respective separation profiles with the standard chromatogram. 
 
2.2.6 Capillary electrophoresis 
Capillary electrophoresis was performed on a BioFocus3000 system (Bio-Rad, 
Hercules, CA, USA) to determine the homogeneity of the protein after RP-HPLC. 
The native protein (1 µg/µl) was injected to a 25 µm x 17 cm coated capillary 
using a pressure mode (5 p.s.i./s) and run in 0.1 M phosphate buffer (pH 2.5) 
under 18 kV at 20 °C for 20 min. The migration was monitored at 200 nm. 
 
2.2.7 CD spectroscopy 
Far-UV CD spectra (260 - 190 nm) were recorded using a Jasco J-810 
spectropolarimeter (Jasco Corporation, Tokyo, Japan). All measurements were 
carried out at room temperature using a 0.1 cm path length capped cuvette. The 
instrument optics and cuvette chamber were continuously flushed with 10 L of 




free environment. The spectra were recorded using a scanning speed of 50 
nm/min, a resolution of 0.1 nm and a bandwidth of 1 nm. A total of three scans 
were recorded and averaged for each spectrum, and the baseline was subtracted 

























2.3.1    Isolation and purification of haditoxin 
The LC/MS profile of O. hannah venom (Pung et al, 2005) showed the presence 
of a 7,535.67 ± 0.60 Da protein (Appendix figure), similar to the calculated 
molecular weight of MTLP-3 homolog identified in the cDNA library of the 
venom gland tissue of O. hannah. Following this calculated mass the protein was 
purified from the crude snake venom using different chromatographic techniques. 
We used a two-step chromatographic approach, where the first step comprised of 
separating the venom components based on their sizes into five peaks using gel 
filtration chromatography (Fig. 2.1). Based on the calibration curve most of the 6-8 
kDa protein elutes out in peak 3. Thus, we fractionated peak 3 using RP-HPLC and 
analyzed the mass of each fraction using ESI-MS. Unfortunately, we were unable to find 
a mass matching to that of the observed one in LC/MS profile. Subsequently, each peak 
of gel filtration chromatography was fractionated by RP-HPLC. The fractions 
were analyzed by ESI-MS to determine the mass and hence the tentative 
identification of the protein. One of the RP-HPLC fractions of peak 2 (marked by 
a black bar in Fig. 2.1) showed a molecular weight similar to that of the LC/MS 
profile. Further, the fractions containing peak 2 were pooled and separated by RP-
HPLC (Fig. 2.2). The mass spectra of fraction 2a (indicated by a black arrow in 
Fig. 2.2) showed a molecular weight of 7535.88 ± 0.64 Da. It was observed that 
this protein eluted earlier in gel filtration chromatography compared to other 
3FTXs (Fig. 2.1, most of the 3FTXs elutes in peak 3). This led us to investigate 



















































































































































































Figure 2.1: Gel filtration chromatogram of O. hannah crude venom. 
Crude venom (100 mg/ml) was fractionated using a Superdex 30 Hiload (16/60) 
column. Column was pre-equilibrated with 50 mM Tris-HCl buffer (pH 7.4). 
Proteins were eluted at a flow rate of 1 ml/min using the same buffer. A black bar 
at peak 2 indicates the fractions containing haditoxin which were pooled and 



















































Figure 2.2: RP-HPLC profile of peak 2 from gel filtration chromatography. 
Fractions containing haditoxin of peak 2 from gel filtration chromatography was 
subjected to RP-HPLC using a Jupiter C18 (5 µ, 300 Å, 4.5 x 250 mm) analytical 
column was equilibrated with aqueous 0.1% (v/v) TFA (buffer A). Protein of 
interest was eluted from the column with a flow rate of 1 ml/min with a gradient 
of 23-49% (over a time period of about 90 minutes) buffer B (80% acetonitrile in 
0.1% TFA). The dotted line (- - -) indicates the gradient of the buffer B. 
Downward arrow at peak 2a indicates fractions containing haditoxin. Elution of 








(discussed in chapter 4). Hence, the protein of interest was renamed as haditoxin 
(O. hannah dimeric toxin) following the nomenclature of dimeric 3FTXs (Pawlak 
et al, 2006; Pawlak et al, 2009). 
 
2.3.2   Identification of haditoxin 
The ESI-MS of fraction 2a (indicated by a black arrow in Fig. 2.2) showed three 
peaks with mass/charge (m/z) ratios ranging from +4 to +6 charges (Fig. 2.3), and 
the final reconstructed mass spectrum showed a molecular weight of 7535.67 ± 
1.25 Da, which corresponds well with the calculated mass of 7534.42 Da (Fig. 
2.4). The ESI-MS spectrum also revealed the purity of haditoxin (Fig. 2.4). N-
terminal Edman degradation sequencing of the first 36 residues of the pure 
haditoxin matched with the cDNA sequence of MTLP-3 homolog (Fig. 2.5) thus 
confirming the identity of the protein. 
 
2.3.3 Assessment of homogeneity of haditoxin 
In order to ensure the uniformity haditoxin was subjected to capillary 
electrophoresis. Haditoxin eluted out as a single peak at about 13 min. The 
presence of a single peak in the electropherogram (Fig. 2.6) indicated the 
homogeneity of the protein, ensuring the absence of contaminants, especially 
other α-neurotoxin(s), cytotoxins and enzymatic proteins such as- phospholipases 
(because haditoxin eluted out in peak 2 in Fig 2.1 together with phopholipases) 













































Figure 2.3: ESI-MS spectrum of the RP-HPLC fraction 2a. 
RP-HPLC fraction containing haditoxin was subjected to ESI-MS using an API-
300 liquid chromatography/tandem mass spectrometry system. The spectrum 
shows a series of multiply charged ions, corresponding to a single, homogenous 










Figure 2.4: Reconstructed ESI-MS spectrum of haditoxin. 





cDNA clone:       TKCYNHQSTTPETTEICPDSGYFCYKSSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ   65 















Figure 2.5: N-terminal sequencing of haditoxin. 
Purified haditoxin was subjected to N-terminal Edman degradation sequencing 
using a Procise 494 pulsed-liquid-phase protein sequencer. The first 36 residues of 










Figure 2.6: Capillary electropherogram of haditoxin. 
Capillary electrophoresis of purified haditoxin was performed on a BioFocus3000 
system. The sample was injected using pressure mode 5 p.s.i./s, and 
electrophoresis runs were carried out using a coated capillary (17 cm x 25 µm) at 
18 kV, with 0.1 M phosphate buffer (pH 2.5) at 20 °C for 20 min. Migration was 

































Figure 2.7: Circular dichroism spectrum of haditoxin. 
 
Far-UV CD spectrum of purified haditoxin. The protein was dissolved in 
deionised water (0.5 mg/ml), and their CD spectra were recorded using a 0.1 cm 
path-length cuvette at room temperature in a Jasco J-810 spectropolarimeter. 
 
 
2.3.4 Secondary structure analysis of haditoxin 
The secondary structural elements of haditoxin were analyzed using far-UV CD 
spectroscopy. The spectrum shows maxima at 230 nm and 198-200 nm and a 
minimum at 215 nm (Fig. 2.7). Thus haditoxin was found to be composed of β-
sheeted structure similar to all other 3FTXs (Harvey, 1991; de Weille et al, 1991; 







Snake envenomation is a socio-medical problem of considerable magnitude. 
Annually about 2.5 million people are bitten by snakes, more than 100,000 fatally. 
However, although bites can be deadly, snake venom is a natural biological 
resource that contains several components of potential therapeutic value. Since 
ages, venom has been used in the treatment of a variety of pathophysiological 
condition in Ayurveda, homeopathy and folk medicine (Koh et al, 2006; Calvete, 
2009). With the advancement of proteomics and genomics, the efficacy of such 
treatments has been substantiated by isolating and purifying components of 
venom and delineating their therapeutic properties for further applications in 
pharmaceuticals and basic research.  
Five novel toxin sequences have been identified in the cDNA library from the 
venom gland tissue of O. hannah (Rajagopalan et al, 2007) (Appendix figure). 
The cysteine arrangement of all these novel sequences led us to the conclusion 
that all of them belong to the 3FTX family of snake venom non-enzymatic 
proteins. One of them, named β-cardiotoxin, has been characterized previously 
(Rajagopalan et al, 2007). Here, the purification and characterization of the 
second novel toxin, haditoxin, (identified previously as MTLP-3 homolog based 
on sequence homology (Rajagopalan et al, 2007) (Fig. 2.9) is described. 
Haditoxin consists of a single polypeptide chain of 65 amino acids and four 
disulfide bridges. The disulfide scaffold of haditoxin as a result of cysteine pairing 
revealed that the protein belongs to the 3FTX family of snake venom proteins. 
Accordingly, it was found that haditoxin shares about 37-57% of similarity (Fig. 




bridges, common to all the 3FTXs contribute substantially (approximately 12%) 
to this homology. The loop regions in between the disulfide bridges are indicated 
by black lines. Haditoxin showed high similarity (80-83%) with muscarinic toxin 
like proteins (MTLP and MTLP-3) and neurotoxin homolog (NL1) (Fig. 2.9). All 
of the three proteins (MTLP, MTLP-3 and NL1) are known as muscarinic toxin 
homologs based on their sequence homology with muscarinic toxins. However, 
there is no available literature describing the molecular target and mechanism of 
action of these homologs. Since, we compared the sequence of haditoxin with that 
of the muscarinic toxins (MT-α, MT1 and MT3) and their homologs, (MTLP-1 
and MTLP-2) (Fig. 2.10) for which the molecular target is known (Kukhtina et al, 
2000; Servant and Fruchart-Gaillard, 2009), and haditoxin was found to share 
only about 51-54% similarity. Therefore, with an expectation to find out the novel 
characteristics of haditoxin we purified the protein from the crude venom of O. 
hannah and examined its pharmacological properties.  
We have isolated and purified haditoxin using a two-step chromatographic 
approach from the crude venom of O. hannah. In gel filtration chromatography, 
haditoxin eluted in peak 2 (Fig. 2.1) together with higher molecular weight 
proteins like- phospholipases, ohanin and opharin (molecular weight range of ~ 
11-25 kDa). This might be due to the existence of these molecules in multimeric 
states or the formation of complexes with any of the other larger molecules that 
elute in the same fraction which demands further investigation. Such interactions 
could be functionally important which led us to further characterize haditoxin 
structurally (discussed in chapter 4). The gel filtration fractions were further 




Haditoxin      DQ902575 ---------TKCYNH--QSTTPETTEI-CPDSGYFCYKSS----WIDGREGRIERGCTFTCPELTPNGKYVYCCRR-DKCNQ------- 65 
MT1            AAB31994 ---------LTCVKS--NSIWFPTSED-CPDGQNLCFKRWQ---YISPRMYDFTRGCAATCPKAEYRDV-INCCGT-DKCNK------- 65  35(52) 
MT2            P18328   ---------LTCVTT--KSIGGVTTED-CPAGQNVCFKRWH---YVTPKNYDIIKGCAATCPKVDNNDP-IRCCGT-DKCND------- 65  34(52) 
Toxin-α        P01426   ---------LECHNQ--QSSQPPTTKT-C-PGETNCYKKV----WRDHRGTIIERGCG--CPTVK-PGIKLNCCTT-DKCNN------- 61  46(57) 
Erabutoxin a   5EBX_A   ---------RICFNH--QSSQPQTTKT-CSPGESSCYNKQ----WSDFRGTIIERGCG--CPTVK-PGIKLSCCES-EVCNN------- 62  41(55) 
WTX weak toxin P82935   ---------LTCLNC--PEMFCGKFQI-CRNGEKICFKKLH---QRRPLSWRYIRGCADTCPVGKPYEM-IECCST-DKCNR------- 65  31(42) 
Candoxin       P81783   ---------MKCKICNFDTCRAGELKV-CASGEKYCFKES----WREARGTRIERGCAATCPKGSVYGLYVLCCTT-DDCN-------- 66  40(55) 
α-Cobratoxin   P01391   ---------IRCFIT---PD--ITSKD-CPNG-HVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTG-VDIQCCST-DNCNPFPTRKRP 71  34(52) 
α-Bungarotoxin P01378   ---------IVCHTT---ATSPISAVT-CPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPY-EEVTCCST-DKCNPHPKQRPG 74  37(55) 
Denmotoxin     DQ366293 QAVGLPHGF--CIQCNRKTWSNCSIGHRCLPYHMTCYTLYK--PDENGEMKWAVKGCARMCPTAK-SGERVKCCTG-ASCNSD------ 77  23(37) 
κ-Bungarotoxin 809178   ---------RTCLIS---PS--STPQT-CPNGQDICFLKAQCDKFCSIRGPVIEQGCVATCPQFRSNYRSLLCCTT-DNCNH------- 66  35(55) 
Cytotoxin II   P01441   ---------LKCKKL--VPLFS---KT-CPAGKNLCYKMFM---VAAP-HVPVKRGCIDVCPKSSLLVK-YVCCNT-DKCN-------- 60  34(48) 
Mambin         P28375   ---------RICYNH--LGTKPPTTET-CQEDS--CYKNI----WT--FDNIIRRGCG--CFTPRGDMPGPYCCES-DKCNL------- 59  42(45) 
Calciseptine   P22947   ---------RICYIH--KASLPRATLT-CVENT--CYKMF----IRTQREYISERGCG--CPTAMWP-QQTECCKG-DRCNK------- 60  35(51) 
Fasciculin 2   P01403   ---------TICYSH--TTTSRAILKD-CGENS--CYRKS----RRHPPKMVLGRGCG--CPPGD-DYLEVKCCTSPDKCNY------- 61  35(46) 
Name Accession # Homology
% Id(Sm)





Figure 2.8: Comparison of the amino acid sequence of haditoxin with the sequences of other three-finger toxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved eight cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number is also stated for each toxin. The source organisms for each of the toxin are as follows- Haditoxin 
(Ophiophagus hannah); MT 1, Muscarinic toxin 1 (Dendroaspis angusticeps); MT 2, Muscarinic toxin 2 (Dendroaspis angusticeps); 
Toxin-α (Naja nigricollis); Erabutoxin-α (); WTX weak toxin (Naja kaouthia); Candoxin (Bungarus candidus); α-Cobratoxin (Naja 
kaouthia); α-Bungarotoxin (Bungarus multicinctus); Denmotoxin (Bioga dendrophila); κ-Bungarotoxin (Bungarus multicinctus); Cytotoxin 





Haditoxin O. hannah             DQ902575 TKCYNHQSTTPETTEICPDSGYFCYKSSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ 65  
MTLP            B. multicinctus      Q9W727   TICYNHLSRTPETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ 65 80(83) 
NL1 N. atra             Q9DEQ3   TICYNHLSRTPETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ 65 80(82) 
MTLP-3       N. kaouthia               P82464   TICYNHLTRTSETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGIYVYCCRRDKCNQ 65 75(80) 
 
Name Organism Accession # Homology
% Id(Sm)








Figure 2.9: Sequence alignment of haditoxin with the most homologous sequences of other three-finger toxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved eight cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The identical residues among the sequences have been highlighted in black. The accession number and the source 
organism are also stated for each toxin. The names of the toxins are as follows- MTLP (Muscarinic toxin like protein), NL1 (Neurotoxin 








Haditoxin O. hannah          DQ902575 TKCYNHQSTTPETTEICPDSGYFCYK-SSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ  65  
MTLP        B. multicinctus  Q9W727 TICYNHLSRTPETTEICPDSWYFCYK-ISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ 65 80(83) 
MTLP-3 N. kaouthia    P82464 TICYNHLTRTSETTEICPDSWYFCYK-ISLADGNDVRIKRGCTFTCPELRPTGIYVYCCRRDKCNQ 65 75(80) 
MTLP-1      N. kaouthia  P82462 LICVKEKFLFSETTETCPDGQNVCFNQAHLIYPGKYKRTRGCAATCPKLQNR-DVIFCCSTDKCNL  65 38(54) 
MTLP-2      N. kaouthia P82463 LTCVKEKSIFGVTTEDCPDGQNLCFKRWHMIVPGRYKKTRGCAATCPIAENR-DVIECCSTDKCNL  65 37(54) 
MTα    D. polylepis P80494 LTCVTSKSIFGITTENCPDGQNLCFKKWYYLNHRYSDITWGCAATCPKPTNVRETIHCCETDKCNE  66 37(52) 
MT3          D. angusticeps  Q8QGR0 LTCVTKNTIFGITTENCPAGQNLCFKRWHYVIPRYTEITRGCAATCPIPENY-DSIHCCKTDKCNE  65 35(52) 
MT1          D. angusticeps AAB31994 LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYR-DVINCCGTDKCNK  65 34(51) 
 
Name Organism Accession # Homology
% Id(Sm)









Figure 2.10: Sequence alignment of haditoxin with the sequences of muscarinic toxins and their homologs. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved eight cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The identical residues among the sequences have been highlighted in black and the homologous residues are highlighted 
in grey. The accession number and source organisms are also stated for each toxin. The names of the toxins are as follows- MTLP 
(Muscarinic toxin like protein), MTLP-3 (Muscarinic toxin like protein-3), MTLP-1 (Muscarinic toxin like protein-1), MTLP-2 





The homogeneity and purity of the isolated protein were confirmed using ESI-MS 
(Fig. 2.3) and capillary electrophoresis (Fig. 2.6). Further, the identity was 
confirmed by N-terminal Edman degradation sequencing (Fig. 2.5). The purified 
protein consists of predominantly β-sheeted secondary structure like all other 
3FTXs.  
To evaluate the muscarinic effects of haditoxin we examined its effect on ex vivo 
smooth muscle preparations, the rat ileum and rat anococcygeus muscle, 
pharmacologically characterized to represent mAChRs. As observed, in both 
preparations the protein had no effect (discussed in chapter 3). The highly 
conserved sequences among different mamba muscarinic toxins include eight 
cysteine residues, the LTCV and TDKCN N- and C-terminal motifs, and the 
GQN(L/V)CFK sequence in the region connecting loops I and II (for a review see, 
Servant and Fruchart-Gaillard, 2009). Haditoxin possesses all the eight cysteine 
residues together with the DKCN motif in the C-terminal but the N-terminal 
LTCV is replaced with TKCY and the inter-loop GQN(L/V)CFK is replaced by 
SGY(F)CYK (Fig. 2.11). Altogether, except for the eight cysteine residues (these 
are conserved for all 3FTXs) haditoxin reserves only the C-terminal motif of the 
conserved sequences of the muscarinic toxins. It also lacks the critical residues 
(Arg34, Met35, Tyr36 and Phe38) responsible for the interaction of toxins with 
the muscarinic receptors. Therefore, it is likely that the observed sequence 
similarity of haditoxin with muscarinic toxin homologs is probably coincidental 
due to either phylogeny or structure, including the presence of the core disulfide 
bridges, and not the function. This merits further investigation, hence we 




symptoms were observed in the in vivo toxicity studies (discussed in chapter 3) 
which directed us to the sequence comparison of haditoxin with that of the snake 
venom α-neurotoxins.  
Thus, a sequence comparison of haditoxin to other snake neurotoxins, including 
short-chain α-neurotoxin, long-chain α-neurotoxins and non-conventional 
neurotoxins, was conducted (Fig. 2.12-2.14). The observed sequence similarity 
with short-chain neurotoxins was about 54-60% (Fig. 2.12), with long-chain 
neurotoxins was about 52-57% (Fig. 2.13) and with that of the non-conventional 
toxins was 42-55% (Fig. 2.14). Despite of the low sequence identity, it was 
observed that some of critical residues involved in the recognition of nicotinic 
acetylcholine receptor (nAChRs) by snake neurotoxins were conserved in 
haditoxin (Trp29, Asp31 and Arg33). This led us to the investigation of 
neuromuscular blockade properties of haditoxin on ex vivo organ-bath 
experiments using nerve-skeletal muscle preparations (rat hemidiaphragm muscle 
and chick biventer cervicis muscle). Potent neuromuscular blockade was observed 
with haditoxin which was partially reversible on chick muscle whereas 
irreversible on rat muscle (discussed in chapter 3).  Therefore, we had also 
compared the sequence of haditoxin to the snake venom neurotoxin and 
neurotoxin homologs which is reported to produce either reversible or partially 
reversible neuromuscular blockade. These include neurotoxins such as-
psedonajatoxin b (Psedonaja textilis), LSIII (Laticauda semifasciata) and 
fasciatoxin (Bungarus fasciatus) as well neurotoxin homologs, such as- CM10 





Haditoxin  O. hannah       DQ902575  TKCYNHQSTTPETTEICPDSGYFCYKS-SWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ 65 
MT1        D. angusticeps  AAB31994  LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYR-DVINCCGTDKCNK 65 
MT2        D. angusticeps  P18328    LTCVTTKSIGGVTTEDCPAGQNVCFKRWHYVTPKNYDIIKGCAATCPKVDNN-DPIRCCGTDKCND 65 
MT3        D. angusticeps  P81031    LTCVTKNTIFGITTENCPAGQNLCFKRWHYVIPRYTEITRGCAATCPIPENY-DSIHCCKTDKCNE 65 
MT4        D. angusticeps  Q9PSN1    LTCVTSKSIFGITTENCPDGQNLCFKKWYYIVPRYSDITWGCAATCPKPTNVRETIHCCETDKCNE 66 
MT7        D. angusticeps  Q8QGR0    LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYR-DVINCCGTDKCNK 65 




Consensus sequence  
 
LTCV----I---T-E-CP-GQN-CFK---Y----------GC-ATCP-------I-CC-TDKCN- 











Figure 2.11: Comparison of the amino acid sequence of haditoxin with the conserved sequences of muscarinic toxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The highly conserved sequences 
(Consensus sequence) among different muscarinic toxins are highlighted in black (identical residues) and grey (homologous residues). The 
conserved eight cysteine residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate 
the segments contributing to the three loops. The accession number and source organisms are also stated for each toxin. The names of the 
toxins are as follows- MT1 (Muscarinic toxin 1), MT2 (Muscarinic toxin 2), MT3 (Muscarinic toxin 3), MT4 (Muscarinic toxin 4), MT7 





Haditoxin    O. hannah       DQ902575           TKCYNHQSTTPETTEICPDSGYFCYKSSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ 65  
Erabutoxin A L. semifasciata 5EBX_A    RICFNHQSSQPQTTKTCSPGESSCYNKQWSDFRGTIIERGCG--CPTVKP-GIKLSCCESEVCNN  62 42(54) 
Erabutoxin B  L. semifasciata  1ERA         RICFNHQSSQPQTTKTCSPGESSCYHKQWSDFRGTIIERGCG--CPTVKP-GIKLSCCESEVCNN 62  42(54) 
Toxin-α       N. nigricollis   1NEA         LECHNQQSSQPPTTKTC-PGETNCYKKVWRDHRGTIIERGCG--CPTVKP-GIKLNCCTTDKCNN 61  46(57) 
α-Neurotoxin   D. polylepis    1NTX         RICYNHQSTTRATTKSC--EENSCYKKYWRDHRGTIIERGCG--CPKVKP-GVGIHCCQSDKCNY 60     49(60) 
Name Organism Accession # Homology
% Id(Sm)









Figure 2.12: Sequence alignment of haditoxin with the sequences of short-chain α-neurotoxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved eight cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The identical residues among the sequences have been highlighted in black and the homologous residues are highlighted 







Hdtx   DQ902575 TKCYNHQSTTPETTEICPDSGYFCYKSSWIDG----REGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ--------------------- 65 
LC-a   P0C8R7   RICYL----APRDTQICAPGQEICYLKSWDDGTGFLKGNRLEFGCAATCPTVKP-GIDIKCCSTDKCNPHP-----KLA----------- 69 43(55)
Lc-b   P0C8R8   RICYL----APRDTQICAPGQEICYLKSWDDGTGSIRGNRLEFGCAATCPTVKR-GIHIKCCSTDKCNPHP-----KLA----------- 69 42(54)
α-Btx  P01378   IVCHTTA-TSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKP-YEEVTCCSTDKCN--P---HPKQRP-G-------- 74 37(52)
α-Ctx  P01391   IRCFI---TPDITSKDCPNG-HVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKT-GVDIQCCSTDNCNPFP----TRKRP---------- 71 34(52)
Lc-ntx ABB83626 TKCYKT--GERIISETCPPGQDLCYMKTWCDVFCGSRGRVIELGCTATCPTVKH-HEQITCCSTDNCNPHP---KMKQR----------- 73 42(57)
Ln-ntx ACQ90251 RKCYK---THPYKSEPCASGENLCYTKTWCDFRCSQLGKAVELGCAATCPTTKP-YEEVTCCSTDDCNRFPNWERPRPRPRGLLSIMDHP 86 40(52)
Name Accession # Homology
% Id(Sm)










Figure 2.13: Sequence alignment of haditoxin with the sequences of long-chain α-neurotoxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number is also stated for each toxin. The source organisms for each of the toxin are as follows- Hdtx, 
Haditoxin (Ophiophagus hannah); Lc-a (Laticauda colubrina); Lc-b (Laticauda colubrina); α-Btx, α-Bungarotoxin (Bungarus 






Name Organism Accession # Homology
% Id(Sm)
Loop I Loop IIILoop II
Haditoxin  O.hannah    DQ902575 TKCYNHQSTTP--ETTEICPDSGYFCYKSSWIDGREG-RIERGCTFTCPELTPNGKYVYCCRRDKCNQ 65 
Candoxin   B.candidus  P81783   MKCKICNFDTCRAGELKVCASGEKYCFKES-WREARGTRIERGCAATCPKGSVYGLYVLCCTTDDCN- 66  40(55) 
WNTx10     N.sputatrix AAL87468 LTCLNCPEVFC--KKFQTCRNGEKICFKKFDERKLFGKRYRRGCAATCPEAKPR-EIVQCCSTDRCNR 65  34(50) 
OxianaWTX  N.oxiana    P85520   LTCLICPEKYC--NKVHTCRNGEKICFKKFTQRKLLGKRYIRGCAATCPEAKPR-EIVECCSTDKCNH 65  32(43) 
WNTX6      N.naja      P29180   LTCLICPEKYC--NKVHTCLNGEKICFKRYSERKLLGKRYIRGCADTCPVRKPR-EIVQCCSTDKCNH 65  31(42) 
WNTx8      N.sputatrix AAL87466 LTCLNCPEMFC--GKFQTCRNGEKICFKMLQQRRPFSLRYIRGCAATCPGTKPR-DMVECCSTDRCNR 65  31(45) 










Figure 2.14: Sequence alignment of haditoxin with the sequences of non-conventional neurotoxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number and source organism are also stated for each toxin. The name of the toxins are as follows- Weak 







Haditoxin    DQ902575 TKCYNHQSTT-PETTEI-CP-DSGYFCYKSSWID----GREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ------ 65 
ToxinS5C10   P01409   RICYNHQSNT-PATTKS-CV-ENS--CYKSIWAD----HRGTIIKRGCG--CPRVKS---KIKCCKSDNCNL------ 58 45(57)
Candoxin     P81783   MKCKICNFDTCRAGELKVCASGEKY-CFKESWR----EARGTRIERGCAATCPKGSVYGLYVLCCTTDDCN------- 66 40(55)
CM10         P01420   MICYKQQSLQFPITTV--CP-GEKN-CYKKQWSG----HRGTIIERGCG--CPSVKKG-IEINCCTTDKCNR------ 61 40(51)
CM12         P01421   MICYKQRSLQFPITTV--CP-GEKN-CYKKQWSG----HRGTIIERGCG--CPSVKKG-IEINCCTTDKCNR------ 61 38(51)
LsIII        P01379   RECYLNP-----HDTQT-CPSGQEI-CYVKSWCNAWCSSRGKVLEFGCAATCPS-VNTGTEIKCCSADKCNTYP---- 66 37(51)
Psdtxnb      P13495   RTCFITPD----VKSKP-CPPGQEV-CYTETWCDGFCGIRGKRVELGCAATCPTPKKTGIDIQCCSTDDCNTFPLRP- 71 34(43)
Fasciatoxin  P14534   LKCHKAQF---PNIETQ-CK-WQT-LCFQRDVKP---HPSSMIVLRGCTSSCGK------GAMCCATDLCNGPSTPST 63 28(40)
Name Accession # Homology
% Id(Sm)










Figure 2.15: Sequence alignment of haditoxin with the sequences of reversible neurotoxins and neurotoxin homologs. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number is also stated for each toxin. The source organisms are as follows- Haditoxin (Ophiophagus 
hannah); ToxinS5C10 (Dendroaspis jamesoni); Candoxin (Bungarus candidus); CM10 and CM12 (Naja haje annulifera); LsIII (Laticauda 






haditoxin exhibited only 40-57% sequence similarity (Fig. 2.15) with these snake 
toxins. 
As haditoxin eluted out earlier in gel filtration chromatography (peak 2 of Fig. 2.1) 
compared to the other 3FTXs (peak 3 of Fig. 2.1) indicating the existence of 
multimeric states of the molecule, therefore we compared the sequence of 
haditoxin with the existing snake venom dimeric 3FTXs. Among them there are 
κ-neurotoxins known to be composed of two identical monomers (homodimers) 
held together by non-covalent interactions such as- κ-bungarotoxin, κ2-
bungarotoxin, κ-flavitoxin and others. Haditoxin bears about 52-57% of 
homology to κ-neurotoxins (Fig. 2.16). Further sequence comparison was also 
performed between haditoxin and covalently linked dimeric neurotoxins held 
together by a disulfide bridge. They are irditoxin (heterodimer of subunit A and B) 
isolated from a colubrid venom (Boiga irregularis) as well covalently (disulfide) 
linked homodimers of α-cobratoxin and heterodimers of α-cobratoxin in 
combination with a variety of three-finger cytotoxins all isolated from an elapid 
venom (Naja kauothia). Haditoxin possesses about 45% similarity with irditoxin 
subunit A and 46% with subunit B (Fig. 2.17). The sequence similarity of the 
protein of interest with that of α-cobratoxin was 52% and 48-49% (Fig. 2.17) to 









Name Accession # Homology
% Id(Sm)
Loop I Loop IIILoop II
Haditoxin  DQ902575  TKCYNHQSTTPETTEICPDSGYFCYKSS----WIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ 65 
κ6-Bgtxn   Q9W729    RTCHISTSSTPQT---CPKGQDICFRKTQCDKFCSIRGAVIEQGCVATCPEFRSNYRSLLCCRTDNCNP 66 38(57) 
κ3-Bgtxn   P15817    RTCLISPSSTPQT---CPNGQDICFRKAQCDNFCHSRGPVIEQGCVATCPQFRSNYRSLLCCRTDNCNH 66 37(57) 
κ5-Bgtxn   O12962    KTCLISPSSTPQT---CPQGQDTCFLKALCDKLCPIRGPVIEQGCAATCPEFRSNYRSLLCCTTDNCNH 66 37(55) 
κ-Flvtxn   P15815    RTCLISPSSTSQT---CPKGQDICFTKAFCDRWCSSRGPVIEQGCAATCPEFTSRYKSLLCCTTDNCNH 66 37(54) 
κ4-Bgtxn   O12961    RTCLISPSSPPQT---CPKGEDICIVKARCDEWCLRRGPLIERGCAATCPEFRSNYRSLLCCTTDNCNH 66 37(52) 
κ2-Bgtxn   P15816    KTCLKTPSSTPQT---CPQGQDICFLKVSCEQFCPIRGPVIEQGCAATCPEFRSNDRSLLCCTTDNCNH 66 35(57) 










Figure 2.16: Sequence alignment of haditoxin with the sequences of κ-neurotoxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number is also stated for each toxin. The source organisms for each of the toxin are as follows- Hdtx, 
Haditoxin (Ophiophagus hannah); κ6-Bgtxn, κ6-bungarotoxin (Bungarus multicinctus); κ3-Bgtxn, κ3-bungarotoxin (Bungarus 
multicinctus); κ5-Bgtxn, κ5-bungarotoxin (Bungarus multicinctus); κ-Flvtxn, κ-flavitoxin (Bungarus flaviceps flaviceps); κ4-Bgtxn, κ4-






Haditoxin     DQ902575 -------TKCY---NHQSTTPETTEICPDSGYFCYKSSWIDGREGR----IERGCTFTCPELTPNGKYVYCCRRDKCNQ------- 65  
CX1           P60305   -------LKCN------KLIPIASKTCPAGKNLCY-KMFMMSDLTIP---VKRGCIDVCPKNSLLVKYV-CCNTDRCN-------- 60 32(48)
CX2           P01445   -------LKCN------KLIPLAYKTCPAGKNLCY-KMFMVSNKTVP---VKRGCIDVCPKNSLLVKYV-CCNTDRCN-------- 60 32(48)
CX3           P01446   -------LKCN------KLIPLAYKTCPAGKNLCY-KMFMVSNKTVP---VKRGCIDACPKNSLLVKYV-CCNTDRCN-------- 60 32(49)
α-Cobratoxin  P01391   -------IRCF------ITPDITSKDCPNG-HVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTGVDIQ-CCSTDNCNPFPTRKRP 71 34(52)
IrTxA         A0S864   QAVGPPYTLCFECNRMTSSDCSTALRC--YRGSCYTLYRPDENCELK-WAVK-GCAETCPTAGPNERVK-CCRSPRCNDD------ 75 28(45)
IrTxB         A0S865   QAKGPPYTLCFECNRETCSNCFKDNRCPPYHRTCYTLYRPDGNGEMK-WAVK-GCAKTCPTAQPGESVQ-CCNTPKCNDY------ 77 34(46)
Name Accession # Homology
% Id(Sm)








Figure 2.17: Sequence alignment of haditoxin with the sequences of covalent dimeric neurotoxins and cytotoxins. 
The number of amino acid residues in each sequence is indicated at the end of the respective sequence. The homology of each of the 
sequence in (%Id) identity and homology or similarity (Sm) with the sequence of haditoxin is also mentioned. The conserved cysteine 
residues are highlighted in black and the disulfide linkages are shown by black lines. The black arrows indicate the segments contributing 
to the three loops. The accession number is also stated for each toxin. The source organisms are as follows- Haditoxin (Ophiophagus 
hannah); CX1, Cytotoxin 1 (Naja kaouthia); CX2, Cytotoxin 2 (Naja kaouthia); CX3, Cytotoxin 3 (Naja kaouthia); α-Cobratoxin (Naja 








In conclusion, a novel three-finger toxin, haditoxin was isolated and purified to 
homogeneity from the venom of an elapid, O. hannah. A detailed sequence 
analysis was carried out where haditoxin was compared with the different class of 
three-finger toxins. Although haditoxin showed high homology (> 80%) with 
muscarinic toxin homologs, it did not exhibit any muscarinic effect on isolated 
tissue. Moreover, a potent neuromuscular blockade was observed when haditoxin 
was applied to the mammalian and avian nerve-skeletal muscle preparation. 
Hence, haditoxin was subjected to a detailed pharmacological characterization 
using in vivo toxicity and ex vivo organ-bath studies as well as the effect of 
haditoxin was also observed on different subtypes of human nicotinic receptors 
































Pharmacological characterization of haditoxin 
 
3.1   INTRODUCTION 
Pharmacology is one of the keystones of the drug discovery process. In drug 
discovery, in vivo, ex vivo and in vitro models using live animals, tissue/organ 
baths and electrophysiology/solid-phase binding studies lead to the development 
of novel, effective and selective molecules that can themselves be used as 
therapeutic agents or can be used to characterize different receptors and 
pathophysiological processes in the larger context of in vivo pharmacology. 
Although, pharmacology means ‘the science of drugs’ (Greek pharmakos, 
medicine or drug; and logos, study) but in the main tasks of pharmacologists 
involves 1) screening of molecules for desired activity, 2) determining their mode 
of action, and 3) quantifying drug activity (dose-response relationship). 
For over one hundred years, isolated tissue and organ preparations have been used 
in regular practice by the pharmacologist (Tyrode, 1910; Krebs and Henseleit 
1932; Krebs, 1950; Parascandola, 1986). Traditionally, tissue-organ baths are 
used to investigate the physiological and pharmacological response of a drug 
molecule on different tissue preparations (ring/vessel or strip) from various 
species (mice, chick, rat, guinea-pig, frog, rabbit, etc.) and finally to generate the 
dose-response relationship. Tissues or organs have been isolated for these studies 
include muscle (Smooth or Skeletal), arterial rings or strips, uterine tissue or Vas 
deferens, ileum, colon, atrial or ventricle and diaphragm. Typically, these 




with an oxygenated physiological solution, which allows the study of evoked 
tissue responses to pharmacological drug/agents (Dose-response studies), 
electrical stimulation or both pharmacological and electrical stimulation (Kenakin, 
2006). The recorded responses or biological activity usually are the 
contraction/relaxation of muscle in the tissue: Force (isometric), Displacement 
(isotonic). The type of transducers/probes (isometric or isotonic) used in organ 
bath setups will vary depending on the type of tissue and physiological parameters 
to be investigated. The advantages of this method include ease in preparation, 
minimal equipment requirements, reproducible concentration–effect curves can be 
obtained using either contractile or relaxant agents as well the independency of 
these preparations from the in vivo systemic influences (Furchgott, 1972). 
Electrophysiology is a well established discipline to study the electrical properties 
of the living cells (for a review see, Scanziani and Häusser, 2009). It is defined as 
the study of endogenous electrical currents in cells and of the effects of applied 
electrical currents on cell function. The electrical activity in a cell is controlled by 
the movement of ions, such as- Na+, K+, Cl– and Ca2+, through ion channels. 
Therefore, molecules that affect the normal activity of the ion channels will alter 
the electrical properties of a cell and these effects can be visualized using different 
electrophysiological techniques. Many venom proteins are well-known to interact 
with the ion channel and thereby altering the electrical properties of the cells. 
Hence, electrophysiology is known to be a routine and reliable technique to 
understand the mechanism of action for different venom proteins as well as to 




This chapter details the pharmacological characterization of haditoxin. The initial 
studies were done to find out the muscarinic effect of haditoxin, because of the 
observed high sequence similarity (discussed in chapter 1), using different 
isolated tissue preparations. Further we performed an in vivo toxicity study with 
haditoxin on mice to observe the biological effects of the protein on living 
organisms. Subsequently, action mechanism of haditoxin was elucidated using 
organ bath studies with different nerve-skeletal muscle preparations. The 
molecular target of this protein was finally identified by electrophysiological 
studies where two-electrode voltage-clamp (TEVC) experiments were performed 


















3.2   MATERIALS AND METHODS 
3.2.1   Drugs and chemicals 
All chemicals and reagents were purchased from Sigma (St. Louis, MO, USA). 
The drugs used in pharmacological studies: acetylcholine chloride, 
Carbamylcholine chloride (carbachol), atropine sulfate monohydrate, d-
tubocurarine chloride, phentolamine methanesulfonate, neostigmine bromide and 
α-bungarotoxin were obtained from Sigma (St. Louis, MO, USA). Potassium 
chloride was obtained from Merck (Darmstadt, Germany). O. hannah venom in 
lyophilized form was obtained from PT Venom Indo Persada (Jakarta, Indonesia) 
and Kentucky Reptile Zoo (Slade, KY, USA). Haditoxin was purified from the 
venom as described in chapter 2 and lyophilized. The lyophilized powder was 
used to prepare the stock solution. The stock solutions of drugs and toxins were 
prepared fresh as and when required by dissolving them in deionized water. 
Further dilutions to required concentrations were made using either normal saline 
(0.89% NaCl) for the in vivo experiments or Krebs physiological salt solution 
(composition described below) for the ex vivo experiments. 
 
3.2.2   Animals 
Swiss albino male mice (3 weeks, 13 ± 2 g) were used for the in vivo toxicity 
study. Animals were acquired from the university Laboratory Animal Center and 
were acclimatized to the Animal Holding Unit surroundings for at least 3 days 
before the experiments. For ex vivo experiments male Sprague Dawely rats (250-
350 g), 3 to 7-day-old domestic chicks (Gallus domesticus) (purchased from 




the day of experimentation. All other animals were kept under standard conditions 
with food and water available ad libitum. The animals were housed four per cage 
in a light controlled room (12 h light/dark cycle, light on 0700 h) at 23°C and 60% 
relative humidity. All animal experiments were conducted according to the 
protocol (021/07a) approved by the Institutional Animal Care and Use Committee 
of the National University of Singapore. 
 
3.2.3   Methods of protein administration 
The protein was dissolved in 200 µl of 0.89% NaCl (Braun, Malaysia) and 
administered through the intraperitoneal route for the in vivo toxicity study in 
mice. The various protein doses were dissolved in 200 µl of 0.89% NaCl solution 
and injected into the peritoneal cavity using a 27 G X [1⁄2]” needle (Becton-
Dickinson, Franklin Lakes, NJ, USA) held at an angle of 45° to peritoneal cavity. 
The injection was made slowly and at a steady rate. 
 
3.2.4   In vivo toxicity study 
Native protein was injected intraperitoneally (i.p.) into the Swiss albino mice at 
doses of 5, 10 and 25 µg/g (n=2). The volume injected was 200 µl, and the protein 
was dissolved in 0.89 % NaCl. The animals were observed for the symptoms were 
observed and recorded to find out biological activity of haditoxin, and in the event 
of death, the times of death were noted. Control animals were injected 200 µl of 






3.2.5   Determination of LD50 
The method of Meier and Theakston (1986) for assessing the toxicity of venom 
and toxins was adapted to determine the lethal dose for 50% population (LD50). 
As suggested by Aird and Kaiser (1985) additional guidelines were also taken into 
account. Male Swiss albino mice were given intraperitoneal injections of weight 
proportional doses (D) (5, 10 and 25 µg/g body weight) of the haditoxin. The 
toxin was dissolved in 0.89 % NaCl up to a volume of 200 µl prior to injection. 
Two animals were used for each dose. The time between injection and death 
(indicating the survival time) was recorded for each animal. The average survival 
time (T) was calculated for each dose of toxin. A plot of D/T (abscissa) versus D 
(ordinate) was constructed and the point where the regression line intersected the 
ordinate depicted the LD50, defined by the method as the smallest dose of toxin 
responsible for killing of the 50% of experimental animals in an unlimited time. 
 
3.2.6    Ex vivo organ bath studies 
Isolated tissue experiments were performed using a conventional organ bath set-
up. The Organ bath with a chamber volume of 6 ml was used for the different 
tissue preparations. Krebs physiological salt solution (118 mM NaCl, 4.8 mM 
KCl, 1.2 mM KH2PO4, 2.4 mM MgSO4, 2.5 mM CaCl2, 25 mM NaHCO3, 11 mM 
D-(+) glucose, pH 7.4) was used for all the tissue-organ bath studies. Deionized 
water was used to prepare the fresh Krebs solution and it is continuously aerated 
with carbogen (5% carbon dioxide in oxygen) for all the isolated tissue 
experiments. The organ bath was maintained at physiological temperature (37 °C) 




at 1-2 g unless specified otherwise. The preparations were allowed to equilibrate 
for about 30-45 min. Krebs solution was changed at intervals of 15 min during the 
equilibration period before the beginning the experiments and the tissue was left 
in contact with the toxin for a maximum of 3 h. Electrical field stimulation (EFS) 
was carried out through platinum ring electrodes using a Grass stimulator S88 
(Grass Instruments, MA, USA). The magnitude of the contractile responses of the 
tissues was measured in gram (g) tension. Data was continuously recorded using a 
PowerLab/Chart 5 (AD Instruments, New South Wales, Australia) via a force 
displacement transducer (Model MLT0201, AD Instruments). A schematic 
representation of organ bath experimental setup is shown in figure 3.1. 
Neuromuscular blockade is expressed as a percentage of the original twitch height 
in the absence of toxin. Dose-response curves representing the percent blockade 
after 30 min of exposure to the respective toxins were plotted.  
 
3.2.7   Reversal studies 
To examine the reversibility of the neuromuscular blockade produced by 
haditoxin, the recovery of the toxin treated tissue was observed after the complete 
neuromuscular blockade or 80% blockade. The toxin was removed from the organ 
bath chamber by extensive washing (3 cycles of 30 sec on 30 sec off pulse with a 
flow rate of 20 ml/min) with fresh Krebs solution and it was continued at 30 min 
intervals over a period of 120 min. The effect of anticholinesterase neostigmine 
was observed on the reversal of the neuromuscular blockade produced by 
haditoxin either by the addition of single doses (3 and 5 µM) or by cumulatively 

























Figure 3.1: Schematic representation of the organ bath experimental setup used for studies of isolated tissues. 
The water bath containing the organ bath chamber is maintained at 37 °C. The organ bath is continuously aerated with carbogan (95% O2 
and 5% CO2) during the experiment. Fresh Krebs solution was supplied to the organ bath by controlled gravity-driven perfusion. The 
isolated tissue was mounted in the organ bath aligned to the platinum ring electrodes (the black ring attached to the electrode in the 
diagram) which is attached to the Grass stimulator S88 (Grass Instruments, MA, USA) through which the electrical field stimulation is 
applied when needed.  The contractile response of the tissues was recorded using a computerized PowerLab/Chart 5 system (AD 




3.2.8    Rat ileum preparations 
Intestinal smooth muscle activity is closely regulated by the parasympathetic 
nervous system. It is presumed, the muscarinic receptors principally reside within 
smooth muscle cells because of their synaptic contact with the cholinergic nerves 
(Buckley and Caulfield, 1992; Eglen et al, 1996). Like all other smooth muscles, 
rat ileum contains heterogeneous populations of muscarinic receptors (~70% M2 
and ~30% M3 as determined by radioligand binding studies) (Ehlert and Tomas, 
1995). The contracture of the smooth muscle in the gastrointestinal tract contains 
both M2- and M3-subtypes of muscarinic receptors. M3 receptor mediates ileal 
contraction, whereas, the role for M2 receptor, is relaxation which is driven by 
modulation of cAMP levels (Eglen et al, 1994; Eglen et al, 1996). The initial 
basis for this conclusion rests on the findings of several investigators who have 
shown that the potencies of subtype selective muscarinic antagonists for blocking 
contraction (see reviews by Eglen et al, 1996). 
Healthy SD rats were euthanized by asphyxiation in an airtight chamber 
connected to a CO2 gas tank. The lower abdomen was cut open with a midline 
incision and the ileum was isolated out. It was then flushed with warm Krebs 
solution and the intact ileum was stripped into approximately 2 cm segments.  
They were then suspended in the organ bath chamber using hooks. Contractile 
response was checked at intervals by adding 50 µM acetylcholine.  The effect of 
haditoxin (1.5 µM, n=3) on the tissue was checked followed by acetylcholine (50 
µM). If there was no blockade, atropine (1 µM), a non-selective muscarinic 





3.2.9    Rat anococcygeus muscle preparations 
The anococcygeus muscles are a pair of smooth muscles of the urogenital tract 
that originate in the upper coccygeal vertebrae and run around the terminal colon 
to the ventral surface (Gibson and McFadzean, 2001; Gillespie, 1972). The rat 
anococcygeus muscle (RAM) consists of a thin sheet of smooth muscle fibres, the 
autonomic innervations of which contains noradrenergic (motor excitatory), 
cholinergic (motor excitatory) and inhibitory (nitrergic) NANC components 
(Gillespie, 1972). As far as effects to exogenous cholinergic agents are concerned, 
the muscle responds to both muscarinic and nicotinic agonists. Muscarinic 
receptors located postjunctionally subserve contraction (Gillespie, 1972). A single 
type of muscarinic receptor, the M3 subtype, mediates the muscarinic contraction 
in RAM. Thus, the isolated RAM may serve as a novel and robust functional 
muscarinic M3 receptor model. 
Healthy SD rats were euthanized by asphyxiation in an airtight chamber 
connected to a CO2 gas tank. The pelvic region of the rat was cut open to expose 
the terminal colon in order to visualize the pair of anococcygeus muscles. The 
muscles were then tied with sutures on both ends and isolated and mounted in the 
organ baths. Motor responses of the muscle were then elicited by EFS of 20-30 V, 
10 Hz, 1 ms pulse width every 2 min and the response was recorded. Haditoxin 
(1.5 µM, n=3) was added in the presence of EFS to find out its effect. If there was 
no blockade, phentolamine (an α-adrenergic antagonist) and atropine (a non-






3.2.10    Rat phrenic nerve-hemidiaphragm muscle preparations 
Pharmacological effect of a drug molecule on nAChRs can be evaluated by 
assessing the ability of the molecule to block the stimulation of the motor nerves 
innervating the skeletal muscle in isolated tissue preparations. The isolated 
phrenic nerve-diaphragm provides a simple preparation of mammalian muscle 
which can be easily stimulated by the phrenic nerve either directly or indirectly 
(Bulbring, 1946). It is a relatively straightforward system consisting of, 220 
motoneurons and one muscle (Gottschall, 1981).  
Healthy SD rats were euthanized by asphyxiation in an airtight chamber 
connected to a CO2 gas tank. The hemidiaphragm muscle associated with phrenic 
nerve was isolated as described by Bulbring (1946). The isolated tissue is 
mounted in the organ bath. Indirect stimulation was performed at a frequency of 
0.2 Hz in rectangular pulses of 0.2 ms duration at a supramaximal voltage of 7–10 
V (Pawlak et al, 2009). Direct muscle stimulation was achieved by electrical 
stimulation (0.2 Hz, 2 ms, 20-30 V) in the presence of dTC (10 µM), which was 
used to abolish neuromuscular transmission. In control experiments, the effect of 
indirect or direct muscle stimulation of the rat phrenic nerve-hemidiaphragm 
muscle (RHD) was observed for a total duration of 90 min. The effects of various 
concentrations of haditoxin (0.15 to 15 µM; n=3), α-bungarotoxin (0.01 to 1.0 
µM; n=3), or vehicle were investigated. The recovery of twitches was assessed by 
washing with Krebs solution, as described in the reversal studies (section 3.2.7 of 






3.2.11    Chick biventer cervicis muscle preparations 
The chick biventer cervicis muscle (CBCM) is an avian nerve-skeletal muscle 
preparation commonly used to evaluate the effect of a drug on neuromuscular 
junction (Harvey et al, 1994 and Crachi et al, 1999). The biventer cervicis is 
innervated by nerves enclosed by the tendon attached to it. The chick muscle is 
multiply innervated, which means the muscle contains both fast and slow fibres. 
Stimulation of the nerves via electrodes in contact with the tendon results in a 
contraction of the muscle generating a twitch response via the fast fibres. The 
slow fibres do not have a propagated action potential, but can be stimulated to 
give a slow contracture by addition of an exogenous agonist such as ACh/CCh or 
KCl, which causes direct muscle stimulation, to the bath (Ginsborg and Warriner, 
1960). Because of this advantage CBCM had been frequently used to assess the 
type of neurotoxicity and direct myotoxicity of the venom and toxins (Harvey et 
al, 1994). 
There are several ways by which venom and toxins can affect the neuromuscular 
transmission. They can interact with the presynaptic membrane interfering with 
the release of neurotransmitter molecules during an action potential or they can 
bind to the postsynaptic nAChRs and thereby inhibiting the binding of ACh to 
these receptors. Additionally, the toxins can also exert their action by directly 
affecting the muscle producing myotoxicity. Using CBCM we can find out the 
mechanism of neurotoxicity (presynaptic, postsynaptic or myotoxic) for a venom 
component. A presynaptic toxin would abolish the nerve evoked twitch response 
without affecting the response to the exogenous agonist of the nicotinic receptors 




elicited by KCl would also be restored. On the contrary, a postsynaptic toxin 
would abolish both the twitch response and the response to the exogenous 
agonists but the response to the direct muscle stimulation by KCl-induced 
depolarization will not be affected. In the case of myotoxic effect, the toxin 
initiates a contracture of the muscle which has a slow onset and irreversible 
nature. The twitch response of the muscle to the nerve stimulation as well the 
response to the exogenous cholinoceptor agonist would be blocked irreversibly. 
On top of this the muscle would not responds to the direct muscle stimulation 
either by exogenous KCl or by electrical stimulation (Rowan et al, 1989; Geh et 
al, 1992; Harvey et al, 1994; Geh et al, 1997). But the myotoxicity is subject to 
further investigation by histopathological studies. 
Healthy chicks were euthanized by asphyxiation in an airtight chamber connected 
to a CO2 gas tank. A midline incision was made down the back of the neck. The 
pairs of biventer cervicis muscles, which lie on either side of the midline, are 
removed and kept in warm Krebs solution. Each of the muscle is attached to a 
tissue holder with ring electrodes around the tendon and mounted in the organ 
bath (Ginsborg and Warriner, 1960). Maximal twitch responses of the muscle 
were elicited indirectly via stimulation of the motor nerve by applying an 
electrical field of 7–10 V potential difference at a frequency of 0.2 Hz in 
supramaximal rectangular pulses of 0.1 ms duration. For direct muscle 
stimulation, the electrodes were lowered from the tendon towards the belly of the 
muscle and twitch response was evoked by electric field stimulation (0.2 Hz, 1 
ms, 20-30 V). To block the neuromuscular transmission during the direct muscle 




experiments, the effect of indirect or direct muscle stimulation of the RHD was 
observed for a total duration of 180 min. The effects of various concentrations of 
haditoxin (0.15 to 15 µM; n=3) on the twitch response as well as direct muscle 
stimulation in the CBCM was investigated. The block response was expressed as 
a percentage of control twitch height in the absence of toxin. Additionally, the 
times taken to block the amplitude of the control twitch response by 50% (t50) and 
80% (t80) were calculated in order to provide a quantitative measure of 
neurotoxicity. For comparison, the effect of α-bungarotoxin (0.01 to 1.0 µM; n=3) 
on the nerve evoked twitch response in CBCM was investigated. An individual 
tissue preparation was used for each dose of toxin. To study the reversibility of 
the neuromuscular blockade produced by haditoxin the recovery of nerve evoked 
twitch response was assessed by washing with Krebs solution, as described in the 
reversal studies (section 3.2.7 of this chapter). 
At appropriate intervals, responses to exogenously applied 300 µM ACh, 10 µM 
CCh or 30 mM KCl were obtained in the absence of an electrical field 
stimulation. The magnitude of the response against these compounds varied from 
tissue to tissue but was reproducible with the same compound for the same tissue. 
After exposure to ACh, CCh or KCl the tissue was washed extensively with fresh 
Krebs solution. The electrical stimulation was then reestablished. In control 
experiments, the quantitative contractile response of the muscle to ACh, CCh or 
KCl before and after 180 min of uninterrupted nerve stimulation was obtained. 
The effects of various concentrations of haditoxin (0.15 to 15 µM; n=3) on the 




of the responses to ACh, CCh and KCl by haditoxin are expressed as a percentage 
of the respective control response prior to the addition of the toxin.  
 
3.2.12    Statistical analysis 
The data were expressed as mean ± standard error of mean (SEM) of at least 3-4 
experiments. The experiments with higher dose of haditoxin (like- 5 and 15 µM) 
and α-bungarotoxin was done with n=3. The data was analyzed using SigmaPlot 
10.0 software (Systat software Inc., San Jose, California, USA). 
 
3.2.13   Electrophysiological characterization of haditoxin 
Two-electrode voltage-clamp (TEVC) experiments were done using Xenopus 
oocytes to observe the effect of haditoxin on different human nicotinic receptor 
subtypes (αβγδ, α7, α3β2 and α4β2). The electrophysiological studies described 
below were carried out in the collaborating laboratory of Professor Daniel 
Bertrand, Department of Physiology, University of Geneva, 1 rue Michel Servet, 
1211 Geneva 4, Switzerland. 
 
3.2.14  Oocyte preparation and cDNA injection 
The study of nAChRs reconstituted in Xenopus oocytes by expression of cloned 
cDNAs is an established method for the electrophysiological characterization of 
ligands that interact with nAChRs. Xenopus oocytes were isolated and prepared as 
previously described (Bertrand et al, 1991). 
The oocytes were prepared and injected as described by Hogg et al, (Hogg et al, 




the various cDNAs (2 ng) encoding for different nicotinic receptor subunits and 
incubated at 18 °C in Barth solution consisting of (in mM) 88 NaCl, 1 KCl, 2.4 
NaHCO3, 10 HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 0.82 
MgSO4.7H2O, 0.33 Ca(NO3)2.4H2O, 0.41 CaCl2.6H2O. Electrophysiological 
experiments were performed 2-3 days after the injection of the oocytes. The pH 
was adjusted to 7.4 with NaOH. All subunits were injected with equal 
concentrations. The medium was supplemented with 20 µg/ml of kanamycin, 100 
units/ml of penicillin and 100 µg/ml of streptomycin to minimize contamination.  
 
3.2.15  Electrophysiological recording 
Electrophysiological recording were performed with a two-electrode voltage-
clamp (GeneClamp amplifier, Axon instruments, Foster City, CA, USA) as 
previously described (Bertrand et al, 1992; Servent et al, 1997; Kasheverov et al, 
2009). The oocytes were clamped at –100 mV and during recordings they were 
perfused with OR2 (oocyte Ringer) medium containing (in mM): 82.5 NaCl, 2.5 
KCl, 1 MgCl2, 2.5 Ca2Cl2, 5 HEPES, and 20 µg/ml BSA. The pH of the medium 
was adjusted to 7.4 prior to use. Atropine (0.5 µM) was added to all solutions to 
block activity of endogenous muscarinic receptors. Just before use, ACh and 
haditoxin were dissolved the OR2 solution and they were applied to the bath by 
gravity driven perfusion. The flow rate was approximately 6 ml/min and the 
chamber volume was less than 100 µl. Control responses were recorded before 
toxin exposure and toxin incubation was carried out in the recording chamber 
during 3–5 min with agitation. ACh concentration was close to the EC50 for 




responses after increasing toxin incubation times. Equilibrium was assumed to be 
reached when no further inhibition of the response was seen. All recordings were 
performed with an automated TEVC robot.  
 
3.2.16  Electrophysiological data analysis 
Data were digitized and analyzed off-line using MATLAB (Mathworks, Natick, 
MA). Dose-response curves for toxin inhibition were fit with the equation:  
y = 1/(1 + ([toxin]/IC50)nH) 
where, y is the normalized response, [toxin] is the toxin concentration, and nH is 


















3.3   RESULTS 
The isolated novel protein haditoxin showed high sequence similarity (80-83%) 
and identity (75-80%) to muscarinic toxin homologs (Fig. 2.9 in chapter 2). The 
similarity observed with muscarinic toxins is about 51-54% (Fig. 2.10 in chapter 
2).  Muscarinic toxins are especially found in mamba venoms and are known to 
interact with the muscarinic acetylcholine receptors (mAChRs), which belong to 
the GPCR superfamily (for review see, Servent and Fruchart-Gaillard, 2009; 
Jerusalinsky et al, 2000). Because of the observed sequence identity it was of 
interest to find out whether haditoxin exerts similar kind of effect as that of the 
muscarinic toxins.  
 
3.3.1 Effect of haditoxin on the cholinergic transmission mediated by 
muscarinic receptors 
To evaluate the effect of haditoxin on muscarinic receptors, we examined 
haditoxin on ex vivo smooth muscle preparations. Accordingly, different isolated 
muscle preparations are used for the study such as- the rat ileum and rat 
anococcygeus muscle. 
Addition of haditoxin did not produce blockade of the contractile response to 
exogenously applied ACh, (Fig 3.2) of the ileum smooth muscle. As expected, the 
contractile response to exogenous ACh in the ileum was completely inhibited by 
the addition of atropine (a non-selective muscarinic receptor antagonist used as a 
positive control). This inferred that there is no interaction between haditoxin and 




In order to further confirm the interaction of haditoxin with muscarinic receptors 
the protein was tested on the rat anococcygeus muscle. As observed in the 
anococcygeus muscle experiment, the contractions elicited by the EFS were 
unaffected after the addition of haditoxin (Fig 3.3) suggesting that the toxin did 
not block the cholinergic receptor mediated contractile responses of the muscle. 
Addition of phentolamine (α-adrenergic antagonist) and atropine (non-selective 
muscarinic receptor antagonist) as positive controls abolished the EFS contractile 
response.  Hence, it can be concluded that haditoxin did not mediate any effect at 
the muscarinic receptors present in the smooth muscle of ileum and the 
anococcygeus muscle.  
 
3.3.2   Biological activity of haditoxin in mice 
Intraperitoneal injection of haditoxin in mice made them quite and sluggish. They 
also showed symptoms of flaccid paralysis particularly of the hind limbs and 
labored breathing which was followed by death presumably due to respiratory 
paralysis. Mice injected with 5, 10 and 25 µg/g dose died after 92, 35 and 19 min, 
respectively (n=2) (Table 3.1). In control experiments, mice injected with equal 
volume of normal saline did not exhibit any symptoms of paralysis and survived. 
On post-mortem examination, no gross changes in the internal organs (heart, 
lungs, kidney, liver, intestine, stomach) notably hemorrhage, was observed. 
 
3.3.3   Lethality of haditoxin in mice 
 The lethality of haditoxin was assessed on mice. To measure the acute toxicity of 
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Figure 3.2: Effect of haditoxin on the cholinergic transmission in the smooth muscle of rat ileum. 
A segment of tracing showing the effect of haditoxin (1.5 µM) on rat ilium muscle preparation. Intact and stripped ileum was isolated from 
male Sprague Dawely rats (250-350 g) and mounted in the organ bath. Contractile response was checked at intervals by adding 50 µM 
acetylcholine (ACh).  The effect of the protein (1.5 µM, n=3) was observed followed by ACh (50 µM). Atropine (1 µM) (a non-selective 





















                         Figure 3.3: Effect of haditoxin on the cholinergic transmission in rat anococcygeus muscle. 
 
A segment of tracing showing the effect of haditoxin (1.5 µM) on rat annococcygeus muscle preparation. The anococcygeus muscles from 
rats were isolated and mounted. Contractile response of the muscle was elicited by EFS of 20-30 V, 10 Hz for 10 s, 1 ms pulse width every 
2 min and was recorded. The black bar indicates the electrical field stimulation (EFS). The effect of the protein of interest (1.5 µM, n=3) on 
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5 + - 20 2 
10 ++ - 32.5 2 







Table 3.1: Effects of haditoxin injected intraperitoneally into 






















method of Meier and Theakston (1986) was followed to determine the LD50 of 
haditoxin. The time of death was recorded for each animal, with the average 
calculated to be 94, 32.5 and 20 min, respectively for the 5, 10 and 25 µg/g doses 
(n=2). The plot of (D) (Y-axis) Vs. (D)/(T) (X-axis) where, D=dose of haditoxin 
and T=survival time, was plotted (Fig 3.4). The LD50 value of haditoxin was 
calculated by the point of intersection of the regression line on the Y-axis. The 
LD50 of haditoxin was determined to be 4.4 µg/g in male Swiss albino mice.  
 
3.3.4 Effect of haditoxin on the cholinergic transmission mediated by 
nicotinic receptors 
The observed peripheral neurotoxic symptoms produced by haditoxin in vivo, 
warranted detailed pharmacological characterization of this protein on 
neuromuscular transmission mediated by nicotinic receptors. Accordingly, 
different isolated muscle preparations such as- CBCM and RHD are used for the 
study.  
 
3.3.5   Effect of haditoxin on neuromuscular transmission in CBCM 
Haditoxin produced a time-dependent blockade of the nerve evoked twitch 
responses of CBCM (Fig. 3.5). The contractile response to exogenous agonists 
(ACh and CCh) was completely inhibited by haditoxin whereas, response to 
exogenous KCl and twitches evoked by direct muscle stimulation were not 
inhibited. No contracture or increase in muscle tone was observed with any of the 
doses of haditoxin tested for up to 180 min following the addition of the toxin. 


































Figure 3.4: Determination of LD50 of haditoxin. 
 
The method described by Meier and Theakston (1986) was followed to determine 
the LD50 of haditoxin. Haditoxin was injected intraperitoneally with doses of 5, 10 
and 25 µg/g into male Swiss albino mice, using two animals for each dose. The 
time between injection and death (survival time) was recorded for each animal 
and the average for each group was calculated. A plot of dose vs. dose/survival 
time was constructed. The LD50 (the smallest dose of the toxin that kills 50% of 
the experimental animals in an unlimited time) is represented by the point where 
the extrapolated regression line intersected the ordinate. The LD50 of haditoxin 





























Figure 3.5: Effect of haditoxin on the twitch response of CBCM elicited by nerve stimulation and exogenously applied  
                    acetylcholine, carbachol and potassium chloride. 
 
A segment of tracing showing the effect of haditoxin (1.5 µM) on chick biventer cervicis muscle preparations (CBCM) (n=3). Twitch 
response of the muscle was elicited by electrical field stimulation (EFS, indicated by the black bar) and by applying exogenous agonists, 
acetylcholine (ACh; 300 µM), carbachol (CCh; 10 µM) and potassium chloride (KCl; 30 mM). The vertical bar represents the magnitude of 






































































































































Figure 3.6: Dose-response curve of haditoxin and α-bungarotoxin on CBCM  
                    and RHD. 
 
The concentration-response curves for the blockade of nerve-evoked twitch 
responses in the chick and rat muscle by of haditoxin and α-bungarotoxin. The 
block is calculated as a percentage of the control twitch responses of the muscle to 
supramaximal nerve stimulation in the absence of toxins. Each data point is the 











myotoxicity. The effect of different dose of haditoxin was examined on CBCM. It 
was observed that haditoxin produces a dose-dependent effect. A dose-response 
curve was constructed and the IC50 of haditoxin on CBCM 0.27 ± 0.07 µM (Fig. 
3.6) (considering the fact that the protein exists as dimer in solution; see in 
chapter 4).  
Addition of α-bungarotoxin also completely inhibited the nerve evoked twitch 
responses of CBCM in a time-dependent fashion, without affecting the twitch 
response elicited by direct muscle stimulation or the response to exogenously 
applied KCl. A dose-response curve was constructed for α-bungarotoxin on 
CBCM and the IC50 of α-bungarotoxin was determined to be 12.1 ± 5.4 nM (Fig 
3.6). Hence, when compared to the α-bungarotoxin, haditoxin was found to be 
~20 times less potent on avian (CBCM) neuromuscular junctions. 
 
3.3.6   Effect of haditoxin on neuromuscular transmission in RHD 
The neuromuscular blockade properties of haditoxin were also evaluated on 
mammalian system. Haditoxin produced a complete time-dependent blockade of 
the nerve-evoked twitch responses in RHD (Fig. 3.7). Like CBCM, the twitch 
response due to direct muscle stimulation was not affected by the protein as well 
as the muscle tone was maintained at baseline for the entire duration of the 
experiment. When tested with was α-bungarotoxin a similar response was 
observed. The dose-dependent relationship for both haditoxin and α-bungarotoxin 
was evaluated for RHD and subsequently, a dose-response curve was constructed. 
The half inhibition (IC50) for haditoxin and α-bungarotoxin was calculated to be 

















                            Figure 3.7: Effect of haditoxin on the twitch response of RHD elicited by nerve stimulation. 
 
A segment of tracing showing the effect of haditoxin (1.5 µM) on rat anococcygeus muscle preparations (CBCM) (n=3). Twitch response 
of the muscle was elicited by electrical field stimulation (EFS), which is indicated by the black bar. The vertical bar represents the 




both the IC50 revealed that haditoxin was about ~18 times less potent on 
mammalian (RHD) neuromuscular junction.  
 
3.3.7   Reversal of neuromuscular blockade produced by haditoxin 
Reversibility of the neuromuscular blockade produced by haditoxin was tested for 
both the preparations (CBCM and RHD) with intermittent washing (indicated by 
black arrows in Fig 3.8 and 3.9). Partial recovery of the nerve evoked twitch 
response (~60% recovery in 120 min) was observed in the CBCM (Fig. 3.8) but 
not in the RHD (Fig. 3.9). In contrast, the neuromuscular blockade produced by α-
bungarotoxin was practically irreversible even after prolonged washing. The 
reversibility was also assessed by the addition of anticholinesterase neostigmine 
which transiently reverses the neuromuscular blockade produced by haditoxin for 
CBCM (Fig 3.10) but failed to produce a long-lasting effect.  These results 
indicate that, unlike typical α-neurotoxins like α-bungarotoxin, haditoxin exhibits 
partial reversibility in action, at least in the CBCM. The reversibility of haditoxin 
on CBCM was compared to that of a practically irreversible neurotoxin (α-
bungarotoxin) and a readily reversible neurotoxin (candoxin) (Nirthanan et al, 
2002) (Fig. 3.11).  
 
3.3.8   Effect of haditoxin on human nAChRs 
Since haditoxin blocked the muscle activity of the CBCM and RHD, we examined 
its activity on the human αβδε-nAChRs. Xenopus oocytes expressing human 
receptors were challenged with different concentrations of haditoxin. Haditoxin at 























Figure 3.8: Reversibility of the nerve evoked twitch response blockade produced by haditoxin in CBCM. 
 
Segment of tracing showing the complete blockade of nerve evoked twitch response in chick biventor cervicis muscle produced by 
haditoxin (1.5 µM). After the complete blockade was achieved, haditoxin was removed from the bath chamber by extensive washing (3 
cycles of 30 sec on 30 sec off pulse with a flow rate of 20 ml/min) with fresh Krebs solution and it was continued at 30 min intervals over a 
period of 120 minutes (indicated as ‘W’ in the tracing). The vertical bar represents the magnitude of twitch response in gram tension and 



















Figure 3.9: Reversibility of the nerve evoked twitch response blockade produced by haditoxin in RHD. 
 
Segment of tracing showing the complete blockade of nerve evoked twitch response in rat hemidiaphragm muscle produced by haditoxin 
(1.5 µM). After the complete blockade was achieved, haditoxin was removed from the bath chamber by extensive washing (3 cycles of 30 
sec on 30 sec off pulse with a flow rate of 20 ml/min) with fresh Krebs solution and it was continued at 30 min intervals over a period of 
120 minutes (indicated as ‘W’ in the tracing). The vertical bar represents the magnitude of twitch response in gram tension and the 



















Figure 3.10: Reversibility of the nerve evoked twitch response blockade produced by haditoxin in CBCM by neostigmine. 
 
Segment of tracing showing the blockade of nerve evoked twitch response in chick biventor cervicis muscle produced by haditoxin (1.5 
µM). After the 80% blockade was achieved, neostigmine (anticholinesterase) was added to the bath chamber cumulatively up to 10 µM at 

















































































Figure 3.11: Comparative reversibility profile of haditoxin, α-bungarotoxin  
                      and candoxin on CBCM. 
 
The reversibility of haditoxin was compared with α-bungarotoxin, a practically 
irreversible neurotoxin and candoxin, a readily reversible neurotoxin on chick 









produced by human αβδε-receptors (Fig. 3.12 A), whereas when applied alone no 
detectable current was produced. The inhibition of the ACh-induced currents by 
haditoxin was practically irreversible within 8 min washout. A dose-response 
curve was constructed and the IC50 value was found to be 550 nM (n=13) (Fig. 
3.12 B). The inhibition curve was adequately described by a single Hill equation 
with a Hill coefficient (nH) of 0.7. This result is in good agreement with the 
findings on ex vivo studies with RHD as discussed earlier.  
Further to determine the subtype specificity, we tested the activity of haditoxin on 
neuronal nACRs (α7-, α3β2- and α4β2-nAChRs). Application of haditoxin alone to 
the oocytes expressing α7-nAChRs produced no effect. However, 10 µM of 
haditoxin completely blocked the ACh-induced current produced by the α7-
receptors (Fig 3.13 A). Similar to the αβδε-receptors the blockade of the ACh-
induced current observed by haditoxin on α7-nAChRs was irreversible (Fig 3.13 
A). An IC50 value of 180 nM (n=4) from the inhibition curve (Fig 3.13 B) with a 
Hill coefficient of 0.8. As shown in figure 3.14 A, haditoxin (10 µM) fully 
blocked the ACh-induced current produced by the α3β2-nAChRs but notably, this 
blockade was fully reversible compared to the long lasting blockade observed at 
α7-nAChRs (Fig. 3.13 A). The construction of the inhibition curve revealed an 
IC50 value of 500 nM (n=4) for α3β2-nAChRs with a nH value of 1.1 (Fig 3.14 B). 
Finally, we tested the effect of haditoxin on α4β2-nAChRs. Application of 10 µM 
haditoxin blocked only 70% of the ACh-induced current with partial reversibility 
(Fig. 3.15 A). The IC50 value of the blockade is in the micromolar range (IC50 = 
2.6 µM, n=3) (Fig. 3.15 B). These results exhibited that haditoxin had a higher 





































































Figure 3.12: Effect of haditoxin on human αβδε-nAChRs expressed in Xenopus oocytes. 
(A) Inhibition of ACh-induced currents in αβδε-nAChRs (neuromuscular junction). 200 µM was used to activate αβδε-nAChRs. First 
three traces are controls, followed by 2 minutes exposure to several haditoxin concentrations ranging from 10 nM to 10 µM. (B) Inhibition 













































Figure 3.13: Effect of haditoxin on human α7-nAChRs expressed in Xenopus oocytes. 
(A) Inhibition of ACh-induced currents in α7-nAChRs. 200 µM was used to activate α7-nAChRs. First three traces are controls, followed 
by 2 minutes exposure to several haditoxin concentrations ranging from 10 nM to 10 µM. (B) Inhibition curves of the fitted data, IC50 and 















































Figure 3.14: Effect of haditoxin on human α3β2-nAChRs expressed in Xenopus oocytes. 
(A) Inhibition of ACh-induced currents in α3β2-nAChRs. 200 µM was used to activate α3β2-nAChRs. First three traces are controls, 
followed by 2 minutes exposure to several haditoxin concentrations ranging from 10 nM to 10 µM. (B) Inhibition curves of the fitted data, 












































                       Figure 3.15: Effect of haditoxin on human α4β2-nAChRs expressed in Xenopus oocytes.  
(A) Inhibition of ACh-induced currents in α4β2-nAChRs. 200 µM was used to activate α4β2-nAChRs. First three traces are controls, 
followed by 2 minutes exposure to several haditoxin concentrations ranging from 10 nM to 10 µM. (B) Inhibition curves of the fitted data, 










αβδε-nAChRs (muscle) 0.55 0.7 13 
α7-nAChRs (neuronal) 0.18 0.8 4 
α3β2-nAChRs (neuronal) 0.5 1.1 4 
α4β2-nAChRs (neuronal) 2.6 0.7 3 
 
α3β2-nAChRs were in the same nanomolar range, whereas for α4β2-nAChRs was 
in the micromolar range (Table 3.2). However, further experiments will be 





Table 3.2: Effect of haditoxin on human nicotinic receptors 
















3.4   DISCUSSION 
Nonenzymatic neurotoxins from snake venom belonging to the 3FTx family 
consist of closely related polypeptides with a MW range of 6500 to 8000 Daltons. 
Functionally, most interfere with cholinergic neurotransmission with high affinity 
and are highly specific for different subtypes of muscarinic or nicotinic 
cholinergic receptors (for details see, chapter 1). This underscores their immense 
potential as lead molecules in drug discovery and as research tools in the detailed 
characterization of different cholinergic receptor subtypes. 
In this chapter, we have described the pharmacological characterization of a novel 
neurotoxin, haditoxin isolated from the venom of O. hannah. Haditoxin belongs 
to the nonenzymatic three-finger toxin family of snake venom proteins. Based on 
the observed sequence homology with muscarinic toxins and their homologs when 
haditoxin was examined for muscarinic activity, the protein failed to show any 
effect on muscarinic receptors present in the smooth muscle of rat ileum and 
anococcygeus muscle. Under physiological conditions the contractile response 
elicited by cholinergic agonist in rat ileum is mediated by M3-subtype of 
muscarinic receptors. Activation of these receptors by ACh activates the G-
protein which in turn through a series of secondary messenger molecules leads to 
an increase of intracellular calcium levels resulting in contraction of the smooth 
muscle (Eglen et al, 1994). Under exceptional circumstances M2 receptors in the 
ileum may produce an indirect contractile response by opposing the relaxing 
effect of cGMP (Ehlert and Thomas, 1995). The anococcygeus muscle preparation 
consists of cholinergic (muscarinic receptor), adrenergic and nitrergic innervation. 




receptors (M3-subtype) (Weiser et al, 1997). It is obvious from the experimental 
results that haditoxin did not interact with the M3-subtype of muscarinic receptors 
present in the both the smooth muscle preparations. Therefore, it is likely that the 
observed sequence similarity of haditoxin with muscarinic toxin homologs is 
probably coincidental due to either phylogeny or structure, including the presence 
of the core disulfide bridges, and not the function. This demands further 
investigation, including electrophysiological studies and/or binding assays on 
other subtypes of mAChRs. 
Typical symptoms of peripheral neurotoxicity (Warrell et al, 1983; Laothong and 
Sitprija, 2001), which are very similar to the observations following the 
experimental envenomation by curare-mimetic neurotoxins (Chang et al, 1979), 
were observed in live mice with the administration of haditoxin. There was 
complete absence of any hemorrhage in the internal organs, indicating the fact 
that haditoxin might not have any cytolytic activity unlike few neurotoxins 
isolated from D. r. russelli and O. hannah venom (Shelke et al, 2002; Jing et al, 
2006). This suggests, there is a possibility that haditoxin might exert its biological 
function by affecting the neurotransmission like the curare-mimetic neurotoxins. 
They are referred to as ''curare-mimetic toxins'' because of their similarity in mode 
of action to that of the arrow poison ‘curare’ (Endo and Tamiya, 1991). They 
interact with the postsynaptic acetylcholine receptors in the neuromuscular 
junction and block the interaction of the receptors with the endogenous ligand 
such as- ACh. This interaction subsequently prevents the opening of the ion 
channel associated with the acetylcholine receptor and results in neuromuscular 




paralysis. The snake venom curare-mimetic neurotoxins (also known as α-
neurotoxins) are divided into two major groups: the short-chain α-neurotoxins, (60 
to 65 amino acids long), which are arranged in a single polypeptide chain and 
cross-linked by four disulphide bridges and the long-chain α-neurotoxins, (66 to 
87 amino acids long), which are also arranged in a single polypeptide chain but 
are cross-linked by five disulphide bridges (Dufton and Harvey, 1989 and Endo 
and Tamiya, 1991). Both the short and the long α-neurotoxins act as antagonists to 
acetylcholine receptors, preventing the interaction between ACh and postsynaptic 
receptors, resulting neuromuscular blockade.  
A sequence comparison of haditoxin (65 amino acids and four disulfide bridges) 
with the α-neurotoxins showed a similarity of 54-60% with the short-chain 
neurotoxins (Fig. 2.12 in chapter 2) and 52-57% with the long-chain neurotoxins 
(Fig. 2.13 in chapter 2). The identity of haditoxin was about 10% higher for short-
chain neurotoxin when compared to long-chain neurotoxins. This could be 
because of the resemblance of the primary structural characteristics of haditoxin 
(65 amino acid residues with 4 conserved disulfide bridges) with short-chain 
neurotoxins which are known to be composed of 60-65 amino acid residues with 
four intramolecular disulfide bridges. Additionally, it was observed that some of 
critical residues involved in the recognition of nAChRs by the α-neurotoxins 
(Endo and Tamiya, 1991; Pillet et al, 1993; Tremeau et al, 1995; Antil et al, 1999; 
Teixeira-Clerc et al, 2002; Fruchart-Gaillard et al, 2002; Bourne et al, 2005; 
Dellisanti et al, 2007) were conserved in haditoxin (Trp29, Asp31 and Arg33). 
This led us to investigate of neuromuscular blockade properties of haditoxin. It 




± 0.07 µM) and mammalian (IC50 = 1.85 ± 0.39 µM) muscle (αβγδ) nAChRs (Fig. 
3.8 and 3.9). This proved the fact that haditoxin has exerted its biological function 
by blocking the neuromuscular junction, similar to that of α-neurotoxins, in the 
mice which is followed by paralysis and subsequent death of the animal.  
Interestingly, the reversibility of this neuromuscular blockade produced by 
haditoxin in the isolated tissues was taxa-specific; it was partially reversible by 
washing on the avian (chick) neuromuscular junction, whereas it was almost 
irreversible on the mammalian (rat) neuromuscular junction. Earlier, we reported 
taxa-specific neurotoxicity of denmotoxin from Boiga dendrophila (Pawlak et al, 
2006) and irditoxin from Boiga irregularis (Pawlak et al, 2009). Taxa-specificity 
manifests the natural targeting of the venom toxins towards their prey (Pawlak et 
al, 2009; Barlow et al, 2009; Daltry et al, 1996; Pahari et al, 2007a). Venom 
composition of snake species is closely associated with its diet. Snakes from the 
Boiga sp. mainly feeds on the non-mammalian prey like birds (Prado-Franceschi 
et al, 1996; Mackessy et al, 2006; Pawlak et al, 2006; Pawlak et al, 2009), 
whereas elapids including the king cobra, mainly prey on snakes and rodents, and 
only occasionally and opportunistically on birds (Mehrtens, 1987; Coborn, 1991). 
Venom compositions of snakes are known to be dependent on prey specificity, in 
order to ensure efficiency in their capture and killing (Daltry et al, 1996). 
Therefore, the taxa-specific reversibility of the neuromuscular blockade produced 
by haditoxin is likely due to the natural species-specificity of the king cobra 
venom and not because of low toxicity. 
In electrophysiological studies, it was an antagonist of muscle (αβδε)  (IC50 = 0.55 




(IC50 = 2.60 µM) nAChRs (Fig 3.12 to 3.15). Interestingly, haditoxin exhibited a 
novel pharmacology with combined blocking activity on muscle (αβδε) as well as 
neuronal (α7, α3β2 and α4β2) nAChRs but with the highest potency on α7-nAChRs. 
Although the primary structural features of haditoxin was similar to that of the 
short chain α-neurotoxins, which recognize only the muscle subtype of nAChRs, 
but haditoxin targets both muscle and neuronal nAChRs. Hitherto, the neuronal 
nAChRs are known to be recognized by either long-chain α-neurotoxins targeting 
the α7-nAChRs (Servent et al, 1997; Servent et al., 2000) or κ-neurotoxins 
targeting the α3β2- and α4β2-nAChRs (Grant and Chiappinelli, 1985; Wolf et al, 
1988). Both long-chain α-neurotoxins and κ-neurotoxins possess an additional 
fifth disulfide bridge at the tip of loop II which is reported to be critical to interact 
with neuronal nAChRs (Servent et al, 1997). Haditoxin is the first one to retain 
the functional properties of both long-chain α-neurotoxins and κ-neurotoxins 
although it lacks the fifth disulfide bridge as well as the long C-terminal tail of 
long-chain α-neurotoxins. 
The blockade produced by haditoxin on α3β2-nAChRs was fully reversible (Fig 
3.14 A) whereas the blockade observed at α7-nAChRs (Fig. 3.13 A) was long 
lasting and practically irreversible. This suggests that the dissociation of haditoxin 
from the α3β2-nAChRs is faster when compared to the α7-nAChRs. Hence, the 
dissociation constant (KOff) value of haditoxin for the α7 receptor is much smaller 
than at α3β2-nAChRs. Although these two receptors (α7 and α3β2) display about 
equivalent IC50’s their respective association constant (KOn) values towards 
haditoxin can be significantly different. However, the experimental protocol used 




binding experiments are needed to elucidate these values. An additional difference 
between these two receptors resides in their structural composition. As the α7-
nAChRs are composed of five α-subunits (this subunit contains the ligand binding 
site) thus it is thought that they display five identical ligand binding sites (Rang et 
al, 2003), while only two binding sites are proposed for the α3β2-nAChRs 
(because these receptors are composed of two α3-subunits and three β2-subunits) 
(Colquhoun and Patrick, 1997; Itier and Bertrand, 2001). The difference in 
number of binding sites and effects on competitive blockade was previously 
discussed for α7- and α4β2-nAChRs showing significant functional outcomes 
(Palma et al, 1996). Interestingly, the electrophysiological results showed that 
haditoxin was almost 3-fold more potent to block ACh-induced responses 
mediated by α7- (IC50 = 180 nM) compared with αβδε- and α3β2-nAChRs and 
only 70% blockade of ACh-induce current was observed with α4β2-nAChRs. The 
reversibility profile was also different for the various subtypes which explain that 
the molecular mechanism of interaction for haditoxin with these receptors is 
entirely different. However, further experiments will be necessary to discriminate 











3.5   CONCLUSIONS 
In summary, we have described the mechanism of action of haditoxin in this 
chapter in detail. Its unique functional features reside in its novel pharmacological 
profiles for the two subtypes of nicotinic receptors. Till date, only long-chain α-
neurotoxins (α-bungarotoxin, α-cobratoxin) and κ-neurotoxins (κ-bungarotoxin) 
have been reported to bind with neuronal nAChRs with high affinity. The 
additional disulfide bridge present in these toxins play a vital role for the 
interaction. Haditoxin is distinctly an exception since it lacks the additional 
disulfide bond at the tip of middle loop but, nonetheless, blocks the neuronal 
receptors (α7- and α3β2-nAChRs) with nanomolar affinity. Moreover, primary 
structure-wise haditoxin is similar to short-chain α-neurotoxin whereas, unlike the 
conventional short-chain α-neurotoxin it interacts with the neuronal receptors with 
nanomolar affinity. Thus, this is the first report of a short-chain interacting with 
neuronal nAChRs. Finally, haditoxin is the first elapid neurotoxin to produce a 
taxa-specific blockade. These novel and interesting findings further led us to 
elucidate the structure as well as structure-function relationship of haditoxin 

















Biophysical and structural characterization  





Biophysical and structural characterization of haditoxin 
 
4.1   INTRODUCTION 
As discussed in the earlier chapters, with the unique functional properties, 
haditoxin is a novel member of the 3FTX family. Additionally, it was observed 
that during protein purification from crude venom, haditoxin eluted earlier 
compared to the other 3FTX members (discussed in chapter 1), which raises the 
possibility for this toxin to exist in an oligomeric state. Thus, there was a need to 
elucidate the structure of haditoxin, to clearly understand the biological function 
of this protein. Hitherto, the only available structural data for haditoxin was the 
information on its secondary structure as revealed by CD spectroscopy (discussed 
in chapter 2). Similar to all other 3FTXs haditoxin was also composed of 
predominantly β-sheet secondary structure. But this data was not enough to 
vividly understand the structure-function relationship of haditoxin. Hence, we 
proceed to determine the oligomeric nature of this protein using different 
biophysical techniques as well as the three-dimensional structure of this novel 
protein.  
Several methods are employed to study the three-dimensional structures of 
proteins. The two techniques that have been widely used in structural biology to 
elucidate protein structure are: single-crystal X-ray diffraction and nuclear 
magnetic resonance (NMR) spectroscopy. X-ray crystallography is a long-
standing and commonly used technique to determine three-dimensional structures 




electrons in the atoms forming the crystal, which generates particular diffraction 
pattern. From this diffraction pattern scientists can reconstruct the position of each 
atom in the crystal and thereby, a three-dimensional map of the molecule can be 
made. To solve the three-dimensional structure of a protein using X-ray 
crystallography it is mandatory to obtain a good quality crystal but, not all 
proteins can be crystallized. An alternative technique to analyze the structure of 
proteins in solution is nuclear magnetic resonance (NMR) spectroscopy. It is 
based on the principle that the nuclei of some elements' atoms (such as hydrogen) 
resonate when they are placed in a powerful magnetic field. Thus, when a 
molecule containing such atoms, like- protein, peptides, organic polymers etc, are 
placed in a powerful magnetic field nuclear magnetic resonance occurs. The NMR 
signal is measured as chemical shifts of the atoms' nuclei in the molecule. The 
chemical shift of a nucleus depends on the chemical environment of that specific 
atom to which the nucleus belongs. The chemical environment in turn is defined 
by the nearby atoms and on their distances from each other. The signals that NMR 
produces are converted to a set of distances between specific pairs of atoms and 
this data is further used to generate models of possible structures. Thus, NMR 
generates a number of possible conformations of protein and the three-
dimensional structure of a protein is the average of all these conformations rather 
than a single structure. 
In this chapter, first we describe the biophysical techniques used to determine the 
oligomeric state of the protein followed by the crystallization, X-ray diffraction 
and data collection of haditoxin. With the purified protein gel filtration 




weight (Mr) of haditoxin and thereby the oligomeric state of the protein. Further, 
we also tried to run a SDS-PAGE using a cross-linker to trap any possible 
oligomers. To elucidate the three-dimensional structure of this protein we set up 
crystal drops using different crystallization screens. The crystals were optimized 
further and diffracted using X-ray. Thus, we obtained the three-dimensional 
structure of haditoxin which was further analyzed for the presence of novel 





















4.2   MATERIALS AND METHODS 
4.2.1   Proteins and reagents 
Haditoxin was purified from the venom of O. hannah as described in chapter 2. 
All the crystallization screens (Hampton and Index screens), crystallization trays, 
coverslips and grease were purchased from Hampton Research (Aliso Viejo, CA). 
The PACT Suite for crystallization was purchased from QIAgen (Hilden, 
Germany). The superdex 75 column (1 cm x 30 cm) was purchased from GE 
Healthcare Life Sciences (Piscataway, NJ, USA). The protein markers used for 
gel filtration studies were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
and the SDS-PAGE markers were bought from Bio-Rad Laboratories (Hercules, 
CA, USA). The cross-linker Bis(sulfosuccinimidyl) suberate were purchased from 
Pierce (Rockford, IL, USA). All other chemicals and reagents used were of 
analytical grade. 
 
4.2.2   Gel filtration chromatography 
The oligomeric states of the protein were examined by gel filtration 
chromatography on a Superdex 75 column (1 cm x 30 cm) equilibrated with 50 
mM Tris-HCl buffer (pH 7.4) using an ÄKTA purifier system at a flow rate of 0.6 
ml/min. Calibration was done using bovine serum albumin (66 kDa), carbonic 
anhydrase (29 kDa), cytochrome C (12.4 kDa), aprotinin (6.5 kDa) and blue 
dextran (200 kDa) as molecular weight markers. Native protein (0.25-10 µM) as 
well as samples (0.25-10 µM) treated 0.6% sodium dodecyl sulfate (SDS) (2 h of 
incubation at room temperature) (Chiappinelli and Lee, 1985) were loaded 




SDS treated samples the column was equilibrated with the same buffer as 
mentioned above containing 0.1% SDS.  
 
4.2.3   CD spectroscopy 
Far-UV CD spectra (260-190 nm) for the protein samples with/without SDS were 
recorded using a Jasco J-810 spectropolarimeter (Jasco Corporation, Tokyo, 
Japan). All measurements were carried out at room temperature using a 0.1 cm 
path length capped cuvette. The instrument optics and cuvette chamber were 
continuously flushed with 10 L of nitrogen/min before and during the recording of 
the spectra to provide an oxygen-free environment. The spectra were recorded 
using a scanning speed of 50 nm/min, a resolution of 0.1 nm and a bandwidth of 1 
nm. A total of three scans were recorded and averaged for each spectrum, and the 
baseline was subtracted with the blank. All samples were dissolved 50 mM Tris-
HCl buffer (pH 7.4) with (0.6%) or without SDS. 
 
4.2.4   Electrophoresis 
Tris-Tricine SDS-PAGE (Schagger and von Jagow, 1987; Schagger, 2006) of the 
protein of interest in the presence or absence of cross-linker Bis(sulfosuccinimidyl) 
suberate (BS3) (Jennings and Nicknish, 1985; Staros, 1982; Staros and 
Anjaneyulu, 1989) was performed on a 12% gel (composition described in 
Appendix figure A.3), under reducing conditions, using Bio-Rad Mini-Protean II 
electrophoresis system. The concentration of BS3 used was 5 mM. The protein 





4.2.5   Crystallization of haditoxin 
Crystallization conditions for the protein were screened with Hampton Research 
screens, index screen and Pact suite screen using hanging-drop vapor-diffusion 
method. Lyophilized protein was dissolved in 10 mM Tris-HCl buffer pH 7.4 with 
100 mM NaCl. The protein concentration was kept at 10 mg/ml and the drops 
were prepared by mixing equal volumes (1 µl) of protein solution (dissolved in 25 
mM Tris buffer pH 7.4) and crystallization solutions. 500 µl reservoir solution 
was placed in each well. Crystallization experiments were performed at room 
temperature 297 K (24 °C). Small rod-shaped crystals were formed within 2-3 
days. Further, optimization was done for few weeks to produce diffraction quality 
crystals. They were briefly soaked in the reservoir solution supplemented with 
10% glycerol as cryo-protectant, prior to the X-ray diffraction data collection. 
Then these crystals were flash-frozen in a nitrogen cold stream at 100 K (-173 °C).  
 
4.2.6   X-ray diffraction and data collection 
The crystals were picked up with a nylon cryo-loop and frozen at 100 K in a 
nitrogen-gas cold stream. Diffraction up to 1.55 Å was obtained using a CCD 
detector mounted on a Bruker V8 rotating anode generator (Bruker AXS, Madison, 
WI, USA). A complete data set was collected, processed and scaled using the 








4.3   RESULTS 
4.3.1   Haditoxin is a dimer  
During the gel filtration of the crude venom we observed that haditoxin eluted 
earlier compared to other 3FTXs (Fig. 2.2, most of the 3FTXs elutes in peak 3 
whereas haditoxin elutes in peak 2). This led us to investigate the oligomeric 
states of this protein. So, we carried out analytical gel filtration experiments using 
a Superdex G-75 column. Protein at concentrations (0.25 to 10 µM) covering the 
IC50 in CBCM (0.27 ± 0.07µM) and RHD (1.85 ± 0.39 µM) preparations, was 
loaded onto the column. At all of these concentrations, the presence of a single 
peak corresponding to a relative molecular weight (Mr) of 16.25 kDa was 
observed (Fig. 4.1), supporting the existence of a dimeric species (the monomeric 
mass is ~7535 Da as observed in ESI-MS, discussed in chapter 2).  
To find out the nature of interaction between the monomers, we observe the effect 
of SDS on dimerization, we treated the protein (0.25 to 10 µM) with SDS (0.6% 
w/v) and eluted using the same gel filtration column. SDS is a well known anionic 
surfactant which is commonly used as detergent. In biochemistry, it is used to 
disrupt any non-covalent interaction in the proteins, denaturing them, and causing 
the molecules to lose their native shape (conformation) (Shapiro et al, 1967). In 
presence of SDS, haditoxin eluted out as a single peak with a Mr of 8.16 kDa (Fig. 
4.1) similar to the monomeric species, which indicates the involvement of non-
covalent interactions in the dimerization process.  
To elucidate the consequence of dimerization on the secondary structure of 
protein we performed CD spectroscopy of the SDS-treated and non-treated protein 




structure which confers that the dimerization has no effect on the secondary 
structure of the protein. Whereas, in presence of SDS the protein had lost its 
original conformation and acquired a random-coil structure as revealed by the 
intense minima around 203 nm in the CD spectrum (Fig. 4.2). This indicates that 
the overall conformation of the protein may play crucial role for dimerization. 
The dimerization was further confirmed by Tris-Tricine SDS-PAGE analysis in 
the presence and absence of a cross-linker, BS3 (Fig. 4.3). BS3 is a chemical 
cross-linker which is homobifunctional, water-soluble, non-cleavable and 
membrane impermeable. It forms an amine to amine covalent bond with the 
protein complexes and thus, the conjugate is available for further analysis 
(Knoller et al, 1991; Dihazi and Sinz, 2003). In the presence of BS3, both the 
dimeric and monomeric species were visualized (Fig. 4.3, lane 1) whereas only 
the monomeric species were observed in its absence (Fig. 4.3, lane 2). Altogether, 
these results indicate the existence of haditoxin as a homodimer in solution at 
pharmacologically relevant concentrations and the dimerization occurs through 
non-covalent interactions.  Further, as observed from the CD studies, the overall 
conformation of haditoxin has a high impact on the dimerization as the dimeric 
species did not appear with the loss of the native conformation upon addition of 
SDS. 
 
4.3.2   X-ray crystal structure of haditoxin 
In order to determine the three-dimensional structure of haditoxin we used X-ray 
crystallographic method. Diffraction quality crystals of haditoxin were obtained 


















































Figure 4.1: Dimerization of haditoxin observed in gel filtration studies.  
 
Gel filtration profile of haditoxin with (gray) and without (black) SDS. 1 µM 
of haditoxin was loaded onto a Superdex 75 column (1 cm x 30 cm) 
equilibrated with 50 mM Tris-HCl buffer (pH 7.4). The protein was eluted out 
with the 50 mM Tris-HCl buffer (pH 7.4) or 50 mM Tris-HCl buffer (pH 7.4) 




































Figure 4.2: Effect of dimerization on secondary structure of haditoxin. 
 
Far-UV CD spectrum of haditoxin (gray) and without (black) SDS. The 
protein (1 µM) was dissolved in 50 mM Tris-HCl buffer (pH 7.4) or 50 mM 
Tris-HCl buffer (pH 7.4) containing 0.6% SDS, and their CD spectra were 



























Figure 4.3: Tris-tricine SDS-PAGE analysis of haditoxin for dimerization. 
 
Tris-tricine SDS-PAGE (12%) analysis of haditoxin with (lane 1) and without 
(lane 2) cross linker, bis(sulfosuccinimidyl)suberate (BS3). M is the marker 
lane. Concentration of BS3 used was 5 mM. Bands for monomer and dimer 
was observed in lane 1 with BS3 whether in lane 2 in the absence of BS3 band 
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a Rsym=∑|Ii-<I>|/∑|I|, where Ii is the intensity of the ith measurement, and <I> is the mean intensity for that 
reflection.
b Rwork=∑|Fobs–Fcalc|/∑|Fobs |, where Fcalc and Fobs are the calculated and observed structure factor 
amplitudes, respectively.
c Rfree=as for Rwork, but for 10 % of the total reflections chosen at random and omitted from refinement.

















condition no. 44). Diffraction up to 1.55 Å was observed and the crystals 
belonged to the space group P21 (Table 4.1).  
 
4.3.3   Structure determination and refinement 
The structure of haditoxin was solved by molecular replacement method (Molrep) 
(Vagin and Teplyakov, 1997). Initially, toxin-α, isolated from Naja nigricollis 
venom (Gilquin et al, 2003) was used as a search model (pdb code 1IQ9; 
sequence identity ~48%). The rotation and translation resulted in a correlation 
factor of 0.07 and Rcryst of 0.57. Further minimization in Refmac (Vagin et al, 
2004) reduced the R factor to 0.42. An excellent quality electron density map was 
calculated at this stage which allowed to auto-build 90% of the haditoxin model 
with ARP/wARP (Perrakis et al, 1999).  Resulting model with the electron 
density map was examined to manually build the rest of the model using Coot 
program (Emsley and Cowtan, 2004). After a few cycles of map fitting and 
refinement, we obtained an R factor of 0.194 (Rfree=0.225) for reflections I>σI 
within 20-1.55 Å resolution. Throughout the refinement (Table 4.1) no NCS 
restraint was employed. All the 65 residues (considering one subunit) are well 
defined in the electron density map (Fig. 4.4) and statistics for the Ramachandran 
plot using PROCHECK (Laskowski et al, 1993) showed the presence of 88.9% of 
non-glycine residues in the most favored region. The asymmetric unit consisted of 
two monomers forming a tight dimer having an approximate dimension of 25 X 
13 X 4 Å (Fig. 4.5). This crystallographic dimer was consistent with the gel 











































Figure 4.5: Overall crystal structure of haditoxin. 
 
Monomer A is shown in red, monomer B is shown in yellow. β-strands and loops 






Each monomer adopted the common “three-finger” fold (Kini, 2002 and Kini and 
Doley, 2010) consisting of three β-sheeted loops protruding from a central core, 
tightened by four highly conserved disulfide bridges (Cys3–Cys24, Cys17–Cys41, 
Cys45–Cys57 and Cys58–Cys63) (Fig. 4.5 and 4.6). Both the monomers were 
related by a 2-fold symmetry and their superposition yielded an rmsd of 0.2 Å for 
65 Cα atoms (Fig. 4.7). They were structurally similar to short-chain α-
neurotoxins like toxin-α and erabutoxins (Fig. 4.8). Loop I formed a two-stranded 
β-sheet (Lys2–Tyr4 and Thr14–Ile16), whereas loops II and III formed a three-
stranded β-sheet (Glu34–Thr42, Phe23–Asp31 and Lys53–Cys58). The anti-
parallel β-strands of the β-sheet were stabilized by mainchain–mainchain 
hydrogen bonding.  
 
4.3.4   Dimeric interface  
The dimeric interface was analysed using the PISA server (Krissinel and Henrick, 
2007). It is mainly formed by loop III of each subunit. Strands D, C, E, E', C' and 
D' form a six β-pleated sheet with an overall right-handed twist (Fig. 4.5) in the 
dimer. Approximately 565 Å2 (or 12 % of the total) surface areas and 17 residues 
of each monomer contributed to the dimerization. The close contacts between the 
monomers were maintained by 14 hydrogen bonds (<3.2 Å) and extensive 
hydrophobic interactions (Table 4.2). Six mainchain–mainchain hydrogen 
bonding contacts existed across the interface involving strand E of monomer A 
and strand E' of monomer B (Table 4.2, Fig. 4.9). Four of the hydrogen bonds 
were observed between the mainchain amide hydrogen and carbonyl oxygen of 


















Figure 4.6: Structure based alignment of haditoxin with other three finger toxins.  
 
Color coding of conserved residues are denoted by boxed red text and invariant residues by red highlight. Accession numbers are shown on 
the left. Secondary structure elements of haditoxin are shown on the top. Numbering is shown for the haditoxin sequence only. Sequence 
























Figure 4.7: Superimposition of both the subunits of haditoxin. 
 
Subunit A and B is shown in cyan and magenta respectively. Both the monomers are 































Figure 4.8: Superimposition subunit A of haditoxin with short-chain α-neurotoxins. 
 

























Figure 4.9: Stereo diagram of the dimeric interface of haditoxin. 
 
The residues to form the hydrogen bonds are labeled. The mainchain-mainchain 
hydrogen bonds are shown in red. The other hydrogen bonds are shown in yellow. For 


































Monomer A Monomer B Distance (Å) 
Main chain 
Cys-57 (O) Val-55 (N) 2.93 
Val-55 (O) Cys-57 (N) 2.85 
Cys-57 (N) Val-55 (O) 2.86 
Val-55 (N] Cys-57 (O) 2.90 
Lys-53 (O) Arg-59 (N) 3.10 
Arg-59 (N) Lys-53 (O) 3.40 
Side chain 
Glu-47 (OE1) Thr-44 (OG1) 2.63 
Glu-47 (OE2) Cys-45 (N) 2.76 
Pro-50 (O) Arg-59 (NE) 3.39 
Thr-49 (O) Arg-59 (NH2) 3.37 
Thr-44 (OG1) Glu-47 (OE1) 2.68 
Cys-45 (N) Glu-47 (OE2) 2.81 
Arg-59 (NH2) Thr-49 (O) 2.66 




the remaining two existed between the carbonyl oxygen of Lys53 (and Lys53') and the amide 
hydrogen of Arg59 (and Arg59') (Table 4.2, Fig. 4.9). 
In addition, there were another eight hydrogen bonding contacts mediated through the side 
chains of Thr44, Cys45, Glu47, Pro50 and Arg59 (Table 4.2, Fig. 4.9). Two hydrophobic 
clusters further stabilized the dimeric structure.  The side chains of Phe23 and Leu48 from 
both monomers formed one cluster, whereas the disulphide bridge between Cys45-Cys57 and 
Val55 of both monomers formed the other. These observations strongly suggest the existence 




















4.4   DISCUSSION 
Three-finger toxins from snake venom consist of a multitude of pharmacologically active 
peptides. All members of this family share a similar scaffold, which consists of three finger-
like loops made of β-sheet structure, emerging from a globular core and stabilized by four 
conserved intramolecular disulfide linkages giving rise to the compact “β-cross” motif (Endo 
and Tamiya, 1987; Harrison and Sternberg, 1996; Kini 2002; Nirthanan et al, 2003; Kini and 
Doley, 2010). Although the members of this family of proteins share similar structural 
scaffold, it has been shown that the subtle differences in their structure contribute to the 
differences in affinity and specificity towards the diverse physiological targets of these 
peptides (Rees et al, 1987; Bilwes et al, 1994; Tsetlin, 1999). Thus, the three-dimentional 
structure of haditoxin essentially helped us to understand the novel structural elements present 
in this protein as well as its structure-function relationship. 
This study provides, till date, the first report of a dimeric short-chain α-neurotoxin, which 
showed clear differences in structure and function hitherto attributed to this class of toxins. 
Haditoxin was a non-covalent homodimer where the monomers were oriented in an opposite 
direction. Structurally, the dimeric quaternary structure of haditoxin was similar to κ-
neurotoxins, whereas individual monomers were similar to short-chain α-neurotoxins. 
Functionally, this homodimer antagonized muscle (αβγδ) and neuronal (α7, α3β2 and α4β2) 
nAChRs, with highest affinity towards α7-nAChRs. Thus, haditoxin was the first dimeric 
neurotoxin to interact with muscle nAChRs as well as the first short-chain α-neurotoxin to 
interact with neuronal α7-nAChRs. On analyzing the primary and tertiary structures of 
haditoxin, it was observed that several structurally invariant residues, essential to maintain the 




binding of short-chain α-neurotoxins to muscle (αβγδ) and long-chain α/κ-neurotoxins to both 
muscle (αβγδ) and neuronal α7 receptors, were conserved in haditoxin. 
 
Structurally invariant residues for haditoxin 
Haditoxin contained all eight conserved cysteine residues that are essential for the three-finger 
folding (Menez et al, 1980; Endo and Tamiya, 1991). They formed four disulfide bridges 
located in the core region of the molecule. It was reported that the chemical reduction of these 
four disulfide bridges disrupt the native conformation of neurotoxins, resulting a total loss of 
neurotoxicity (Menez et al, 1980). 
In addition, haditoxin possessed several other structurally invariant residues, responsible for 
the stability of the three-finger fold. For example, Tyr25 (numbering of the residues are 
according to erabutoxin-a, unless stated otherwise), the crucial residue stabilizing the 
antiparallel β-sheet structure (Torres et al, 2001), was conserved in a similar three-
dimensional orientation in haditoxin. Similarly, the structurally invariant Gly40, involved in 
the tight packing of the three-dimensional fold by accommodating the bulky side chain of the 
Tyr25 (Menez et al, 1984; Endo and Tamiya, 1991) was also conserved. The two proline 
residues Pro44 and Pro48, potentially associated with the formation of the β-turn (Endo and 
Tamiya, 1991) were conserved in haditoxin as Pro46 and Pro50. Interestingly, some charged 
amino acid residues forming salt bridges had also been conserved in three-finger toxins for 
structural stability. The salt bridge between the N-terminal amino group and the carboxyl 
group of Glu58 in erabutoxin-a maintains the native conformation (Endo and Tamiya, 1991) 
of the toxin. A similar role had been found for the salt bridge between the N-terminal amino 
group and the carboxyl group of Asp58 in haditoxin. The electrostatic interaction between the 




Tamiya, 1991) was conserved as well in haditoxin by the bond between the C-terminal 
carboxyl group and the guanidinium group of the Arg39. Thus, presence of these structurally 
invariant residues contributed to the stable three-finger fold of haditoxin.  
 
Functionally invariant residues for haditoxin 
The subtle structural variations that exist between different classes of three-finger toxins may 
often reflect some functional significance (Menez, 1998). For instance, the high affinity 
binding of long-chain α-neurotoxins, but not short-chain α-neurotoxins, to neuronal α7 
receptors has been clearly attributed to structural variations in loop II of long-chain α-
neurotoxins (Servent et al, 1997; Fruchart-Gaillard et al, 2002) compared to the short-chain 
ones. The crystal structure of haditoxin revealed the characteristic three-finger scaffold with 
the core containing four conserved disulfide bridges. The superimposition of the α-carbon 
backbone structure of haditoxin with that of a short-chain α-neurotoxin (erabutoxins, toxin-α) 
(Fig. 4.8) and a long-chain α-neurotoxin (α-cobratoxin) (Fig. 4.10) showed a better overall fit 
between haditoxin and short-chain α-neurotoxin, especially with respect to loop sizes and the 
short C-terminal tail. However, haditoxin differed markedly from the long-chain α-
neurotoxins such as- α-cobratoxin in the region of the middle loop because of the fifth 
disulfide bridge present at the tip of this loop as well as the size and disposition of the first (N-
terminus) loop and the C-terminus tail. The possible functional implications of these 
differences are discussed below in details.  
Extensive structure-function relationship studies on the short-chain α-neurotoxin, erabutoxin-
a (Teixeira-Clerc et al, 2002; Pillet et al, 1993; Tremeau et al, 1995; Endo and Tamiya, 1991), 
and long-chain α-neurotoxins, α-cobratoxin (Bourne et al, 2005; Antil et al, 1999) and α-






















Figure 4.10: Superimposition subunit A of haditoxin with α-cobratoxin. 
 
Subunit A is shown in red, α-cobratoxin (long-chain α-neurotoxin) in blue. The 










residues involved in the recognition of nAChRs by snake neurotoxins. The crucial residues for 
α-neurotoxins to bind to muscle (αβγδ) nAChRs are Lys27, Trp29, Asp31, Phe32, Arg33, and 
Lys47. Haditoxin possessed three of them (Trp29, Asp31 and Arg33) in homologous positions. 
Additionally, each type of toxin possesses specific residues that recognized muscle or 
neuronal nAChRs. For muscle (αβγδ) nAChRs, these are His6, Gln7, Ser8, Ser9, and Gln10 in 
loop I and Tyr25, Gly34, Ile36, and Glu38 in loop II of short-chain α-neurotoxins such as- 
erabutoxin-a (Teixeira-Clerc et al, 2002) and Arg36 in loop II and Phe65 in the C-terminus 
tail of long-chain α-neurotoxins such as - α-cobratoxin (Bourne et al, 2005). His6, Gln7 and 
Ser8 in the loop I and Tyr25, Gly34, Ile37 and Glu38 in the loop II were conserved in 
haditoxin as the muscle-subtype specific determinants of short-chain α-neurotoxins. Moreover, 
Arg36, muscle-subtype specific determinant of long-chain α-neurotoxins was also conserved 
in haditoxin. The presence of these multiple functional determinants might explain the potent 
neurotoxicity exhibited by haditoxin on mammalian and avian muscle (αβγδ) nAChR.  
On the contrary, the specific determinants (Ala28 and Lys35; α-cobratoxin numbering) of 
long-chain α-neurotoxins towards the neuronal (α7) nAChRs (Antil-Delbeke et al, 2000) were 
not conserved in haditoxin. Significantly, haditoxin also lacked the 5th disulfide bridge 
responsible for the cyclization of loop II which is considered to be a hallmark determinant for 
the ability of neurotoxins such as α-bungarotoxin and κ-bungarotoxins to interact with their 
specific neuronal nAChR targets (Antil-Delbeke et al, 2000; Osipov et al, 2008; Grant et al, 
1998; Servent et al, 1997; Servent et al, 1998; Bourne et al, 2005). This is somewhat 
surprising given the high affinity of haditoxin for the neuronal α7- (IC50 = 0.18 µM), α3β2- 
(IC50 = 0.5 µM) and α4β2- (IC50 = 2.6 µM) nAChRs. 
The crystal structure of cobratoxin in complex with AChBP revealed the critical residues of 




homopentamaric neuronal nicotinic receptors). This structure provides a lead template 
resembling a curaremimetic α-neurotoxin bound to homopentamaric neuronal nicotinic 
receptors. The residues of cobratoxin involved in the interaction are Thr6, Pro7, Ile9 in loop I; 
Trp25, Cys26-Cys30, Asp27, Ala28, Phe 29, Ser31, Ile32, Arg33, Gly34, Lys35, Arg36, 
Val37 in loop II and Phe65, Arg68 in the C-terminal tail (Fig. 4.11 A). This correlates well 
with the previous mutagenesis studies as the replacement of residues indicated in bold results 
in more than 5-7 folds decrease in the affinity towards the target receptor (Fruchart-Gaillard et 
al, 2002). Based on these residues we have aligned the sequence of α-cobratoxin with 
haditoxin (Fig, 4.11 top). The putative residues of haditoxin which might be critical to interact 
with α7-nAChRs are highlighted, the red and green residues are identical whereas the magenta 
ones are similar (Fig. 4.11 B).  
Previously, candoxin, a non-conventional 3FTX (Nirthanan et al, 2002) was found to be an 
exception of a 3FTX that did not have the 5th disulfide bridge in loop II (candoxin has a 5th 
disulfide bridge in loop I), but still retained the ability to interact with neuronal (α7) nAChRs 
(Nirthanan et al, 2003a). A superimposition of haditoxin and candoxin is represented in figure 
4.12. It was suggested thus that candoxin may likely interact with neuronal α7-nAChRs using 
alternate, novel points of contact. Likewise, it is plausible that haditoxin possesses unique 
combinations of determinants which enabled its interaction with α7-, as well as α3β2- and 
α4β2-nAChRs. A detailed structure-function analysis to decipher these novel determinants is 
beyond the scope of this report. 
Until now, the only dimeric neurotoxins known to interact with neuronal nAChRs are the κ-
neurotoxins. In the case of κ-neurotoxins which interact with neuronal α3β2- and α4β2-nAChRs 
with high affinity (Grant and Chiappinelli, 1985; Wolf et al, 1988), the critical functional 

















Figure 4.11: Critical residues for α-cobratoxin and haditoxin to interact with α7-nAChRs. 
 
(A) The critical residues of α-cobratoxin to interact with AChBP, as identified in Bourne et al, (2005), are highlighted in CPK 
representation. The red coloured residues are those whose mutations cause an affinity decrease of more than 5-7 folds as proved by 
mutagenesis studies, green indicates the rest. On top, alignment of α-cobratoxin and haditoxin, the red highlighted residues are identical 
whereas the magenta ones are similar. (B) Putative functional residues of haditoxin for interaction with α7 receptors (colour coding is same 























Figure 4.12: Superimposition subunit A of haditoxin with candoxin. 
 
Subunit A of haditoxin is shown in red, candoxin (a non-conventional neurotoxin) in 









position, which may contribute in part to high affinity interaction with α3β2- (IC50 = 0.5 µM) 
and α4β2- (IC50 = 2.6 µM) nAChRs. Mutagenesis studies on κ-bungarotoxin  revealed that the 
replacement of Pro36 to an amino acid residue bearing a bulky charged sidechain, like the Lys 
found in α-bungarotoxin, causes a 16 fold decrease in the efficacy of the toxin to block 
neurotransmission in the chick ciliary ganglion assay (Fiordalisi et al, 1994). Haditoxin bore 
an equivalent glycine residue, lacking bulky charged sidechain, which could explain the high 
affinity of this toxin towards the neuronal (α3β2 and α4β2) nAChRs.  
 
Comparison of haditoxin with snake venom derived dimeric 3FTXs 
Few known examples of dimeric three-finger neurotoxins derived from snake venoms exist 
(Chiappinelli and Lee, 1985; Osipov et al, 2008; Pawlak et al, 2009). Amongst them, the most 
well studied and characterized are the κ-neurotoxins, known to be composed of two identical 
monomers held together by non-covalent interactions (Dewan et al, 1994; Oswald et al, 1991). 
The observed dimeric form of haditoxin, with the characteristic six β-pleated sheets, was 
similar to that formed by κ-bungarotoxin (Dewan et al, 1994). Superposition of both 
molecules yielded an rmsd of 1.95 Å for 104 Cα atoms (Fig. 4.13). The major deviations were 
located in the loops between the antiparallel β-strands.  
Each monomer in κ-bungarotoxin was structurally homologous to long-chain α-neurotoxins, 
with the additional fifth disulfide bridge in the middle loop unlike haditoxin, which resembled 
short-chain α-neurotoxins (Fig. 4.9) with only four disulfide bridge. The dimeric interface for 
both haditoxin and κ-bungarotoxin was maintained by six mainchain-mainchain hydrogen 
bonds (Dewan et al, 1994). In addition, haditoxin had eight sidechain hydrogen bonding 
contacts between the monomers, whereas only three similar contacts were observed in κ-



























Figure 4.13: Haditoxin vs κ-bungarotoxin. 
 
Superimposition of the Cα atoms of haditoxin with κ-bungarotoxin. Haditoxin and κ-





























Figure 4.14: Stereo diagram of comparison of dimer interface of haditoxin (top) and κ-
bungarotoxin (bottom).  
 
The residues to form the hydrogen bonds are labeled. The mainchain-mainchain hydrogen 






than κ-bungarotoxin.  The side chain interactions in κ-bungarotoxin are maintained by Phe49, 
Leu57, and Ile20, which are strictly conserved in all κ-neurotoxins (Dewan et al, 1994; Grant 
et al, 1997). Mutagenesis studies have proven that replacing Phe49 or Ile20 with alanines 
renders a toxin with an apparent lack of ability to fold into the native structure, even as a 
monomer (Grant et al, 1997). The same result has been observed with deletion studies 
(deletion of Arg54) with an aim to generate a 65 residue long protein, as found in the α-
neurotoxins, from the 66 residue long κ-bungarotoxin (Grant et al, 1997). Whereas haditoxin 
being a 65 residue long protein lacked both Phe49 and Ile20 but still retained the intact 
dimeric structure. The electrostatic surface potential for both the molecules were apparently 
similar except for the tip of loop II which revealed a strong positive patch for haditoxin 
compared to κ-bungarotoxin (Fig. 4.15) (Dewan et al, 1994).  
Functionally κ-neurotoxins interact with the neuronal (α3β2 and α4β2) nAChRs with high 
affinity (Grant and Chiappinelli, 1985; Wolf et al, 1988), whereas haditoxin interacted with 
both muscle (αβγδ) and a variety of neuronal (α7, α3β2 and α4β2) nAChRs. The crystal 
structure of the κ-bungarotoxin dimer showed that the guanidinium groups of the essential 
arginine residues, situated at the tip of the loop II, maintains nearly identical distance (44 Å) 
(Dewan et al, 1994) as like the acetylcholine binding sites in the pentameric receptor (30-50 Å) 
(Herz et al, 1989; Unwin, 1993). The κ-bungarotoxin dimer may interact with both the 
acetylcholine binding sites on a single neuronal receptor and physically block ion flow by 
spanning the channel (Dewan et al, 1994; Grant et al, 1997). But this mode of interaction did 
not explain the inability of the κ-neurotoxins to block the muscle nAChRs. Haditoxin 
maintained a distance of ~52 Å between the guanidinium groups of the critical arginine 
residues present in the turn region of the second loop which is almost similar to the 







Figure 4.15: Comparison of the electrostatic surface of haditoxin and κ-bungarotoxin. 
 
Electrostatic surface of haditoxin (top) and κ-bungarotoxin (bottom). The irientation are the 
same as the Figure 2 (top) before rotation. The location of Arg33 and Glu34 of haditoxin and 







neurotoxins, haditoxin interacted with both muscle and neuronal nAChRs. This supports the 
fact that the dimeric toxins may have a unique mode of interaction with the nAChRs which 
demands further investigation. 
More recently, other heterodimeric 3FTXs from elapid venoms have been reported, including 
covalently (disulfide) linked homodimers of a long-chain α-neurotoxin (α-cobratoxin) and 
heterodimers of α-cobratoxin in combination with a variety of three-finger cytotoxins (Osipov 
et al, 2008). Unlike haditoxin, all of these dimers were formed by covalent bonding (disulfide 
linkage) of the monomeric units. Functionally, the α-cobratoxin-cytotoxin heterodimers were 
able to block neuronal (α7) nAChRs whereas the α-cobratoxin homodimer exhibited blockade 
of both neuronal α7 and α3β2 nAChRs, unlike monomeric α-cobratoxin which interacts with 
muscle (αβγδ) and neuronal (α7) nAChRs (Osipov et al, 2008).  
Our laboratory has also reported on a colubrid venom derived covalently linked heterodimeric 
3FTX, irditoxin (Pawlak et al, 2009), which was found to target muscle (αβγδ) nAChRs, in 
sharp contrast to the reported function of elapid dimeric toxins (Osipov et al, 2008). Another 
distinguishing feature was that the subunits of irditoxin structurally resemble nonconventional 
three-finger neurotoxins (Pawlak et al, 2009). A comparison of the three-dimensional 
structures for haditoxin and irditoxin is presented in figure 4.16. Haditoxin, was both 
structurally and functionally distinct from the α-cobratoxin hetero/homodimers as well as 
irditoxin. Structurally, haditoxin was a non-covalently-linked homodimer of the short-chain 
α-neurotoxin type and functionally, it has a broad pharmacological profile with high affinity 















Figure 4.16: Structural comparison of haditoxin and irditoxin. 
 
(A) Homodimeric structure of haditoxin. The dimer is composed of two non-covalently 
attached subunits, each of which is similar to short-chain neurotoxins with four 
disulfide bridges (shown in yellow sticks), (B) Heterodimeric structure of irditoxin. 
This dimer consists of two different monomers attached together with a disulfide bridge 
(shown in yellow stick) each subunit of irditoxin adopts a structure similar to the non-
conventional neurotoxins with additional disulfide bridge in loop I (all disulfide bridges 










To conclude, we have characterized a novel neurotoxin, haditoxin, with unique structural and 
functional profile. The three-dimentional crystal structure of the protein revealed that it exists 
as a homodimeric species in solution at pharmacologically relevant concentrations. Each 
monomer is similar to short-chain α-neurotoxins with respect to the number of amino acid 
residues and the four conserved disulfide bridges. Functionally, haditoxin interacts with the 
muscle and a variety of neuronal nAChRs, with the highest affinity for α7-nAChRs. Thus, 
haditoxin is the first reported dimeric three-finger toxin recognizing the muscle (αβγδ) 




















Structure-function relationship of haditoxin 
 
5.1   INTRODUCTION 
There is an intimate correlation between protein structure and function. The interaction of 
the proteins, via the molecular recognition site, with their target molecules results the 
specific biological function. Despite the complexity in size, structure and conformation of 
the proteins, the molecular recognition or interaction sites are compact and well defined. 
These protein-protein interaction sites may be continuous or discontinuous. Continuous 
interaction sites are formed by a stretch of amino acid residues linked directly to each 
other such as- the snake venom disintegrins, the potent inhibitors of the platelet 
aggregation, interact with the fibrinogen receptor, integrin αIIbβ3 (Huang et al, 1987), 
using a conserved tripeptide motif consisting of arginine-glycine-aspartic acid (RGD) 
residues (for review see, Calvete, 2005; Calvete et al, 2005). On the contrary, the 
discontinuous protein-protein interaction sites can be brought together through a specific 
three-dimensional fold of the protein. For example, the long-chain and short-chain α-
neurotoxins from snake venom recognize the muscle nicotinic acetylcholine receptor 
though specific determinants which are common for both the subclass (Servent et al, 
2000; Servent and Menez, 2001). These specific determinants consist of amino acid 
residues which are brought together to form the interaction site by the unique three 
dimensional fold of these neurotoxins.  
Certainly, the task of delineating the molecular recognition site of a protein is a formidable 




dimensional structure of the protein, preferably by co-crystallizing the ligand-receptor 
complex (Cunningham and Wells, 1993). An example will be the co-crystallization of a 
long-chain α-neurotoxin, α-cobratoxin with acetylcholine binding protein (AChBP), a 
homolog of the ligand-binding (amino-terminal) domain of nicotinic receptors, isolated 
from marine and fresh water snails (Smit et al, 2001; Brejc et al, 2001; Brejc et al, 2002; 
Hansen et al, 2004 and Bourne et al, 2005). This was a major breakthrough in 
understanding the mechanism of interaction between a snake venom α-neurotoxin and the 
nicotinic receptor.  
On the other hand, the functional determinants of a protein can also be analyzed using 
site-directed mutagenesis, chemical modification and design of synthetic peptides derived 
from potential interaction sites as well as molecular modeling based on known structural 
templates (Menez, 1998; Servent and Menez, 2001). These methods, combined with 
available literature on the tertiary structure of neurotoxins, have now permitted the 
accurate delineation of the interaction sites by which different classes of neurotoxins 
recognize various subsets of nicotinic acetylcholine receptors (Pillet et al, 1993; Trémeau 
et al, 1995; Servent et al, 1997; Grant et al, 1998; Antil et al, 1999; Antil-Delbeke et al, 
2000; Boulain and Menez, 1993; Zeng et al, 2001; Moise et al, 2002; Bourne et al, 2005 ; 
Dellisanti et al, 2007). 
As discussed earlier, we have purified and characterized haditoxin, a novel member of the 
three-finger neurotoxin family, with unique structural and functional profile. It is the first 
reported dimeric three-finger toxin recognizing the muscle (αβγδ) nAChR as well as the 
first short-chain α-neurotoxin to target the neuronal α7-nAChR with nanomolar affinity. In 




respect to its function (specifically its inhibition of muscle (αβγδ) and neuronal (α7, α4β2 
and α3β2) nicotinic acetylcholine receptors) as well as structure (especially the quaternary 
structure similar to snake venom dimeric neurotoxins) based on current knowledge of the 
structure-function relationships between snake venom neurotoxins and nicotinic 
acetylcholine receptors.  
In this chapter, we describe the preliminary results of the structure-function relationship 
studies of haditoxin. Initially, we observed the interaction of haditoxin with acetylcholine 
binding protein using radioligand binding assays with an ultimate aim of co-
crystallization. Using Ca2+ dependent fluorescence assay (Ca2+/Fluo4) we also observed 
the interaction of haditoxin with other ion-channel receptors, such as- 5-hydroxytriptamine 
type 3 (5-HT3) receptors, to find out the cross-reactivity, if any. Finally, we expressed 
haditoxin using a heterologous expression system and characterized the recombinant 














5.2   MATERIALS AND METHODS 
5.2.1   Reagents and kits 
The details of reagents and kits used for this part of the study are as follows: Agarose, LB 
Broth, LB agar, oligonucletides (1st Base Pte. Ltd., Singapore), long PCR enzyme mix 
and restriction endonucleases (Fermentas International Inc., Burlinton, Ontario, Canada), 
DNA ladders, X-gal, IPTG (Promega Corporation, Madison, WI, USA), gel red stain and 
SeeBlue® Plus2 prestained protein ladder (Invitrogen by Life Technologies, Carlsbad, 
CA, USA), Gel extraction kit and PCR purification kit, (Qiagen, Hilden, Germany), Gene 
All Exprep Plasmid Quick kit (Gene All, Seoul, Korea), Cleanseq sequencing cleanup 
magnetic beads (Agencourt Bioscience, Beverly, MA) and ABI PRISM BigDye 
Terminator v3.1 cycle sequencing kit (PE Applied Biosystems, Foster City, CA). All the 
kits employed in this study were used according to the manufacturer’s instructions. 
Haditoxin was purified from the venom of O. hannah as described in chapter 2 and the 
lyophilized powder was used for the radioligand and Ca2+/Fluo4 assay. For recombinant 
expression the gene was obtained from the cDNA clone. The Ni-NTA (Nickle-
Nitrolotriacetic acid) agarose resin was purchased from Qiagen (Hilden, Germany). Empty 
columns for gravity flow were obtained from Biorad (Hercules, CA, USA). All the reverse 
phase (RP) columns, Semiprep (5 µ, 300 Å, 10 mm x 250 mm) and analytical (5 µ, 300 Å, 
4.6 mm x 250 mm), for High Performance Liquid Chromatography (HPLC) were 
purchased from Phenomenex (Torrance, CA, USA). Most of the standard drugs and 
chemicals used for the organ bath assay are the same as mentioned in chapter 3. Deionized 




chemicals were purchased from Sigma Aldrich, Milwaukee, WI, USA and 1st Base 
(Singapore). 
 
5.2.2   Radioligand binding assay with acetylcholine binding protein 
The interaction studies of haditoxin with acetylcholine binding protein (AChBP), 
described below were carried out in the collaborating laboratory of Professor Palmer 
Taylor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of 
California, San Diego,  9500 Gilman Drive, La Jolla, California 92093, United States of 
America. 
An antimouse scintillation proximity assay (SPA, Amersham Biosciences, Piscataway, NJ, 
USA) was adapted for use in a soluble radioligand binding assay as described previously 
(Hibbs et al, 2004 and Utsintong et al, 2009). A total of five soluble acetylcholine-binding 
proteins (AChBP) were used for the study, AChBP from the freshwater snail Lymnaea 
stagnalis (Ls), from the marine species Aplysia californica (Ac) together with three 
mutants of Ac binding protein. All the binding proteins are recombinantly expressed and 
purified in Professor Taylor’s lab. AChBP (final concentration ~500 pM binding sites for 
Lymnaea stagnalis, Ls; ~1 nM binding sites for Aplysia californica, Ac and its mutants), 
polyvinyltoluene anti-mouse SPA scintillation beads (0.1 mg/ml), monoclonal anti-FLAG 
M2 antibody from mouse, and [3H] epibatidine (5 nM final concentration for Ls, 20 nM 
for Ac and mutants) were combined in a phosphate buffer (0.1 M, pH 7.0) with fixed 
concentrations of the haditoxin at 10 µM in a final volume of 100 µL. Nicotine at a 
concentration of 10 µM was used as positive control. The resulting mixtures were allowed 




6500 liquid scintillation counter. The result was calculated by the fraction of 
[3H]epibatidine. 
 
5.2.3   Ca2+/Fluo-4 assay on 5-HT3 receptors 
The interaction studies of haditoxin on human (h) 5-HT3 receptors, described below were 
carried out in the collaborating laboratory of Assoc. Professor Anders Asbjørn Jensen, 
Faculty of Pharmaceutical sciences, University of Copenhagen, Universitetsparken 2, 
2100 Copenhagen, Denmark. 
The functional characterization of haditoxin at h5-HT3A and h5-HT3AB cell lines was 
performed using the Ca2+/Fluo-4 assay as previously described (Jenson et al, 2010 and 
Jørgensen et al, 2011). Cell lines containing 5-HT3 receptor subtypes were split into poly-
d-lysine-coated black 96- well plates with clear bottom. Following 16–24 h incubation 
with the 5-HT3 receptor cell lines, the culture medium was aspirated and the cells were 
incubated in assay buffer (50 µL) (Hank’s Buffered Saline Solution containing 20 mm 
HEPES, 10 mm CaCl2, 1 mm MgCl2 and 2.5 mm probenecid, pH 7.4) supplemented with 
6 mm Fluo-4/AM at 37 °C for 1 h. Then the buffer was aspirated, the cells were washed 
once with assay buffer (100 µL), and finally 100 µL of assay buffer was added to the cells. 
The 96-well plate was assayed in a NOVOstarTM microplate reader measuring emission 
(in fluorescence units, FU) at 520 nm caused by excitation at 485 nm before and up to 60 
sec after addition of agonist/antagonist solution (33 µL) in assay buffer. Serotonin was 
used as agonist for both h5-HT3A and h5-HT3AB receptors. The experiments were 
performed in duplicate at least three times for each compound tested. For the testing of the 




concentrations of the agonist for the respective receptors. For the testing of the compounds 
as antagonists, an EC70-EC95 concentration of the agonist was used. 
 
5.2.4   Bacterial strains and plasmids 
E. coli bacterial strains (DH5α and BL21(DE3)) were obtained from Novagen (EMD 
chemicals Inc., Darmstadt, Germany) and the expression vector (pLICC) was a kind gift 
from Professor Glenn King (Institute for Molecular Bioscience, University of Queensland, 
Australia). The schematic representation of the vector is shown in figure 5.1. In the pLICC 
vector, the gene of interest is encoded as a MalE-His6-MBP-fusion protein, with a tobacco 
etch virus (TEV) protease site engineered between the MBP and toxin coding regions. At 
the beginning of the construct the MalE signal sequence is used to ensure the export of the 
protein of interest into the redox environment of the periplasm (the signal sequence is 
cleaved off during this process). The hexahistidine tag enables purification of the MBP-
fusion protein using nickel affinity chromatography. The maltose binding protein (MBP) 
is used to facilitate the folding and solubility of the protein of interest. The TEV cleavage 
site enables the pure recombinant toxin to be realised from the MBP tag. The pLICC 
vector contains an ampicillin resistance gene (AmpR) for selection, and T7 promoter to 




























Figure 5.1: Schematic representation of the (A) plasmid pLICC  and (B) pLICC:Haditoxin.  
 
The regions encoding the restriction sites (KpnI and Sac I), His6 tag, MBP, MalE (periplasmic 
signal peptide), TEV cleavage site, and Haditoxin are indicated, as are the T7 promoter and 
ampicillin resistance gene. The plasmid used to produce a MalE-His6-MBP-Sf1a fusion protein 








5.2.5   Cloning of haditoxin gene into pLICC plasmid 
Haditoxin gene was cloned into pLICC vector flanking restriction enzyme sites KpnI and 
SacI at 5’ and 3’ end, respectively. As a result of using KpnI restriction site in the 5’ end, 
the TEV cleavage site present in the vector was removed. Hence, we incorporated the new 
TEV cleavage site in the forward primer to generate the tag free protein. An additional 
glycine (Gly) residue was incorporated in the forward primer at the beginning of the 
haditoxin sequence for TEV protease recognition. The primers used for amplification were 
forward primer- (Fwd:ATAGGTACCGAAAACCTGTACTTCCAAGGCACCAAATGC) 
and reverse primer- (Rev: AGCGCGAGCTCCTGGTTGCATTTATCGCGGCG). The 
amplified product was double digested and ligated into pLICC plasmid followed by 
transformation (using heat shock) into DH5α competent cells. The sequence of the gene of 
interest was confirmed by DNA sequencing. Upon confirmation the plasmid containing 
the gene of interest was isolated from DH5α cells and transformed (using heat shock) into 
BL21(DE3) cells for test expression. 
 
5.2.6   Sequence Analysis 
The nucleotide sequences were read using Chromas Lite and Gene Runner. Sequence 
analysis was carried out using the BLAST program at the NCBI Database 
(www.ncbi.nlm.nih.gov) and ExPASy proteomics tools (www.expasy.org). Sequence 






5.2.7   Recombinant protein expression 
For 50 ml expression, a single colony harboring recombinant vector was used for 
inoculation of 2 ml of LB medium containing appropriate antibiotic (as mentioned above) 
and incubated at 37 °C with overnight shaking. The overnight grown culture was 
inoculated into 50 ml of fresh LB ampicillin medium. The flask with the bacterial culture 
was incubated at 37 °C with shaking until the optical density (OD) of the culture reached 
in between 0.8-1.3. At this stage, 1 ml of culture is taken out as ‘uninduced sample’ and 
incubated for 4 hours at 37 °C without being induced by IPTG. This is used as negative 
control. The rest of the culture is induced with 1 mM IPTG and incubated for further 4 
hours 37 °C. After each hour 1 ml of culture was taken out for a time course evaluation of 
expression. After incubation the cells were harvested by centrifugation at 8,000 rpm for 10 
mins at room temperature and the cell pellets were stored at -80 °C until mini-purification. 
Later, for large scale production of protein BL21(DE3) cells harboring pLICC with the 
gene of interest were induced with 1 mM IPTG and incubated at 37 °C for about 4 h. 
Before incubation, 1 ml aliquot was kept aside as unduced control. After the induction 
time is over, the cells were harvested by centrifuging the cultures at 8,000 rpm for 30 min. 
The cell pellets were stored at -80 °C until further purification. The expression of 
recombinant protein in E. coli was analyzed by Tris-tricine SDS-PAGE as described in 
chapter 4 (section 4.2.4). 
 
5.2.8   Extraction of the recombinant protein 
The cells expressing the protein were thawed on ice to prevent cell lysis. The pellets from 




EDTA buffer (TSE buffer) pH 8.0, using magnetic stirrer until a uniform suspension was 
obtained. The volume of TSE buffer added was 100 µL for 1 ml culture, 5 ml for 50 ml of 
culture and 60 ml for 1 L culture. A 30 µL aliquot of each suspension (hereafter referred 
to as “whole cell extract” (WE)) was removed and set aside for SDS-PAGE analysis. The 
remainder was centrifuged at 12,000 rpm for 10 min and the supernatant was discarded. 
The pellets were resuspended in ice-chilled water to induce hypotonic shock and break the 
outer membrane. The volume of water used depends on the culture volume- 100 µL for 1 
ml, 5 ml for 50 ml and 60 ml for 1 L of culture. 9. Light stirring on the magnetic stirrer 
was done to resuspend the pellets and to ensure that all the cells receive the osmotic shock 
induced by water uniformly. 30 µL aliquot of each suspension (hereafter referred to as 
“Whole cell Suspension in water” (WW)) was removed and set aside for SDS-PAGE 
analysis. After this the mixture was again centrifuged at 12,000 rpm for a further 10 min 
and similarly, 30 µL sample of the supernatant was collected (hereafter referred to as 
“periplasmic cell extract” (PE)). Then a small scraping of the pellets were taken out and 
resuspended in 100 µL SDS-PAGE running buffer, and a 30 µL aliquot was retained 
(henceforth referred to as “cytoplasmic cell extract” (CE)). For the uninduced sample (1 
ml) the pellet is boiled with 1% SDS for 10 min and 30 µL was taken for SDS-PAGE 
analysis. All the samples (Uninduced, WE, WW, PE and CE) was analyzed by 12% tris-
tricine SDS-PAGE. 
 
5.2.9   Affinity purification 
The Ni-NTA resin stored in 20% ethanol was poured into gravity flow column and 




mM Tris, 200 mM NaCl, 10% glycerol, pH 8.0). The periplasmic extract (PE) was 
collected in a beaker on ice and 2.6 mL 0.5 M Tris pH 8.0, 2.6 mL 5 M NaCl and 6.5 mL 
100% glycerol was added to get final concentration of ~20 mM Tris, ~200 mM NaCl and 
~10% glycerol (i.e. TNG buffer).  The addition of the components was split into three 
steps. The 6mL of pre-equilibrated Ni-NTA resin slurry was then added to the buffered 
PE. The mixture was stirred for 1 h to allow binding to resin. This was then poured into an 
empty gravity flow column. The flow through was collected and the column was washed 
extensively (5-6 times, each with 50 ml for pellet from 1 L culture) with wash buffer 
(TNG buffer with 15 mM imidazole). The protein bound to the beads was eluted out using 
TNG buffer with 250 mM imidazole (20 ml). The imidazole was removed from the eluate 
with an Amicon Ultra 3 kDa centrifugal filter (Millipore, Billerica, MA, USA) using TNG 
buffer. The final solution was made up to 10 mL by the addition of redox buffer (final 
concentration of GSSH:GSG = 1:10). TEV protease (expressed and purified) was added to 
the solution, before incubation for 12–13 h with shaking, in order to release the 
recombinant haditoxin from the MBP fusion protein. TEV enzyme was used in a w/w ratio 
of 1:20 with that of the fusion protein. Finally, the solution was passed over the Ni-NTA 
Superflow matrix in order to capture the His6-MBP and His6-TEV. The flow through 
containing recombinant peptide toxin was collected in TNG buffer. 
 
5.2.10   Purification of the cleaved protein using RP-HPLC 
The recombinant tag free haditoxin was further purified using RP-HPLC. The cleaved 
protein was filtered before injecting into a Jupiter C18 analytical column preequilibrated 




TEV protease cleavage) was eluted with a linear gradient of 25%-45% of buffer B (80% 
acetonitrile (v/v) in 0.1% (v/v) TFA) at a flow rate of 1 ml/min. The fractions were 
collected and further they were subjected to ESI-MS for mass determination. 
 
5.2.11   Mass determination 
Fractions obtained from the RP-HPLC were directly injected into an API-300 LC/MS/MS 
system (PerkinElmer Life Sciences, Wellesley, MA, USA) to determine the mass of the 
proteins present. Electrospray ionization mass spectrum (ESI-MS) was acquired in a same 
method as described in chapter 2 (section 2.2.4). Analyte software (PerkinElmer Life 
Sciences, Wellesley, MA, USA) was used to analyze and deconvolute the raw mass data. 
Fractions showing the expected MW were pooled and lyophilized. 
 
5.2.12  Ex vivo organ bath studies with recombinant haditoxin 
Isolated tissue experiments with chick biventor cervicis muscle (CBCM) using organ bath 
were performed following the same procedure as described in chapter 3 (section 3.2.6 and 
3.2.11). The effects of various concentrations of haditoxin (0.03 to 10 µM; n=3) on the 
response of exogenous ACh, CCh or KCl on CBCM were investigated. Blockade of the 
responses to ACh, CCh and KCl by haditoxin are expressed as a percentage of the 
respective control response prior to the addition of the toxin.  
 
5.2.13  Statistical analysis 
The data were expressed as mean ± standard error of mean (SEM) of at least 3 




done with n=3. The data was analyzed using Origin software version 5.0 (OriginLab, 

























5.3   RESULTS 
5.3.1   Interaction of haditoxin with AChBP 
The soluble acetylcholine-binding protein (AChBP) is a structural homologue of the 
extracellular ligand binding domain of muscle-type and neuronal nAChRs (Smit et al, 
2001; Brejc et al, 2001; Hansen et al, 2004). 10 µM of haditoxin was screened for its 
ability to compete or interfere with the binding of [3H]epibatidine to the 5 AChBPs (Ls, 
Ac and the three Ac mutants, AcY55W, Ac5’, Ac2’3’’6 ), as measured by a scintillation 
proximity assay (Fig. 5.2). As shown in the figure haditoxin failed to show significant 
interference for the binding of [3H]epibatidine to the binding proteins. These results 
suggested that either haditoxin did not interact with the binding protein or it did not 
competed with [3H]epibatidine for the same binding site. As expected, significant 
interference for the binding of [3H]epibatidine to the binding proteins was observed with 
nicotine except for the mutant Ac2’3’’6. 
 
5.3.2   Interaction of haditoxin with 5-HT3 receptors 
We have characterized haditoxin for its interaction with 5-HT3 receptors using 
Ca2+/Fluo4 asaay. This experiment was done to find out the specificity of the toxin 
towards nicotinic receptors, since ligands targeting nicotinic receptors (especially α7-
nAChR) often hit other cys-loop receptors belonging to the super family ligand-gated ion 
channel receptors (for review see, Connolly and Wafford 2004; Ortells and Lunt, 1995). 
The cross reactivity was mostly observed with the 5-HT3 receptors because of the high 
(30%) sequence homology observed between these two class of receptors (Maricq et al, 




















































    Figure 5.2:  Interaction of haditoxin with acetylcholine binding protein and mutants. 
 
Compititive radioligand binding assay of haditoxin vs. Acetylcholine binding proteins (Ls: 
Lymnaea stagnalis; Ac: Aplysia californica and Ac y55W, Ac5’ & Ac2’3”6: Aplysia californica 
mutants). The concentration of haditoxin used was 10 µM. Nicotine (10 µM) was used as positive 
control. The radioligand used was [3H] Epibatidine. Results were expressed as fraction of 








reactivity of haditoxin towards 5-HT3A and 5-HT3AB receptors using Ca2+/Fluo4 assay. As 
observed in table 5.1 and figure 5.3 haditoxin did not exhibited any kind of activity 
(neither as antagonists or potentiators) at these receptors up to a concentration of 30 µM. 
As expected, 5-hydroxytryptamine or serotonin exhibited a potent agonistic effect and 
ondansetron, 5-HT3 receptor blocker (Zoldan et al, 1996), exhibited a potent antagonistic 
effect. Hence, it can be concluded that haditoxin did not interact with 5-HT3 receptors and 
it is a selective blocker for the nicotinic receptors, unlike the small molecular nicotinic 
ligands including acetylcholine (Gurley and Lanthorn, 1998; Steward et al, 2000; Machu 
et al, 2001; Broad et al, 2002; Drisdel et al, 2008). 
 
5.3.3 Recombinant expression and purification of haditoxin 
Recombinant haditoxin was successfully produced using the E. coli periplasmic 
expression system. The denaturing gel (SDS-PAGE) showing over-expression and initial 
purification of the toxins can be seen in figure 5.4. Comparison of the whole-cell extracts 
for the negative control (lane 1, labeled “Un”) and the periplamic extract after IPTG 
induction (lane 5, labeled “PE”) reveals that an intense band at ~49 kDa, consistent with 
the expected size of the His6-MBP-haditoxin fusion protein, is only present after IPTG 
induction. Moreover, as expected, this protein was found predominantly in the periplasmic 
fraction (labeled “PE”), with only minimal amounts, if any, present in the cytoplasmic 
extract (lane 6, labeled “CE”). Hence, it was concluded that the MBP-haditoxin fusion 
proteins have been highly over-expressed in E. coli and are found almost exclusively in 















The IC50 values were obtained using the Ca2+/Fluo-4 assay at 5-HT3A- and 5-HT3AB-
HEK293 cell lines. An assay concentration of 1 µM serotonin was used as agonist in the 
antagonist experiments. The EC50 values for serotonin and the IC50 values for the antagonists 
are given in µM with pEC50 ± S.E.M. and pIC50 ± S.E.M. values in brackets, respectively, and 






































Figure 5.3: Dose-dependent inhibition curve of haditoxin on 5-HT3A receptors. 
 
The data points were obtained from the Fluo4-Ca2+ assay using 5-HT3A/ HEK293 cell 
lines. Ondansetron, a standard antagonist was used as a positive control. Antagonism was 










Lane 7, 8, 9 and 10 in figure 5.4 shows the result of the affinity chromatography using Ni-
NTA beads. The flow through (lane 7, labeled as “Flt”) and washes (lane 8 and 9, labeled 
as “W1” and “W2” respectively) showed that the MBP-haditoxin fusion protein was 
bound to the Ni-NTA beads and the intense band in lane 10 (labeled as “Elu”) indicates 
that the protein was eluted out from the column along with the elution buffer. Following 
nickel affinity chromatography, TEV cleavage of the fusion protein was performed. The 
intense bands in lane 2, 3, 4 and 5 in figure 5.5 indicates the successful cleavage of the 
fusion protein and release of both the fusion partners (one band at ~ 7 kDa, which is 
probably of the toxin and the other band at ~45 kDa, which is probably the His6-MBP. 
The untagged recombinant toxin was eluted out from the Ni-NTA column whereas the 
His6-MBP remained in the column and was further eluted out using elution buffer 
containing imidazole as shown in lane 7 and 8 of figure 5.5. Post cleavage the toxin was 
further purified using RPHPLC. The resulting HPLC chromatogram is shown in figure 
5.6. The peak indicated by the black arrow is the fraction containing recombinant 
haditoxin. All the peaks obtained from the RP-HPLC was subjected to ESI-MS for mass 
confirmation and hence identity. The molecular weight of the peak indicate by the black 
arrow in figure 5.6 showed three peaks with mass/charge ratios ranging from +5 to +7 
charges (Fig. 5.7 A), and the final reconstructed spectrum showed a molecular weight of 
7592.01 ± 0.66 Da (Fig. 5.7 B) similar to the calculated mass of the recombinant haditoxin 






















Figure 5.4: SDS-PAGE picture showing over-expression and affinity purification of 
recombinant haditoxin. 
 
Lane markings on the top indicate- Un: uninduced whole cell extract, M: Marker for protein 
molecular-weight standards, WE: induced whole cell extract, WW: whole cell extracts of 
cells suspended in water, PE: periplasmic extract, CE: cytoplasmic extract, Flt: flowthrough, 
W1: wash first time, W2: wash second time and Elu: Elution of recombinant haditoxin. The 
masses for each of the standard are shown on the left of the gel. The thick band in between 
55 and 45 Da as seen in lane 5, in the periplasmic extract is presumed to be the MBP-toxin 




























Figure 5.5: SDS-PAGE picture showing TEV cleavage of recombinant haditoxin. 
 
Lane markings on the top indicate- M: Marker for protein molecular-weight standards, 
Cleavage 1: Cleavage reaction was set up with lower concentration of fusion protein, 
Cleavage 2: Cleavage reaction was set up with higher concentration of fusion protein and 
Elu aftr clvg: Elution of MBP after separating the tag free recombinant haditoxin. The 
masses for each of the standard are shown on the left of the gel. The thick bands near 7 
kDa as seen in lane 1, 2, 3 and 4 are presumed to be the tag free haditoxin (calculated 
molecular weight ~ 7592 Da) and the bands near 43 kDa as seen in lane 1, 2, 3, 4, 6 and 7 








































          
 
 
                  Figure 5.6: RP-HPLC profile of recombinant haditoxin. 
After TEV cleavage recombinant haditoxin was subjected to RP-HPLC using a Jupiter 
C18 (5 µ, 300 Å, 4.5 x 250 mm) analytical column was equilibrated with aqueous 0.1% 
(v/v) TFA (buffer A). The protein was eluted from the column with a flow rate of 1 
ml/min with a gradient of 23-49% (over a time period of about 90 minutes) buffer B (80% 
acetonitrile in 0.1% TFA). The dotted line (- - -) indicates the gradient of the buffer B. The 
black downward arrow indicates the peak containing recombinant haditoxin. Elution of 













































Figure 5.7: ESI-MS spectrum of the recombinant haditoxin. 
 
RP-HPLC fraction containing recombinant haditoxin was subjected to ESI-MS using an 
API-300 liquid chromatography/tandem mass spectrometry system. The spectrum shows a 
series of multiply charged ions ranging from +5 to +7 charges (A), corresponding to a 










5.3.4   Functional characterization of recombinant haditoxin using CBCM 
Recombinant haditoxin produced a time-dependent blockade of the nerve evoked twitch 
responses of CBCM (Fig. 5.8). The contractile response to exogenous agonists (ACh and 
CCh) was completely inhibited by haditoxin whereas, response to exogenous KCl and 
twitches evoked by direct muscle stimulation were not inhibited. No contracture or 
increase in muscle tone was observed with any of the doses of haditoxin tested for up to 
180 minutes following the addition of the toxin. This indicates a post-synaptic 
neuromuscular blockade and an absence of direct myotoxicity. The dose-dependent effect 
of recombinant haditoxin was examined on CBCM. A dose-response curve was 
constructed and the IC50 of recombinant haditoxin on CBCM was calculated to be 0.25 ± 
0.10 µM (Fig. 5.9) (considering the monomeric mass of the protein).  
Addition of native haditoxin, purified from the venom (as described in chapter 2) also 
completely inhibited the nerve evoked twitch responses of CBCM in a time-dependent 
fashion, without affecting the twitch response elicited by direct muscle stimulation or the 
response to exogenously applied KCl (already discussed in chapter 3). A dose-response 
curve was constructed for native haditoxin on CBCM and the IC50 was determined to be 
0.27 ± 0.07 µM (Fig 3.6, chapter 3). Hence, compared to the native haditoxin the 



























Figure 5.8: Effect of recombinant (r) haditoxin on the twitch response of CBCM elicited 
by nerve stimulation and exogenously applied acetylcholine, carbachol and potassium 
chloride. 
 
A segment of tracing showing the effect of haditoxin (3 µM) on chick biventer cervicis muscle 
preparations (CBCM) (n=3). Twitch response of the muscle was elicited by electrical field 
stimulation (EFS, indicated by the black bar) and by applying exogenous agonists, 
acetylcholine (ACh; 300 µM), carbachol (CCh; 10 µM) and potassium chloride (KCl; 30 mM). 
The vertical bar represents the magnitude of twitch response in gram tension and the horizontal 



















































Figure 5.9: Dose-response curve of recombinant haditoxin on CBCM. 
 
The concentration-response curve for the blockade of nerve-evoked twitch responses in 
the chick muscle by of recombinant haditoxin. The block is calculated as a percentage of 
the control twitch responses of the muscle to supramaximal nerve stimulation in the 









5.4   DISCUSSION 
Mother Nature has always reengineered proteins for new functions through evolutionary 
processes. Understanding how protein architectures evolve to accommodate a variety of 
functions remains a primary focus in protein chemistry. Knowledge about the 
relationships between protein structure and function has the potential to reveal 
fundamental characteristics of protein structures as well as the explicit manner in which 
they deliver their associated functions. To vivdly understand the structure-function 
paradigm, particularly useful structural information is extracted from the primary amino 
acid sequences and the associated tertiary/quaternary structures. The task becomes more 
difficult when the group of proteins being investigated belongs to a structurally similar 
family but functionally diverse. A classical example of such a family is the snake venom 
three-finger toxins. All the proteins in this family share a similar pattern of protein 
folding: three β-stranded loops extending from a central core, which is stabilized by the 
four conserved disulfide bonds. Because of their appearance, this family of proteins is 
called the three-finger toxin family.  However, they exhibit distinct pharmacological 
properties including neurotoxic, cardiotoxic, anticoagulant and antiplatelet effects. It has 
been observed that slight alterations in the primary structure (the amino acid residues) of 
these proteins may result a completely different physiological function, while retaining the 
same three-finger fold. Therefore, their structure-function relationships are subtle and 
complicated. 
We have characterized a novel three-finger neurotoxin, haditoxin from the venom of king 
cobra. Haditoxin In this chapter, we have described few experiments which have been 




protein. Haditoxin is the first dimeric α-neurotoxin to interact with the muscle type 
nicotinic receptors as well as the first short-chain α-neurotoxin to interact with the 
neuronal α7 nicotinic receptors although it lacks the extra disulfide bridge at the tip of the 
loop 2, known to be essential to interact with neuronal receptors. Therefore, to find out the 
novel structural elements through which haditoxin interacts with the nicotinic receptors we 
tried to observe the interaction of haditoxin with acetylcholine binding protein (AChBP). 
AChBP is a novel glial-derived soluble protein, which is an analogue of the ligand-
binding domains of the nicotinic acetylcholine receptor (nAChRs) (Brejc et al, 2001; 
Smith et al, 2001; Brejc et al, 2001).  Like the nAChRs, it assembles into a homopentamer 
with ligand-binding characteristics that are typical for a nicotinic receptor. Until now, 
several nicotinic small molecular ligands and α-conotoxins have been co-crystallized with 
AChBP (Hansen, et al, 2004; Celie et al, 2004; Ulen et al, 2006). Structures of such 
complexes have provided insights into the ligand binding site present at the cleft formed 
by subunit-subunit interface of nAChR. Till date, the first and only snake venom 
neurotoxin co-crystallized with AChBP was the long-chain α-neurotoxin, α-cobratoxin, 
isolated from the venom of Naja kauothia (Bourne et al, 2005). This revealed the 
toxin/receptor interaction site present at subunit-subunit interface. The interaction sites 
deduced from the structure of AChBP-toxin complex contribute greatly to the 
understanding of nAChR-snake neurotoxin interactions. However, there are not much 
structural details available on how a dimeric neurotoxin interacts with the nicotinic 
receptor. 
Therefore, with an ultimate aim to co-crystallize haditoxin with AChBP we observed the 




As shown by the results haditoxin did not show any competition with epibatidine to 
interact with the AChBP or its mutants. This could be because of the specificity of 
haditoxin towards vertebrate nicotinic acetylcholine receptors and not to the invertebrate 
analog. There is also another possibility that haditoxin may bind to a different site 
compared to epibatidine, which made it non-competitive, but this can only be confirmed 
with further experiments. 
Nicotinic receptors are pentamaric ligand-gated ion channel receptors (for review see, 
Karlin, 2002). The ligand binding site of this receptor is characterized by a cysteine loop 
between Cys119 and Cys132 (Torpedo α-subunit numbering). This is common with other 
members of the ligand gated ion channels including gamma amino butyric acid 
(GABAA,C), glycine, and 5-hydroxytryptamine (5-HT3) receptors. Hence, together, these 
receptors belong to the "Cys-loop" superfamily of ligand-gated ion channels (Ortells and 
Lunt, 1995; Le Novère and Changeux, 1999; Corringer et al, 2000). Among all these 
receptors 5-HT3 receptor shares about 30% sequence homology with the nicotinic 
receptors (Maricq et al, 1991; Werner et al, 1994). As a result of this, the ligands which 
binds to nicotinic receptors (including acetylcholine) also interacts with 5-HT3 receptors 
and vice-versa. Because of this cross interaction there are several disadvantages when 
using either nicotinic ligands or 5-HT3 receptor ligands in clinical practice. Hence, we 
wanted to check the interaction of haditoxin, which is a nicotinic ligand, towards 5-HT3 
receptors using Ca2+/Fluo4 assay. Haditoxin did not exhibit any kind of interaction with 5-
HT3 receptors. Therefore, it can be concluded that haditoxin is specific towards nicotinic 
receptors only, without any cross reactivity with 5-HT3 receptors. Thus, haditoxin can be 




nicotinic receptors and these elements can be used as a model to design drugs specific 
towards nicotinic receptors. 
Haditoxin is the first dimeric α-neurotoxin interacting with the muscle nicotinic receptors. 
Therefore, we wanted to know what will happen if the protein become monomeric. To 
answer this question we decided to perform mutagenesis studies of the interface residues, 
but this demands the recombinant expression of haditoxin. Hence, we proceeded for the 
recombinant expression of wild-type haditoxin in bacterial system. Haditoxin was 
expressed successfully in bacteria using a periplasmic expression vector. The expressed 
toxin was purified and the tag was cleaved off. The untagged protein was further purified 
using RP-HPLC and the identity was confirmed by mass spectrometry. Next, it was 
necessary to assess the functional properties of recombinant haditoxin thus, we performed 
ex vivo organ bath studies using chick biventer cervicis muscle. It was observed that the 
recombinant haditoxin acts similar to the native one producing a potent post-synaptic 
neuromuscular blockade. The IC50 of the recombinant toxin (0.25 ± 0.10 µM in Fig. 5.9), 
as determined from the dose-response curve, was comparable to that of the native one 
(0.27 ± 0.07 µM in Fig 3.6, chapter 3). Currently, we are designing the mutants to alter the 
dimeric interface of wild-type haditoxin which will allow us to express the monomeric 
toxin. This will be followed by the tissue organ bath assay and/or electrophysiological 
assay to evaluate the functional properties of the monomeric haditoxin. It will reveal the 







5.5   CONCLUSIONS 
In summary, haditoxin does not compete with the radioligand to interact with the 
invertebrate nicotinic receptor homolog, AChBP, possibly because of its specificity 
towards vertebrate nicotinic receptors or the binding site for the radioligand and haditoxin 
is different in the AChBP. Haditoxin did not show any cross reactivity toward other cys-
loop ion channel receptors such as- 5-HT3 receptors and it was found to be a specific 
antagonist for nicotinic receptors. We have successfully expressed recombinant haditoxin 
and it was found to be equipotent on CBCM compared to the native one. Further site-
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CHAPTER SIX 
Conclusions and future prospective 
 
6.1 CONCLUSIONS 
This thesis reports the isolation and characterization of a novel three-finger toxin, 
haditoxin. It was first identified in the cDNA library of the venom gland tissue of 
O. hannah. According to the cDNA sequence, haditoxin consists of a single 
polypeptide chain of 66 amino acid residues with a calculated molecular mass of 
7534.42 Da. The primary structure of haditoxin revealed that the cysteine bonding 
pattern is conserved with the members of the three-finger family of snake venom 
proteins, which shows that the protein is a members of this family. Based on the 
primary structure, haditoxin exhibited about 37-57% of homology with other 
3FTXs including, muscarinic toxins, short-chain α-neurotoxins, long-chain α-
neurotoxins, κ-neurotoxins and non-conventional neurotoxins. Interestingly, it 
was found that haditoxin shared the highest sequence homology (~ 80%) with the 
muscarinic toxins homologs, MTLP-3 (the name ‘MTLP’ was given based on the 
observed sequence identity with muscarinic toxins), with unknown molecular 
targets. 
For detailed structural and functional analysis haditoxin was purified to 
homogeneity from the crude venom of O. hannah, by successive gel filtration 
chromatography and reverse-phase HPLC. The identity of the purified protein 
was confirmed by N-terminal sequencing. Purified haditoxin was found to be 




structure was found to be predominantly β-sheet similar to other three-finger 
toxins. Surprisingly, when we tested haditoxin for muscarinic activity (based on 
the observed sequence homology), it failed to show any activity. Further in vivo 
assay in mice with haditoxin showed symptoms of peripheral neurotoxicity 
similar to α-neurotoxins. Hence, we observed the effect of haditoxin on the 
neuromuscular junction. The toxin produced a potent neuromuscular blockade in 
isolated nerve-muscle preparation. The reversibility of this blockade was species 
specific, probably because of the dietary nature of the snake. Based on the 
primary sequence (65 amino acids with four disulfide bridges) and the 
neuromuscular blocking property haditoxin was more likely similar to a short-
chain α-neurotoxin. The neuromuscular blockade effect was further confirmed by 
electrophysiology studies on expressed muscle (αβγδ) type nAChRs. 
Surprisingly, in the electrophysiology experiments haditoxin showed nanomolar 
affinity towards α7-nAChRs. This was a very interesting finding because, till date 
none of the other short-chain α-neurotoxins are known to interact with neuronal 
nAChRs. This is the first report of a short-chain α-neurtoxins targeting the 
neuronal α7-nAChRs. Haditoxin also produced a potent blockade on α3β2-
nAChRs, but the blockade for α4β2-nAChRs is in micromolar range. Moreover, in 
these experiments it was also observed that haditoxin produced a readily 
reversible blockade for the α3β2-nAChRs whereas the blockade for the α7-
receptors was long lasting. These data strongly suggest that the nature of binding 




Another interesting finding of this study was the high probability for the 
oligomeric nature of haditoxin. In the initial gel filtration studies during protein 
purification it was observed that this protein elutes earlier compared to other 
three-finger toxins. This could be as a consequence of oligomerization. To 
investigate the issue we performed gel filtration chromatography with purified 
haditoxin. It eluted with a relative molecular weight of 8.16 kDa, which is 
approximately double the molecular weight of haditoxin as observed in ESI-MS 
(~ 7.535 Da). The dimerization was further confirmed by SDS-PAGE in presence 
of a cross-linker. Thus, it is clear that haditoxin existed as a homodimer in 
solution. 
The high resolution crystal structure of haditoxin supported the dimeric nature of 
the protein. The molecule was composed of two identical monomers held together 
by non-covalent interactions, similar to the κ-neurotoxins. Each of the monomer 
adapted a structure similar to the short-chain α-neurotoxins with four 
intramolecular disulfide bridges. Thus, haditoxin is the first dimeric short-chain α-
neurotoxins.                                                                                                                                                                                  
The three dimensional structure of haditoxin revealed the presence of some 
functionally invariant residues in α-neurotoxins and κ-neurotoxins that are 
important for binding to muscle (αβγδ) and neuronal (α3β2 and α4β2) nAChRs. 
These putative functionally important residues were found to be located in 
homologous positions and in similar spatial disposition in the tertiary structure of 
haditoxin which can explain the potent neuromuscular blockade as well as the 




Interestingly however, haditoxin lacked the fifth disulfide bridge at the tip of loop 
II in long-chain α-neurotoxins, hitherto considered to be crucial for neurotoxins to 
bind to α7-nicotinic receptors with high affinity. Moreover, haditoxin also lacks 
the specific determinants of long-chain α-neurotoxins known to be critical for the 
interaction with α7-nicotinic receptors. Thus, haditoxin is the first known toxin 
documented that lacks this important structural configuration, and yet still capable 
of mediating a functional block of α7 nicotinic receptors at nanomolar 
concentrations. Clearly therefore, haditoxin utilizes other, yet undetermined, 
functional determinants in its interaction with the neuronal α7-nAChRs. 
To investigate these novel structural elements we have initiated the structure-
function relationship studies of haditoxin. In order to co-crystallize the protein 
with the acetylcholine binding protein (AChBP), the homolog for the ligand 
binding domain of nicotinic receptors, we studied the interaction of haditoxin with 
AChBP using competitive radioligand binding experiments. Haditoxin did not 
compete with the radioligand to interact with AChBP. We have also examined the 
interaction of haditoxin towards other ligand-gated ion channel receptors, but 
unlike the small molecular ligands, haditoxin did not show any interaction with 
them. Finally, we expressed recombinant haditoxin in bacterial expression system 
for further site-directed mutagenesis studies. The recombinant protein was 







6.2 FUTURE PERSPECTIVE  
The work described in this thesis has addressed some fundamental issues related 
to the structure and function of haditoxin, a novel three-finger neurotoxin from 
king cobra venom. We have also initiated preliminary structure-function 
relationship studies to understand novel elements responsible for the unique 
pharmacological properties of the toxin. However, there are some pertinent 
questions, answers for which will open up new and exciting avenues of 
investigation in the future. Some of them are discussed in the following sections.  
 
6.2.1 Role of the dimeric structure of haditoxin towards neuromuscular                
            blockade 
Haditoxin is the first dimeric neurotoxin to interact with muscle type nicotinic 
receptors. It will be interesting to examine the function of haditoxin in a 
monomeric form. This can be achieved by mutating the amino acid residues 
which present at the dimeric interface and important to maintain the non-covalent 
interaction. This can be followed by expression and functional characterization of 
the mutant protein(s). 
 
6.2.2 Novel structural elements of haditoxin to interact with α7-nAChR 
Haditoxin lacks the extra disulfide bridge compared to all the snake venom 




determinants of long-chain α-neurotoxins (Ala28 and Lys35; α-cobratoxin 
numbering) towards the neuronal (α7) nAChRs. Thus, it is of great interest to find 
out the structural elements responsible for the nanomolar affinity of haditoxin 
towards α7-nAChRs, possibly by site-directed mutagenesis studies followed by 
the functional characterization of the mutants on the same receptor.   
 
6.2.3 Binding mode of haditoxin to α7-nAChR 
The mode of binding of haditoxin towards the α7-nAChR is also crucial to 
understand. One of our collaborators has constructed a series of receptor mutants 
with mutations in the orthosteric binding site of α7-nAChR. Binding mode of 
haditoxin can be investigated, by characterizing the impact of different mutations 
on the antagonism produced on α7-nAChR. 
 
6.2.4 Structural determinants of haditoxin conferring reversibility 
It has already been suggested that the reversibility of neuromuscular blockade 
produced by some neurotoxins may be associated with a specific area of 
interaction on the toxin molecule, distinct from the receptor recognition site 
(Harvey and Rodger, 1978). Site directed mutagenesis of individual residues in 
haditoxin may be able to identify specific residue(s), if any, that may be involved 




haditoxin. Understandably, this will be a formidable challenge because of the lack 
of information to postulate the possible residues that could be involved. 
 
6.2.5 Kinetics of interaction between haditoxin and neuronal receptors 
In the electrophysiology experiments there was a 3-fold difference in the EC50 of 
haditoxin towards α7- and α3β2-nAChRs but the blockade on α3β2-nAChRs was 
readily reversible, whereas the blockade for the α7-nAChRs was practically 
irreversible. This reveals that the association and dissociation of haditoxin for 
these two receptors are very different. Radioligand binding experiments can be 
performed to analyze in details the kinetics of binding for haditoxin towards these 




















Adem A, Asblom A, Johansson G, Mbugua PM, Karlsson E. (1988) Toxins from 
the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of 
quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta 
968(3), 340–345. 
 
Adem A, Karlsson E. (1997) Muscarinic receptor subtype selective toxins. Life Sci. 
60(13-14), 1069-1076. 
 
Aird SD, Kaiser II. (1985) Toxicity Assays. Toxicon. 23(1), 11-13. 
 
Aird SD, Womble GC, Yates JR 3rd, Griffin PR. (1999) Primary structure of 
gamma-bungarotoxin, a new postsynaptic neurotoxin from venom of Bungarus 
multicinctus. Toxicon. 37(4), 609-625. 
 
Albrand JP, Blackledge MJ, Pascaud F, Hollecker M, Marion D. (1995) NMR and 
restrained molecular dynamics study of the three-dimensional solution structure of 
toxin FS2, a specific blocker of the L-type calcium channel, isolated from black 
mamba venom. Biochemistry. 34(17), 5923-5937. 
 
Antil S, Gaillard C, Tamiya T, Corringer PJ, Changeux JP, Servent D, Menez A. 
(2000) Molecular determinants by which a long chain toxin from snake venom 
interacts with the neuronal alpha 7-nicotinic acetylcholine receptor. J Biol Chem. 
275(38), 29594-29601. 
 
Antil S, Servent D, Ménez A. (1999) Variability among the sites by which 
curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by 






Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. (2006) 
SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous 
epithelium. J Cell Physiol. 208(1), 238-245. 
 
Arias HR. (2000) Localization of agonist and competitive antagonist binding sites 
on nicotinic acetylcholine receptors. Neurochem Int. 36, 595-645. 
 
Ashcroft FM (2000) Ion channels and disease: channelopathies. Academic Press: 
California. 
 
Bailey GS. (1998) Enzymes from snake venom. Alaken Inc., Fort Collins, Colarado. 
 
Barchan D, Kachalsky S, Neumann D, Vogel Z, Ovadia M, Kochva E, Fuchs S. 
(1992) How the mongoose can fight the snake: the binding site of the mongoose 
acetylcholine receptor. Proc Natl Acad Sci. 89(16), 7717-21. 
 
Baraka A. (1974) Nerve and muscle stimulation of the rat isolated phrenic 
nervedaiphragm preparation. Anesth Analg. 53(4), 594-596. 
 
Bargmann C. (2005) Neuroscience: Genomics reaches the synapse. Nature 436, 
473-474. 
 
Barlow A, Pook CE, Harrison RA, Wüster W. (2009) Coevolution of diet and prey-
specific venom activity supports the role of selection in snake venom evolution. 
Proc Biol Sci. 276(1666), 2443-2449.  
 
Bertrand D, Cooper E, Valera S, Rungger D, Ballivet M. (1991) Electrophysiology 
of neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes 
following nuclear injection of genes or cDNAs. In: Conn M, Editor, Methods in 
Neuroscience, Vol. 4. Academic Press, San Diego, pp. 174-193. 
 
Bilwes A, Rees B, Moras D, Menez R, Menez A. (1994) X-ray structure at 1.55 A 
of toxin gamma, a cardiotoxin from Naja nigricollis venom. Crystal packing reveals 





Birrell GW, Earl ST, Wallis TP, Masci PP, de Jersey J, Gorman JJ, Lavin MF. 
(2007) The diversity of bioactive proteins in Australian snake venoms. Mol Cell 
Proteomics. 6(6), 973-986. 
 
Bogin O. (2005) Venom peptides and their mimetics as potential drugs. Modulator. 
19, 14–20. (www.almone.com) 
 
Bourne Y, Talley TT, Hansen SB, Taylor P, Marchot P. (2005) Crystal structure of 
a Cbtx-AChBP complex reveals essential interactions between snake alpha-
neurotoxins and nicotinic receptors. EMBO J. 24(8), 1512-1522. 
 
Bourne Y, Taylor P, Marchot P. (1995) Acetylcholinesterase inhibition by 
fasciculin: crystal structure of the complex. Cell. 83(3), 503-512. 
 
Bradley KN. (2000) Muscarinic toxins from the green mamba. Pharmacol Ther. 
85(2), 87–109. 
 
Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smith AB, 
Sixma TK. (2001) Crystal structure of an Ach-binding protein reveals the ligand 
binding domain of nicotinic receptors. Nature. 411(6835), 269-276. 
 
Brejc K, van Dijk WJ, Smit AB, Sixma TK. (2002) The 2.7 A structure of AChBP, 
homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. 
Novartis Found Symp. 245, 22-29.  
 
Broad LM, Felthouse C, Zwart R, McPhie GI, Pearson KH, Craig PJ, Wallace L, 
Broadmore RJ, Boot JR, Keenan M, Baker SR, Sher E. (2002) PSAB-OFP, a 
selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 
receptor. Eur J Pharmacol. 452(2), 137-144. 
 
Buckley NJ, Caulfield MP. (1992) Transmission: acetylcholine. In: Burnstock G. 
and Hoyle CHV. (Ed.), Autonomic Neuroeffector Mechanisms. Harwood Academic 





Bulbring E. (1946) Observations on the isolated phrenic nerve diaphragm 
preparations of the rat. Br J Pharmacol. 1, 38 - 61. 
 
Calvete JJ. (2005) Structure-function correlations of snake venom disintegrins. Curr 
Pharm Des. 11(7), 829-835. 
 
Calvete JJ, Marcinkiewicz C, Monleón D, Esteve V, Celda B, Juárez P, Sanz L. 
(2005) Snake venom disintegrins: evolution of structure and function. Toxicon. 
45(8), 1063-1074. 
 
Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutiérrez JM. (2009) Venoms, 
venomics, antivenomics. FEBS Lett. 583(11), 1736-1743. 
Caulfield MP, Birdsall NJ. (1998) International Union of Pharmacology. XVII. 
Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 50(2), 279–
290. 
 
Celie PH, van Rossum-Fikkert SE, van Dijk WJ, Brejc K, Smit AB, Sixma TK. 
(2004) Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as 
studied in AChBP crystal structures. Neuron. 41(6), 907-914. 
 
Cervenansky C, Dajas F, Harvey AL, Karlsson E. (1991) Fasciculins, 
anticholinesterase toxins from mamba venoms: biochemistry and pharmacology. In: 
Harvey AL. (Ed.), Snake Toxins. Pergamon Press, New York. pp. 303-321. 
 
Chang CC. (1979) The action of snake venoms on nerve and muscle. In: Lee CY. 
(Ed.) Snake Venoms, Handbook of Experimental Pharmacology, Vol. 52, Springer- 
Verlag, Berlin, pp. 309-376. 
 
Chang CC, Lee CY. (1963) Isolation of neurotoxins from the venom of Bungarus 
multicinctus and their modes of neuromuscular blocking action. Arch Int 





Changeux JP. (1990) The TiPS lecture. The nicotinic acetylcholine receptor: an 
allosteric protein prototype of ligand-gated ion channels. Trends Pharmacol Sci. 
11(12), 485-492. 
 
Changeux J, Edelstein SJ. (2001) Allosteric mechanisms in normal and pathological 
nicotinic acetylcholine receptors. Curr Opin Neurobiol. 11(3), 369-77. 
 
Changeux JP, Edelstein S J. (1998) Allosteric receptors after 30 years. Neuron. 21, 
959-980. 
 
Changeux JP, Kasai M, Lee CY. (1970) Use of a snake venom toxin to characterize 
the cholinergic receptor protein. Proc Natl Acad Sci USA. 67(3), 1241-1247. 
 
Chatrath ST, Chapeaurouge A, Lin Q, Lim TK, Dunstan N, Mirtschin P, Kumar PP, 
Kini RM. (2011) Identification of novel proteins from the venom of a cryptic snake 
Drysdalia coronoides by a combined transcriptomics and proteomics approach. J 
Proteome Res. 10(2), 739-750. 
 
Chen D, Patrick JW. (1997) The α-bungarotoxin-binding nicotinic acetylcholine 
receptor from rat brain contains only the α7 subunit. J Biol Chem. 272, 24024-
24029. 
 
Chiappinelli VA, Lee JC. (1985) kappa-Bungarotoxin. Self-association of a 
neuronal nicotinic receptor probe. J Biol Chem. 260(10), 6182-6186. 
 
Chiappinelli,V.A. and Wolf,K.M. (1989). Kappa-neurotoxins: heterodimer 
formation between different neuronal nicotinic receptor antagonists. Biochemistry. 
28, 8543-8547. 
 
Chicheportiche R, Vincent JP, Kopeyan C, Schweitz H, Lazdunski M. (1975) 
Structure-function relationship in the binding of snake neurotoxins to the torpedo 





Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, Huber M, 
Bertrand D, Hohl D. (2003) Identification of SLURP-1 as an epidermal 
neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet. 
12(22), 3017-3024. 
 
Coborn J. (1991) The Atlas of Snakes of the World, TFH Publications, New Jersey, 
USA. 
 
Cogger HG. (2000) Reptiles & Amphibians of Australia. Reed New Holland: 
Sydney, Australia. 
 
Colquhoun LM, Patrick JW. (1997) Alpha3, beta2, and beta4 form heterotrimeric 
neuronal nicotinic acetylcholine receptors in Xenopus oocytes. J Neurochem. 69(6), 
2355-2362. 
 
Colubridae species list at the TIGR Reptile Database. Accessed 4 December 2008. 
Conant R, Collins JT. (1991) A Field Guide to Reptiles and Amphibians: Eastern 
and Central North America. Houghton Mifflin, Boston. pp. 450, 48 plates. 
 
Connolly CN, Wafford KA. (2004) The Cys-loop superfamily of ligand-gated ion 
channels: the impact of receptor structure on function. Biochem Soc Trans. 32(Pt3), 
529-534. 
 
Corringer PJ, Le Novère N, Changeux JP. (2000) Nicotinic receptors at the amino-
acid level. Annu Rev Pharmacol Toxicol. 40, 431-458. 
 
Crachi MT, Hammer LW, Hodgson WC. (1999) A pharmacological examination of 
venom from the Papuan taipan (Oxyuranus scutellatus canni). Toxicon. 37(12), 
1721-1734. 
 
Cunningham BC, Wells JA. (1993) Comparison of a structural and a functional 





Daltry JC, Wüster W, Thorpe RS. (1996) Diet and snake venom evolution. Nature. 
379(6565), 537-540. 
 
de Weille JR, Schweitz H, Maes P, Tartar A, Lazdunski M. (1991) Calciseptine, a 
peptide isolated from black mamba venom, is a specific blocker of the L-type 
calcium channel. Proc Natl Acad Sci U S A. 88(6), 2437-2440. 
 
Deacock ARD, Davies TDW. (1958) The influence of certain ganglionic blocking 
agents on neuromuscular transmission. Brit J Anaesth. 30(5), 217-225.  
 
Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, Chen L. (2007) Crystal structure of the 
extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A 
resolution. Nat Neurosci. 10(8), 953-962. 
 
Dewan JC, Grant GA, Sacchettini JC. (1994) Crystal structure of kappa-
bungarotoxin at 2.3-A resolution. Biochemistry. 33(44), 13147-13154. 
 
Dihazi GH, Sinz A. (2003) Mapping low-resolution three-dimensional protein 
structures using chemical cross-linking and Fourier transform ion-cyclotron 
resonance mass spectrometry. Rapid Commun Mass Spectrom. 17(17), 2005-2014. 
 
Doley R, Mackessy SP, Kini RM. (2009) Role of accelerated segment switch in 
exons to alter targeting (ASSET) in the molecular evolution of snake venom 
proteins. BMC Evol Biol. 9, 146. 
 
Drenth J, Low BW, Richardson JS, Wright CS. (1980) The toxinagglutinin fold. A 
new group of small protein structures organized around a four-disulfide core. J Biol 
Chem. 255(7), 2652-2655. 
 
Drisdel RC, Sharp D, Henderson T, Hales TG, Green WN. (2008) High affinity 






Dufton MJ. (1993) Kill and cure: the promising future for venom research. 
Endeavour. 17(3), 138-140. 
 
Dufton MJ, Harvey AL. (1989) The long and the short of snake toxins. Trends 
Pharmacol Sci. 10(7), 258-259. 
 
Dufton MJ, Hider RC. (1988) Structure and pharmacology of elapid cytotoxins. 
Pharmacol Ther. 36(1), 1-40. 
 
Durand JF. (2004) "The origin of snakes." Geoscience Africa 2004. Abstract 
Volume, University of the Witwatersrand, Johannesburg, South Africa. pp. 187. 
 
Durant NN. (1984) The physiology of neuromuscular transmission. In: Katz R (Ed.) 
Muscle Relaxants. Grune and Stratton Inc., Orlando, Florida, pp. 19-52. 
 
Eglen RM, Hegde RS, Watson N. (1996) Muscarinic receptor subtypes and smooth 
muscle function. Pharmacol Rev. 48, 531–565. 
 
Eglen RM, Reddy H, Watson N, Challis RAJ. (1994) Muscarinic receptor subtypes 
in smooth muscle. Trends Pharmacol Sci. 15(4), 114–117. 
 
Ehlert FJ, Thomas EA. (1995) Functional role of M2 muscarinic receptors in the 
guinea pig ileum. Life Sci. 56(11-12), 965-971. 
 
Emsley P, Cowtan K. (2004) Coot: model-building tools for molecular graphics. 
Acta Crystallogr D Biol Crystallogr. 60(P 12 Pt 1), 2126-2132. 
 
Endo T, Tamiya N. (1987) Current view on the structure-function relationship of 
postsynaptic neurotoxins from snake venoms. Pharmacol Ther. 34(3), 403-451. 
 
Endo T, Tamiya N. (1991) Structure-function relationships of postsynaptic 
neurotoxins from snake venoms. In: Harvey AL. (Ed.), Snake Toxins.  Pergamon 





Fairley NH. (1929a) The dentition and biting mechanism of Australian snakes. Med 
J Aust. 1, 313-317. 
 
Fairley NH. (1929b) The present position of snake bite and the snake bitten in 
Australia. Med J Aust. 1, 296-312. 
 
Feldman, S. (1996) Neuromuscular block. Butterworth – Heinemann, Oxford. 
 
Fernandez JH, Neshich G, Camargo ACM. (2004) Using bradykininpotentiating 
peptide structures to develop new antihypertensive drugs. Genet Mol Res. 3(4), 
554–563. 
 
Fiordalisi JJ, al Rabiee R, Chiappinelli VA, Grant GA. (1994) Site-directed 
mutagenesis of kappa-bungarotoxin: implications for neuronal receptor specificity. 
Biochemistry. 33(13), 3872-3877. 
 
Fleming TJ, O’hUigin C, Malek TR. (1993) Characterization of two novel Ly-6 
genes. Protein sequence and potential structural similarity to α-bungarotoxin and 
other neurotoxins. J Immunol. 150(12), 5379–5390. 
 
Fletcher CM, Harrison RA, Lachmann PJ, Neuhaus D. (1994) Structure of a soluble, 
glycosylated form of the human complement regulatory protein CD59. Structure, 
2(3), 185-199. 
 
Freitas MA, Geno PW, Sumner LW, Cooke ME, Hudiburg SA, Ownby CL, Kaiser 
II, Odell GV. (1992) Citrate is a major component of snake venoms. Toxicon. 30(4), 
461-464. 
 
Friedrich C, Tu AT. (1971) Role of metals in snake venoms for hemorrhagic, 
esterase and proteolytic activities. Biochem Pharmacol. 20(7), 1549-1556. 
 
Fruchart-Gaillard C, Gilquin B, Antil-Delbeke S, Le Novère N, Tamiya T, 




model of a complex between a snake toxin and the alpha7 nicotinic receptor. Proc 
Natl Acad Sci USA. 99(5), 3216-3221. 
 
Fry BG. (2005) From genome to "venome": molecular origin and evolution of the 
snake venom proteome inferred from phylogenetic analysis of toxin sequences and 
related body proteins. Genome Res. 15(3), 403-420. 
Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal 
N, Poelmann RE, Norman JA. (2008) Evolution of an arsenal: structural and 
functional diversification of the venom system in the advanced snakes 
(Caenophidia). Mol Cell Proteomics 7(2), 215–246. 
 
Fry BG, Vidal N, Norman JA, Vonk FJ, Scheib H, Ramjan SF, Kuruppu S, Fung K, 
Hedges SB, Richardson MK, Hodgson WC, Ignjatovic V, Summerhayes E, Kochva 
E. (2006) Early evolution of the venom system in lizards and snakes. Nature. 
439(7076), 584–588. 
 
Fry BG, Vidal N, van der Weerd L, Kochva E, Renjifo C. (2009) Evolution and 
diversification of the Toxicofera reptile venom system. J Proteomics. 72(2), 127–
136. 
 
Fry BG, Wuster W, Kini RM, Brusic V, Khan A, Venkataraman D, Rooney AP. 
(2003) Molecular evolution and phylogeny of elapid snake venom three-finger 
toxins. J Mol Evol. 57(1), 110–129. 
 
Fujimi TJ, Nakajyo T, Nishimura E, Ogura E, Tsuchiya T, Tamiya T. (2003) 
Molecular evolution and diversification of snake toxin genes, revealed by analysis 
of intron sequences. Gene. 313, 111-118. 
 
Furchgott RF. (1972) The classification of adrenoceptors (adrenergic receptors): An 
evaluation from the standpoint of receptor theory. In: Blaschko H. and Muscholl E. 
(Ed.), Handbook of Experimental Pharmacology, Catecholamines. Springer-Verlag, 





Galzi JL, Revah F, Black D, Goeldner M, Hirth C, Changeux JP. (1990) 
Identification of a novel amino acid α- tyrosine 93 within the cholinergic ligand-
binding sites of the acetylcholine receptor by photolabeling. Additional evidence for 
a three-loop model of the cholinergic ligand-binding site. J Biol Chem 265, 10430–
10437. 
 
Gay EA, Bienstock RJ, Lamb PW & Yakel JL (2007). Structural determinates for 
apolipoprotein E-derived peptide interaction with the α7 nicotinic acetylcholine 
receptor. Mol Pharmacol 72, 838–849. 
 
Geh SL, Rowan EG, Harvey AL. (1992) Neuromuscular effects of three 
phospholipases A2 from the venom of Pseudechis australis, the Australian king 
brown snake. Toxicon. 30(9), 1051 – 1057. 
 
Geh SL, Vincent A, Rang S, Abrahams T, Jacobson L, Lang B, Warrell DA. (1997) 
Identification of phospholipase A2 and neurotoxic activities in the venom of the 
New Guinean small-eyed snake (Micropechis ikaheka). Toxicon. 35(1), 101 - 109. 
Gibson A, McFadzean I. (2001) Biology of the anococcygeus muscle. Int Rev Cyt. 
205, 1-35. 
 
Gidrol X, Chrestin H, Tan HL, Kush A. (1994) Hevein, a lectin-like protein from 
Hevea brasiliensis (rubber tree) is involved in the coagulation of latex. J Biol Chem. 
269(12), 9278-9283. 
 
Gillespie JS. (1972) The rat anococcygeus muscle and its response to nerve 
stimulation and to some drugs. Br J Pharmacol. 45(3), 404 - 416. 
 
Gilquin B, Bourgoin M, Menez R, le Du MH, Servent D, Zinn-Justin S, Menez A. 
(2003) Motions and structural variability within toxins: implication for their use as 
scaffolds for protein engineering. Protein Sci. 12(2), 266-277. 
 
Ginsborg BL, Warriner JN. (1960) The isolated chick biventer cervicis nervemuscle 





Gold BS, Dart RC, Barish RA. (2002) Bites of venomous snakes. N Engl J Med. 
347(5), 347-356. 
 
Gopalakrishnakone P, Chou  LM (1990) Snake of medical importance. Singapore: 
Venom and toxins research group.  
 
Gottschall J. (1981) The diaphragm of the rat and its innervation. Muscle fiber 
composition; perikarya and axons of efferent and afferent neurons. Anat Embryol 
(Berl). 161(4), 405–417. 
 
Grant GA, al Rabiee R, Xu XL, Zhang Y. (1997) Critical interactions at the dimer 
interface of kappa-bungarotoxin, a neuronal nicotinic acetylcholine receptor 
antagonist. Biochemistry. 36(11), 3353-3358. 
 
Grant GA, Chiappinelli VA. (1985) kappa-Bungarotoxin: complete amino acid 
sequence of a neuronal nicotinic receptor probe. Biochemistry. 24(6), 1532-1537. 
 
Grant GA, Luetje CW, Summers R, Xu XL. (1998) Differential roles for disulfide 
bonds in the structural integrity and biological activity of kappa-Bungarotoxin, a 
neuronal nicotinic acetylcholine receptor antagonist. Biochemistry. 37(35), 12166-
12171. 
 
Greenwald J, Fischer WH, Vale WW, Choe S. (1999) Three-finger toxin fold for the 
extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat 
Struct Biol. 6(1) 18-22. 
 
Grutter T, Changeux JP. (2001) Nicotinic receptors in wonderland. Trends Biochem 
Sci. 26, 459-463. 
 
Gumley TP, McKenzie IFC, Sandrin MS. (1995) Tissue expression, structure and 






Gurley DA, Lanthorn TH. (1998) Nicotinic agonists competitively antagonize 
serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes. Neurosci  Lett. 
247(2-3), 107–110. 
 
Hansen SB, Talley TT, Radic Z, Taylor P. (2004) Structural and ligand recognition 
characteristics of an acetylcholine-binding protein from Aplysia californica.  J Biol 
Chem. 279(23), 24197-24202. 
 
Harris JB. (1991) Phospholipases in snake venoms and their effects on nerve and 
muscle. In: Harvey AL. (Ed.), Snake Toxins. Pergamon Press, New York. pp. 91–
129. 
 
Harrison PM, Sternberg MJ. (1996) The disulphide beta-cross: from cystine 
geometry and clustering to classification of small disulphide-rich protein folds. J 
Mol Biol. 264(3), 603-623. 
 
Harvey AL. (1991) Snake Toxins. Pergamon Press, New York, USA. 
 
Harvey AL. (2002) Toxins 'R' Us: more pharmacological tools from nature's 
superstore. Trends Pharmacol Sci. 23(5), 201-203. 
 
Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. (1994) Screening 
of snake venoms for neurotoxic and myotoxic effects using simple in vitro 
preparations from rodents and chicks. Toxicon. 32(3), 257-265. 
 
Harvey AL, Bradley KN, Cochran SA, Rowan EG, Pratt JA, Quillfeldt JA, 
Jerusalinsky DA. (1998) What can toxins tell us for drug discovery? Toxicon 
36(11), 1635–1640. 
 
Harvey AL, Rodger IW. (1978) Reversibility of neuromuscular blockade produced 






Herz JM, Johnson DA, Taylor P. (1989) Distance between the agonist and 
noncompetitive inhibitor sites on the nicotinic acetylcholine receptor. J Biol Chem. 
264(21), 12439-12448. 
 
Hibbs RE, Talley TT, Taylor P. (2004) Acrylodan-conjugated cysteine side chains 
reveal conformational state and ligand site locations of the acetylcholine-binding 
protein. J Biol Chem. 279(27), 28483-28491. (SPA Assay) 
 
Hider RC, Karlsson E, Namiranian S. (1991) Separation and purification of toxins 
from snake venoms. In: Harvey AL. (Ed.), Snake Toxins. Pergamon Press, New 
York. pp. 1-34. 
 
Hogg RC, Bandelier F, Benoit A, Dosch R, Bertrand D. (2008) An automated 
system for intracellular and intranuclear injection. J Neurosci Methods. 169(1), 65-
75. 
 
Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. (1987) Trigramin. A low 
molecular weight peptide inhibiting fibrinogen interaction with platelet receptors 
expressed on glycoprotein IIb-IIIa complex. J Biol Chem. 262(33), 16157-16163. 
 
Ibanez-Tallon I, Miwa JM, Wang HL, Adams NC, Crabtree GW, Sine SM, Heintz 
N. (2002) Novel modulation of neuronal nicotinic acetylcholine receptors by 
association with the endogenous prototoxin lynx1. Neuron. 33(6), 893-903. 
 
Itier V, Bertrand D. (2001) Neuronal nicotinic receptors: from protein structure to 
function. FEBS letters. 504(3), 118–125. 
Iwanaga S, Suzuki T. (1979) Enzymes in snake venom. In: Lee CY. (Ed.) Snake 
Venoms, Handbook of Experimental Pharmacology, Vol. 52. Springer-Verlag, 
Berlin, pp. 61-158. 
 
Jennings ML, Nicknish JS. (1985) Localization of a site of intermolecular cross-





Jensen AA, Bergmann ML, Sander T, Balle T. (2010) Ginkgolide X is a potent 
antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine 
receptors. J Biol Chem. 285(13), 10141-10153. (Fluo4 assay) 
 
Jerusalinsky D, Harvey AL. (1994) Toxins from mamba venoms: small proteins 
with selectivities for different subtypes of muscarinic acetylcholine receptors. 
Trends Pharmacol Sci. 15(11), 424-430. 
 
Jerusalinsky D, Kornisiuk E, Alfaro P, Quillfeldt J, Ferreira A, Rial VE, Durán R, 
Cerveñansky C. (2000) Muscarinic toxins: novel pharmacological tools for the 
muscarinic cholinergic system. Toxicon. 38(6), 747-761. 
 
Jiang M, Haggblad J, Heilbronn E. (1987) Isolation and pharmacological 
characterization of a new alpha-neurotoxin (alpha-AgTx) from venom of the viper 
Agkistrodon halys (Pallas). Toxicon. 25(9), 1019-1022. 
 
Jørgensen CG, Frølund B, Kehler J, Jensen AA. (2011) Discovery of benzamide 
analogues as a novel class of 5-HT₃ receptor agonists. ChemMedChem. 6(4), 725-
736. (Fluo4 assay) 
 
Junqueira-de-Azevedo IL, Ching AT, Carvalho E, Faria F, Nishiyama MY Jr, Ho 
PL, Diniz MR. (2006) Lachesis muta (Viperidae) cDNAs reveal diverging pit viper 
molecules and scaffolds typical of cobra (Elapidae) venoms: implications for snake 
toxin repertoire evolution. Genetics. 173(2), 877-889. 
 
Kao PN, Dwork AJ, Kaldany RR, Silver ML, Wideman J, Stein S, Karlin A. (1984) 
Identification of the α subunit half-cystine specifically labeled by an affinity reagent 
for the acetylcholine receptor binding site. J Biol Chem 259, 11662–11665. 
 
Karlin A. (2002) Emerging structure of the nicotinic acetylcholine receptors. Nature 
Rev. Neurosci. 3(2), 102-114. 
Karlsson E. (1979) Chemistry of protein toxins in snake venoms. In: Lee CY. (Ed.) 
Snake venoms, Handbook of Experimental Pharmacology, Vol. 52. Springer-





Karlsson E, Eaker DL, Porath J. (1966) Purification of a neurotoxin from the venom 
of Naja nigricollis. Biochim Biophys Acta. 127(2), 505-520. 
 
Karlsson E, Jolkonen M, Mulugeta E, Onali P, Adem A. (2000) Snake toxins with 
high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie. 82(9-
10), 793–806. 
 
Karlsson E, Mbugua PM, Rodriguez-Ithurralde D. (1984) Fasciculins, 
anticholinesterase toxins from the venom of the green mamba Dendroaspis 
angusticeps. J Physiol (Paris). 79(4), 232-240. 
 
Kasheverov IE, Zhmak MN, Fish A, Rucktooa P, Khruschov AY, Osipov AV, 
Ziganshin RH, D'hoedt D, Bertrand D, Sixma TK, Smit AB, Tsetlin VI. (2009) 
Interaction of alpha-conotoxin ImII and its analogs with nicotinic receptors and 
acetylcholine-binding proteins: additional binding sites on Torpedo receptor. J 
Neurochem. 111(4), 934-944. 
 
Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran 
A, Premaratna R, Savioli L, Lalloo DG, de Silva HJ. (2008) Estimation of the global 
burden of snakebite. PloS Med. 5(11), e218. 
 
Katz B, Thesleff S. (1957) A study of the desensitization produced by acetylcholine 
at the motor end-plate. J Physiol. 138(1), 63-80.  
 
Kenakin TP. (2006) A Pharmacology Primer: Theory, Application and Methods, 
2nd ed. Academic Press/Elsevier, Amsterdam. 
 
Kieffer B, Driscoll PC, Campbell ID, Willis AC, van der Merwe A, Davis SJ. 
(1994) Three-dimensional solution structure of the extracellular region of the 
complement regulator protein CD59, a new cell-surface protein domain related to 





Kini RM. (2002) Molecular moulds with multiple missions: functional sites in 
three-finger toxins. Clin Exp Pharmacol Physiol. 29(9), 815–822. 
 
Kini RM. (2010) A protein biochemist’s sandbox Toxin treasure in. Features, 
Poisons and antidotes.  The Biochemical Society. 
 
Kini RM, Chan YM. (1999) Accelerated evolution and molecular surface of venom 
phospholipase A2 enzymes. J Mol Evol. 48(2) 125-132. 
 
Kini RM, Doley R. (2010) Structure, function and evolution of three-finger toxins: 
mini proteins with multiple targets. Toxicon. 56(6), 855-67. 
 
Kirsch T, Sebald W, Dreyer MK. (2000) Crystal structure of the BMP-2- BRIA 
ectodomain complex. Nat Struct Biol. 7(6), 492-496. 
 
Knoller S, Shpungin S, Pick E. (1991) The membrane-associated component of the 
amphiphile-activated, cytosol-dependent superoxide-forming NADPH oxidase of 
macrophages is identical to cytochrome b559. J Biol Chem. 266(5), 2795-2804. 
 
Koh DCI, Armugam A, Jeyaseelan K. (2006) Snake venom components and their 
applications in biomedicine. Cell Mol Life Sci. 63(24), 3030–3041. 
 
Kolbe HVJ, Huber A, Cordier P, Rasmussen UB, Bouchon B, Jaquinod M, Vlasak 
R, Delot EC, Kreil G. (1993) Xenoxins, a family of peptides from dorsal gland 
secretion of Xenopus laevis related to snake venom cytotoxins and neurotoxins. J 
Biol Chem. 268(22), 16458-16464. 
 
Kordis D, Gubensek F. (2000) Adaptive evolution of animal toxin multigene 
families. Gene. 261(1), 43-52. 
 






Krebs HA, Henseleit K. (1932) Untersuchungenuber die Harnstoffbildung im 
Tierkorper. Z Physiol Chem. 210, 33-66. 
 
Kreienkamp HJ, Sine SM, Maeda RK, Taylor P. (1994) Glycosylation sites 
selectively interfere with α-toxin binding to the nicotinic acetylcholine receptor. J 
Biol Chem. 269, 8108-8114. 
 
Krissinel E, Henrick K. (2007) Inference of macromolecular assemblies from 
crystalline state. J Mol Biol. 372(3), 774-797. 
 
Kukhtina VV, Weise C, Muranova TA, Starkov VG, Franke P, Hucho F, Wnendt S, 
Gillen C, Tsetlin VI, Utkin YN. (2000) Muscarinic toxin-like proteins from cobra 
venom. Eur J Biochem. 267(23), 6784-6789. 
 
Kumar TK, Jayaraman G, Lee CS, Arunkumar AI, Sivaraman T, Samuel D, Yu C. 
(1997) Snake venom cardiotoxins-structure, dynamics, function and folding. J 
Biomol Struct Dyn. 15(3), 431-463. 
 
Kuruppu S, Reeve S, Smith AI, Hodgson WC. (2005) Isolation and pharmacological 
characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the 
Papuan black snake (Pseudechis papuanus). Biochem Pharmacol. 70(5), 794-800. 
 
Langley JN. (1907) On the contraction of muscle, chiefly in relation to the presence 
of "receptive" substances: Part I. J Physiol. 36(4-5), 347-384. 
 
Langmead CJ, Watson J, Reavill C. (2008) Muscarinic acetylcholine receptors as 
CNS drug targets. Pharmacol Ther. 117(2), 232–243. 
 
Laothong C, Sitprija V. (2001) Decreased parasympathetic activities in Malayan 
krait (Bungarus candidus) envenoming. Toxicon. 39(9), 1353-1357. 
 
Laskowski RA, MacArthur MW, Moss DS, Thornton JM. (1993) Procheck: a 
program to check the stereochemical quality of protein structures. J Appl 





Lawson R, Slowinski JB, Crother BI, Burbrink FT. (2005) Phylogeny of the 
Colubroidea (Serpentes): new evidence from mitochondrial and nuclear genes. Mol 
Phylogenet Evol. 37(2), 581–601. 
 
le Du MH, Housset D, Marchot P, Bougis PE, Navaza J, Fontecilla-Camps JC. 
(1996) Structure of fasciculin 2 from green mamba snake venom: evidence for 
unusual loop flexibility. Acta Crystallogr D Biol Crystallogr. 52(Pt 1), 87-92. 
 
Le Novère N, Changeux JP. (1999) The ligand gated ion channel database. Nucleic 
Acids Res. 27(1), 340-342. 
 
Lee AM, Jacoby DB, Fryer AD. (2001) Selective muscarinic receptor antagonists 
for airway diseases. Curr Opin Pharmacol. 1(3), 223–229. 
 
Lee CY. (1972) Chemistry and pharmacology of polypeptide toxins in snake 
venoms. Annu Rev Pharmacol. 12, 265-286. 
 
Léna C, Changeux JP. (1997) Pathological mutations of nicotinic receptors and 
nicotine-based therapies for brain disorders. Curr Opin Neurobiol. 7, 674-682. 
 
Lewis RJ, Garcia ML. (2003) Therapeutic potential of venom peptides. Nat Rev 
Drug Discov. 2(10), 790-802. 
 
Li J, Zhang H, Liu J, Xu K. (2006) Novel genes encoding six kinds of three-finger 
toxins in Ophiophagus hannah (king cobra) and function characterization of two 
recombinant long-chain neurotoxins. Biochem J. 398(2), 233–242. 
 
Lindstrom J. (1997) Nicotinic acetylcholine receptors in health and disease. Mol 
Neurobiol. 15, 193-222. 
 
Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Menez 
A. (2005) Crystal structure of the human urokinase plasminogen activator receptor 





Louw AI, Visser L. (1978) The synergism of cardiotoxin and phospholipase A2 in 
hemolysis. Biochim Biophys Acta 512(1), 163-171. 
 
Lumsden NG, Fry BG, Ventura S, Kini RM, Hodgson WC. (2005) Pharmacological 
characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove 
catsnake). Toxicon. 45(3), 329-334. 
Machu TK, Hamilton ME, Frye TF, Shanklin CL, Harris MC, Sun H, Tenner Jr, TE, 
Soti FS, Kem WR. (2001) Benzylidene analogs of anabaseine display partial agonist 
and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor. J 
Pharmacol Exp Ther. 299(3), 1112 – 1119. 
 
Mackessy SP, Sixberry NM, Heyborne WH, Fritts T. (2006) Venom of the Brown 
Treesnake, Boiga irregularis: ontogenetic shifts and taxa-specific toxicity. Toxicon. 
47(5), 537-548. 
 
Marchot P, Bourne Y, Prowse CN, Bougis PE, Taylor P. (1998) Inhibition of mouse 
acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis 
of fasciculin. Toxicon. 36(11), 1613-1622. 
 
Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. (1991) Primary structure 
and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. 
Science. 254(5030), 432-437. 
 
Mark O'Shea. (2005) Venomous Snakes of the World. New Holland Publishers: 
London, UK. pp. 14. 
 
Mc Dowell, Samuel B. (1972) The evolution of the tongue of snakes and its bearing 
on snake origins. Evolutionary Biology .6, 191–273. 
 
McDowell RS, Dennis MS, Louie A, Shuster M, Mulkerrin MG, Lazarus RA. 
(1992) Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation 






McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine 
receptors expressed by vertebrate neurons. Annu Rev Physiol. 57, 521–546. 
 
Mehrtens J. (1987) Living Snakes of the World, Sterling, New York, USA. 
 
Meier J, Theakston RDG. (1986) Approximate LD50 determinations of snake 
venoms using eight to ten experimental animals. Toxicon. 24(4), 395 – 410. 
 
Menez A. (1998) Functional architectures of animal toxins: a clue to drug design? 
Toxicon. 36(11), 1557-1572. 
 
Ménez A. (2002) Perspectives in Molecular Toxinology. John Wiley & Sons Ltd., 
Chichester, UK. 
 
Menez A, Bouet F, Guschlbauer W, Fromageot P. (1980) Refolding of reduced 
short neurotoxins: circular dichroism analysis. Biochemistry. 19(18), 4166-4172. 
 
Menez A, Boulain JC, Bouet F, Couderc J, Faure G, Rousselet A, Tremeau O, 
Gatineau E, Fromageot P. (1984) On the molecular mechanisms of neutralization of 
a cobra neurotoxin by specific antibodies. J Physiol (Paris). 79(4), 196-206. 
 
Ménez A, Stöcklin R, Mebs D. (2006) ‘‘Venomics” or: the venomous systems 
genome project. Toxicon 47(3), 255–259. 
 
Merril CR. (1990) Gel-staining techniques. Methods Enzymol. 182, 477-488. 
 
Meyer MD, Decker MW, Rueter LE, Anderson DJ, Dart MJ, Kim KH, Sullivan JP 
Williams M (2000) The identification of novel structural compound classes 
exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic 





Miwa JM, Ibanez-Tallon I, Crabtree GW, Sanchez R, Sali A, Role LW, Heintz N. 
(1999) Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine 
receptors in the mammalian CNS. Neuron. 23(1), 105 – 114. 
 
Middleton RE, Cohen JB. (1991) Mapping of the acetylcholine binding site of the 
nicotinic acetylcholine receptor: [3H]nicotine as an agonist photoaffinity label. 
Biochemistry. 30, 6987–6997. 
 
Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C, 
Sakmann B. (1986) Molecular distinction between fetal and adult forms of muscle 
acetylcholine receptor. Nature. 321(6068):406-11. 
 
Miyazawa A, Fujiyoshi Y, Stowell M & Unwin N. (1999) Nicotinic acetylcholine 
receptor at 4.6 Å resolution: transverse tunnels in the channel wall. J Mol Biol. 288, 
765–786. 
 
Moise L, Piserchio A, Basus VJ, Hawrot E. (2002) NMR structural analysis of α-
bungarotoxin and its complex with the principal α-neurotoxin-binding sequence on 
the α7 subunit of a neuronal nicotinic acetylcholine receptor. J. Biol. Chem. 
277(14), 12406-12417. 
 
Nakashima K, Nobuhisa I, Deshimaru M, Nakai M, Ogawa T, Shimohigashi Y, 
Fukumaki Y, Hattori M, Sakaki Y, Hattori S. (1995) Accelerated evolution in the 
protein-coding regions is universal in crotalinae snake venom gland phospholipase 
A2 isozyme genes. Proc Natl Acad Sci U S A. 92(12), 5605-5609. 
 
Nakashima K, Ogawa T, Oda N, Hattori M, Sakaki Y, Kihara H, Ohno M. (1993) 
Accelerated evolution of Trimeresurus flavoviridis venom gland phospholipase A2 
isozymes. Proc Natl Acad Sci U S A. 90(13), 5964-5968. 
 
Nau F, Guérin-Dubiard C, Désert C, Gautron J, Bouton S, Gribonval J, Lagarrigue 
S. (2003) Cloning and characterization of HEP21, a new member of the uPAR/Ly6 






Neubig RR, Cohen JB. (1979) Equilibrium binding of [3H] tubocurarine and [3H] 
acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand 
interactions. Biochemistry 18, 5464-5475. 
 
Nirthanan S, Charpantier E, Gopalakrishnakone P, Gwee MC, Khoo HE, Cheah LS, 
Bertrand D, Kini RM. (2002) Candoxin, a novel toxin from Bungarus candidus, is a 
reversible antagonist of muscle (alphabetagammadelta) but a poorly reversible 
antagonist of neuronal alpha 7 nicotinic acetylcholine receptors. J Biol Chem. 
277(20), 17811-17820. 
 
Nirthanan S, Charpantier E, Gopalakrishnakone P, Gwee MC, Khoo HE, Cheah LS, 
Kini RM, Bertrand D. (2003a) Neuromuscular effects of candoxin, a novel toxin 
from the venom of the Malayan krait (Bungarus candidus). Br J Pharmacol. 139(4), 
832-844. 
 
Nirthanan S, Gopalakrishnakone P, Gwee MC, Khoo HE, Kini RM. (2003) Non-
conventional toxins from Elapid venoms. Toxicon. 41(4), 397-407. 
 
Nirthanan S, Gwee MC. (2004) Three-finger alpha-neurotoxins and the nicotinic 
acetylcholine receptor, forty years on. J Pharmacol Sci. 94(1), 1-17. 
 
Nobuhisa I, Nakashima K, Deshimaru M, Ogawa T, Shimohigashi Y, Fukumaki Y, 
Sakaki Y, Hattori S, Kihara H, Ohno M. (1996) Accelerated evolution of 
Trimeresurus okinavensis venom gland phospholipase A2 isozyme-encoding genes. 
Gene. 172(2), 267-272. 
 
Odell GV, Fenton AW, Ownby CL, Doss MP, Schmidt JO. (1999) The role of 
venom citrate. Toxicon. 37(3), 407-409. 
 
Ohno M, Menez R, Ogawa T, Danse JM, Shimohigashi Y, Fromen C, Ducancel F, 
Zinn-Justin S, le Du MH, Boulain JC, Tamiya T, Menez A. (1998) Molecular 




a mechanism of accelerated evolution? Prog Nucleic Acid Res Mol Biol. 59, 307-
364. 
 
Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P. (1999) 
Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native 
receptors. J Pharmacol Exp Ther. 288(1), 164-170. 
 
OmPraba G, Chapeaurouge A, Doley R, Devi KR, Padmanaban P, Venkatraman C, 
Velmurugan D, Lin Q, Kini RM. (2010) Identification of a novel family of snake 
venom proteins Veficolins from Cerberus rynchops using a venom gland 
transcriptomics and proteomics approach. J Proteome Res. 9(4), 1882-1893. 
Ortells MO, Lunt GG. (1995) Evolutionary history of the ligand-gated ion-channel 
superfamily of receptors. Trends Neurosci. 18(3), 121-127. 
 
Osipov AV, Kasheverov IE, Makarova YV, Starkov VG, Vorontsova OV, 
Ziganshin RK, Andreeva TV, Serebryakova MV, Benoit A, Hogg RC, Bertrand D, 
Tsetlin VI, Utkin YN. (2008) Naturally occurring disulfide-bound dimers of three-
fingered toxins: a paradigm for biological activity diversification. J Biol Chem. 
283(21), 14571-14580. 
 
Oswald RE, Sutcliffe MJ, Bamberger M, Loring RH, Braswell E, Dobson CM. 
(1991) Solution structure of neuronal bungarotoxin determined by two-dimensional 
NMR spectroscopy: sequence-specific assignments, secondary structure, and dimer 
formation. Biochemistry. 30(20), 4901-4909. 
 
Otwinowski Z, Minor W. (1997) Processing of X-ray Diffraction Data Collected in 
Oscillation Mode. In Carter CW and Sweet JRM editors. Methods Enzymol. 
Academic Press, New York. 
 
Pahari S, Bickford D, Fry BG, Kini RM. (2007a) Expression pattern of three-finger 
toxin and phospholipase A2 genes in the venom glands of two sea snakes, Lapemis 
curtus and Acalyptophis peronii: comparison of evolution of these toxins in land 





Pahari S, Mackessy SP, Kini RM. (2007) The venom gland transcriptome of the 
Desert Massasauga rattlesnake (Sistrurus catenatus edwardsii): towards an 
understanding of venom composition among advanced snakes (Superfamily 
Colubroidea). BMC Mol Biol. 8, 115. 
 
Pal SK, Gomes A, Dasgupta SC, Gomes A. (2002) Snake venom as therapeutic 
agents: from toxin to drug development. Indian J Exp Biol. 40(12), 1353-1358. 
 
Pan HL, Chen SR, Eisenach JC (1999) Intrathecal clonidine alleviates allodynia in 
neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors. 
Anesthesiology 90, 509-514. 
 
Palma E, Bertrand S, Binzoni T, Bertrand D. (1996) Neuronal nicotinic α7 receptor 
expressed in Xenopus oocytes presents five putative binding sites for 
methyllycaconitine. J Physiol. 491, 151-161. 
 
Palmer CA, Hollis DM, Watts RA, Houck LD, McCall MA, Gregg RG, Feldhoff 
PW, Feldhoff RC, Arnold SJ. (2007) Plethodontid modulating factor, a 
hypervariable salamander courtship pheromone in the three-finger protein 
superfamily. FEBS J. 274(9), 2300-2310. 
 
Parascandola J. (1986) The development of receptor theory. In: Parnham MJ. and 
Bruinvels J. (Ed.), Pharmacological Methods, Receptors and Chemotherapy. 
Elsevier/North-Holland, Amsterdam. Vol. 3, pp. 129-158. 
 
 
Paterson D, Nordberg A. (2000) Neuronal nicotinic receptors in the human brain. 
Prog Neurobiol. 61(1), 75-111. 
 
Pawlak J, Mackessy SP, Fry BG, Bhatia M, Mourier G, Fruchart-Gaillard C, 
Servent D, Menez R, Stura E, Menez A, Kini RM. (2006) Denmotoxin, a three-
finger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with 





Pawlak J, Mackessy SP, Sixberry NM, Stura EA, le Du MH, Menez R, Foo CS, 
Menez A, Nirthanan S, Kini RM. (2009) Irditoxin, a novel covalently linked 
heterodimeric three-finger toxin with high taxon-specific neurotoxicity. FASEB J. 
23(2), 534-545. 
 
Perrakis A, Morris R, Lamzin VS. (1999) Automated protein model building 
combined with iterative structure refinement. Nat Struct Biol. 6(5), 458-463. 
 
Phelps T. (1981) In: Poisonous Snakes. Blandford Press: Dorset. 
 
Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, LeNovere N, Vincent P, 
Pich EM, Brulet P, Changeux JP. (1995) Abnormal avoidance learning in mice 
lacking functional high-affinity nicotine receptor in the brain. Nature 374, 65-67. 
 
Pillet L, Tremeau O, Ducancel F, Drevet P, Zinn-Justin S, Pinkasfeld S, Boulain JC, 
Menez A. (1993) Genetic engineering of snake toxins. Role of invariant residues in 
the structural and functional properties of a curaremimetic toxin, as probed by site-
directed mutagenesis. J Biol Chem. 268(2), 909-916. 
 
Ploug M, Ellis V. (1994) Structure-function relationships in the receptor 
forurokinase-type plasminogen activator. Comparison to other members of the Ly-6 
family and snake venom α-neurotoxins. FEBS Lett. 349(2), 163-168. 
 
Pollard BJ. (1994) Components of the neuromuscular junction. In: Pollard, B.J. 
(Ed.) Applied Neuromuscular Pharmacology. Oxford University Press, New York, 
pp.17-43. 
 
Prado-Franceschi J, Hyslop S, Cogo JC, Andrade AL, Assakura M, Cruz-Höfling 
MA, Rodrigues-Simioni L. (1996) The effects of Duvernoy's gland secretion from 
the xenodontine colubrid Philodryas olfersii on striated muscle and the 
neuromuscular junction: partial characterization of a neuromuscular fraction. 





Pung YF, Wong PT, Kumar PP, Hodgson WC, Kini RM. (2005) Ohanin, a novel 
protein from king cobra venom, induces hypolocomotion and hyperalgesia in mice. 
J Biol Chem. 280(13), 13137-13147. 
 
Pyron RA, Burbrink FT, Colli GR, de Oca AN, Vitt LJ, Kuczynski CA, Wiens JJ. 
(2011) The phylogeny of advanced snakes (Colubroidea), with discovery of a new 
subfamily and comparison of support methods for likelihood trees. Mol Phylogenet 
Evol. 58(2), 329-342.  
 
Rajagopalan N, Pung YF, Zhu YZ, Wong PT, Kumar PP, Kini RM. (2007) Beta-
cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom 
with beta-blocker activity. FASEB J. 21(13), 3685-3695. 
 
Ramanathan VK, Hall ZW. (1999) Altered glycosylation sites of the delta subunit of 
the acetylcholine receptor (AChR) reduce alpha delta association and receptor 
assembly. J Biol Chem. 274(29), 20513-20. 
 
Rang HP, Dale MM, Ritter JM Moore PK. (2003) Pharmacology, 5th ed. Churchill 
Livingstone: Philadelphia, US. pp. 138.  
 
Rees B, Samama JP, Thierry JC, Gilibert M, Fischer J, Schweitz H, Lazdunski M, 
Moras D. (1987) Crystal structure of a snake venom cardiotoxin. Proc Natl Acad Sci 
U S A. 84(10), 3132-3136. 
 
Reiter MJ, Cowburn DA, Prives JM, Karlin A. (1972) Affinity labeling of the 
acetylcholine receptor in the electroplax: electrophoretic separation in sodium 
dodecyl sulfate. Proc Natl Acad Sci. 69, 1168–1172. 
 
Ricciardi A, le Du MH, Khayati M, Dajas F, Boulain JC, Menez A, Ducancel F. 
(2000) Do structural deviations between toxins adopting the same fold reflect 





Rocha e Silva M, Beraldo WT, Rosenfeld G. (1949) Bradykinin, a hypotensive and 
a smooth muscle stimulating factor released from plasma globulin by snake venom 
and by trypsin. Am J Physiol. 156(2), 261–273. 
 
Rowan EG, Harvey AL, Takasaki C, Tamiya N. (1989) Neuromuscular effects of 
three phospholipase A2 from the venom of the Australian king brown snake 
Pseudechis australis. Toxicon. 27(5), 551-560. 
 
Savitzky AH. (1980) The role of venom delivery strategies in snake evolution. 
Evolution. 34(6), 1194-1204. 
 
Scanziani M, Häusser M. (2009) Electrophysiology in the age of light. Nature. 
461(7266), 930-939.   
 
Scarr E, Dean B. (2008) Muscarinic receptors: do they have a role in the pathology 
and treatment of schizophrenia? J Neurochem. 107(5), 1188–1195. 
 
Schägger H. (2006) Tricine-SDS-PAGE. Nat Protoc. 1(1), 16-22. 
 
Schägger H, von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. 
Anal Biochem. 166(2), 368-379. 
 
Segalas I, Roumestand C, Zinn-Justin S, Gilquin B, Menez R, Menez A, Toma F. 
(1995) Solution structure of a green mamba toxin that activates muscarinic 
acetylcholine receptors, as studied by nuclear magnetic resonance and molecular 
modelling. Biochemistry. 34(4), 1248-60. 
 
Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. (1993) Molecular 
cloning, functional properties, and distribution of rat brain α7: a nicotinic cation 
channel highly permeable to calcium. J Neurosci. 13, 596-604. 
 






Servent D, Antil S, Gaillard C, Corringer PJ, Changeux JP, Menez A. (2000) 
Molecular characterization of the specificity of interactions of various neurotoxins 
on two distinct nicotinic acetylcholine receptors. Eur J Pharmacol. 393(1-3), 197-
204. 
 
Servent D, Fruchart-Gaillard C. (2009) Muscarinic toxins: tools for the study of the 
pharmacological and functional properties of muscarinic receptors. J. Neurochem. 
109(5), 1193-1202. 
 
Servent D, Menez A. (2001) Snake neurotoxins that interact with nicotinic 
acetylcholine receptors. In: Massaro, EJ. (Ed.), Handbook of Neurotoxicology. 
Humana, Totowa, New Jersey. Vol. 1, pp 385-425. 
 
Servent D, Mourier G, Antil S, Menez A. (1998) How do snake curaremimetic 
toxins discriminate between nicotinic acetylcholine receptor subtypes. Toxicol Lett. 
102-103, 199-203. 
 
Servent D, Winckler-Dietrich V, Hu HY, Kessler P, Drevet P, Bertrand D, Menez 
A. (1997) Only snake curaremimetic toxins with a fifth disulfide bond have high 
affinity for the neuronal alpha7 nicotinic receptor. J Biol Chem. 272,(39) 24279-
24286. 
 
Shapiro AL, Viñuela E, Maizel JV Jr. (1967) Molecular weight estimation of 
polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem 
Biophys Res Commun. 28(5), 815-820. 
 
Shelke RRJ, Sathish S, Gowda TV. (2002) Isolation and characterization of a novel 
postsynaptic/cytotoxic neurotoxin from Daboia russelli russelli venom. J Peptide 
Res. 59(6), 257–263. 
 





Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, Lodder H, 
van der Schors RC, van Elk R, Sorgedrager B, Brejc K, Sixma TK, Geraerts WP. 
(2001) A glia-derived acetylcholine-binding protein that modulates synaptic 
transmission. Nature. 411(6835), 261-268. 
 
Starkov VG, Poliak I, Vul'fius EA, Kriukova EV, Tsetlin VI, Utkin I. (2009) New 
weak toxins from the cobra venom. Bioorg Khim. 35(1), 15-24. 
 
Staros JV. (1982) N-hydroxysulfosuccinimide active esters: bis(N-
hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, 
membrane-impermeant, protein cross-linkers. Biochemistry. 21(17), 3950-3955. 
 
Staros JV, Anjaneyulu PS. (1989) Membrane-impermeant cross-linking reagents. 
Methods Enzymol. 172, 609-628. 
 
Steward LJ, Boess FG, Steele JA, Liu D, Wong N, Martin IL. (2000) Importance of 
phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine(3A) receptor. 
Mol. Pharmacol. 57(6), 1249– 1255. 
 
Tan LC, Kuruppu S, Smith AI, Reeve S, Hodgson WC. (2006) Isolation and 
pharmacological characterisation of hostoxin-1, a postsynaptic neurotoxin from the 
venom of the Stephen's banded snake (Hoplocephalus stephensi). 
Neuropharmacology. 51(4), 782-788. 
 
Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D. (2002) Role of 
nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull. 
57, 133-150. 
 
Teixeira-Clerc F, Menez A, Kessler P. (2002) How do short neurotoxins bind to a 






Torres AM, Kini RM, Selvanayagam N, Kuchel PW. (2001) NMR structure of 
bucandin, a neurotoxin from the venom of the Malayan krait (Bungarus candidus). 
Biochem J. 360(Pt 3), 539-548. 
 
Torres AM, Wong HY, Desai M, Moochhala S, Kuchel P W, Kini RM. (2003) 
Identification of a novel family of proteins in snake venoms. J Biol Chem. 278(41), 
40097-40104. 
 
Trémeau O, Lemaire C, Drevet P, Pinkasfeld S, Ducancel F, Boulain JC, Menez A. 
(1995) Genetic engineering of snake toxins. The functional site of erabutoxin a, as 
delineated by site-directed mutagenesis, includes variant residues. J Biol Chem. 
270(16), 9362-9369. 
 
Tsetlin V. (1999) Snake venom alpha-neurotoxins and other 'three-finger' proteins. 
Eur J Biochem. 264(2), 281-286. 
 
Tsuneki H, Kimura I, Dezaki K, Kimura M, Sala C, Fumagalli G. (1995) 
Immunohistochemical localization of neuronal nicotinic receptor subtypes at the 
preand postjunctional sites in mouse diaphragm muscle. Neurosci Lett. 196, 13–16. 
 
Tyrode MV. (1910) Mode of action of some purgative salts. Arch Int Pharmacodyn 
Ther. 20, 205-210. 
 
Ulens C, Hogg RC, Celie PH, Bertrand D, Tsetlin V, Smit AB,  Sixma TK. (2006) 
Structural determinants of selective alpha-conotoxin binding to a nicotinic 
acetylcholine receptor homolog AChBP. Proc Natl Acad Sci U S A. 103(10), 3615-
3620. 
 
Unwin N. (1993) Nicotinic acetylcholine receptor at 9 A resolution. J Mol Biol. 
229(4), 1101-1124. 
 
Unwin N. (2005) Refined structure of the nicotinic acetylcholine receptor at 4A 





Utkin YN, Kukhtina V V,  Kryukova EV,Chiodini F, Bertrand D, Methfessel C, 
Tsetlin VI. (2001) "Weak toxin" from Naja kaouthia is a nontoxic antagonist of 
alpha 7 and muscle-type nicotinic acetylcholine receptors. J Biol Chem. 276:15810-
15815. 
 
Utsintong M, Talley TT, Taylor PW, Olson AJ, Vajragupta O. (2009) Virtual 
screening against alpha-cobratoxin. J Biomol Screen. 14(9), 1109-1118. (SPA assay) 
 
Vagin A, Steiner RA, Lebedev AA, Potterton L, McNicholas S, Long F, Murshudov 
GN. (2004) REFMAC5 dictionary: organization of prior chemical knowledge and 
guidelines for its use. Acta Crystallogr D Biol Crystallogr. 60(Pt 12 Pt 1), 2184-
2195. 
 
Vagin A, Teplyakov A. (1997) MOLREP: an Automated Program for Molecular 
Replacement. J Appl Crystallogr. 30, 1022-1025. 
 
Vidal N, Delmas AS, David P, Cruaud C, Couloux A, Hedges SB. (2007) The 
phylogeny and classification of caenophidian snakes inferred from seven nuclear 
protein-coding genes. C R Biol. 330(2), 182–187. 
 
Viljoen CC, Botes DP. (1973) Snake venom toxins. The purification and amino acid 
sequence of toxin F VII from Dendroaspis angusticeps venom. J Biol Chem. 
248(14), 4915-4919. 
 
Voitenko SV, Bobryshev AY, Skok VI. (2000) Intracellular regulation of neuronal 
nicotinic cholinoreceptors. Neurosci Behav Physiol. 30, 19¯ 25. 
 
Wang D, Chiara DC, Xie Y, Cohen JB. (2000) Probing the structure of the nicotinic 
acetylcholine receptor with 4-benzoylbenzoylcholine, a novel photoaffinity 
competitive antagonist. J Biol Chem 275, 28666–28674. 
 
Wang ZZ, Hardy SF, Hall ZW. (1996) Assembly of the nicotinic acetylcholine 
receptor. The first transmembrane domains of truncated alpha and delta subunits are 





Warrell DA, Looareesuwan S, White NJ, Theakston RDG, Warrell MJ, Kosakarn 
W, Reid HA. (1983) Severe neurotoxic envenoming by Malayan krait Bungarus 
candidus (Linnaeus): response to antivenom and anticholinesterase. Br Med J. 
286(6366), 678-682. 
 
Weiser M, Mutschler E, Lambrecht G. (1997) Characterization of postjunctional 
muscarinic receptors mediating contraction in rat anococcygeus muscle. Naunyn 
Schmiedebergs Arch Pharmacol. 356(5), 671 - 677. 
 
Welsh JH. (1967) Acetylcholine in snake venoms. In: Russell EE. and Sanders PR. 
(Ed.), Animal Toxins. Pergamon Press, New York. pp. 363 – 368. 
 
Werner P, Kawashima E, Reid J, Hussy N, Lundström K, Buell G, Humbert Y, 
Jones KA. (1994) Organization of the mouse 5-HT3 receptor gene and functional 
expression of two splice variants. Brain Res Mol Brain Res. 26(1-2), 233-241. 
 
White J. (1998) Venomous Snakes. In: Geordie T. (Ed.), Australia's Most 
Dangerous Spiders, Snakes and Marine Creatures: Australian geographic field 
guide. Sydney: Australian Geographic Pty. Ltd. pp. 11-54.  
 
Wolf KM, Ciarleglio A, Chiappinelli VA. (1988) kappa-Bungarotoxin: binding of a 
neuronal nicotinic receptor antagonist to chick optic lobe and skeletal muscle. Brain 
Res. 439(1-2), 249-258. 
 
Wonnacott S. (1997) Presynaptic nicotinic acetylcholine receptors. Trends 
Neurosci. 20, 92-98. 
 
Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou CN, Patrick JW, 
Role L, De Biasi M, Beaudet AL. (1999a) Megacystis, mydriasis, and ion channel 
defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor. Proc Natl 





Xu W, Orr-Urtreger A, Nigro F, Gelber S, Sutcliffe SB, Armstrong D, Patrick JW, 
Role L, Beaudet AL, M De Biasi. (1999b) Multiorgan autonomic dysfunction in 
mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine 
receptors. J Neurosci. 19, 9298-9305. 
Yakel JL. (2010) Gating of nicotinic ACh receptors: latest insights into ligand 
binding and function. J Physiol. 588(4), 597-602. 
 
Zaher H, Grazziotin FG, Cadle JE, Murphy RW, Moura-Leite JC, Bonatto SL. 
(2009) Molecular phylogeny of advanced snakes (Serpentes, Caenophidia) with an 
emphasis on South America xenodontines: a revised classification and descriptions 
of new taxa. Pap Av Zool. 49, 115–153. 
 
Zeng H, Moise L, Grant M A, Hawrot E. (2001) The solution structure of a complex 
formed between α-bungarotoxin and an 18-mer cognate peptide derived from the α1 
subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol 
Chem. 276(25), 22930-22940. 
 
Zoldan J, Friedberg G, Livneh M, Melamed E. (1995) Psychosis in advanced 
Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. 



















Figure A.1: LC/MS profile of O. hannah crude venom. 
The masses of 4 novel proteins identified from the cDNA library are highlighted with green 
boxes. The proteins and peptide eluted during 30-35 min showed the presence of a protein with 
molecular weight of 7,535.67 ± 0.60 Da, similar to the mass of haditoxin. Reproduced with 
permission from Prof. R Manjunatha Kini, Department of Biological Sciences, National 





































































































































































































































































































































































































Structural and Functional Characterization of a Novel
Homodimeric Three-finger Neurotoxin from the Venom of
Ophiophagus hannah (King Cobra)*□S
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Snake venoms are a mixture of pharmacologically active pro-
teins and polypeptides that have led to the development of
molecular probes and therapeutic agents. Here, we describe the
structural and functional characterization of a novel neuro-
toxin, haditoxin, from the venomofOphiophagus hannah (King
cobra). Haditoxin exhibited novel pharmacology with antago-
nism toward muscle () and neuronal (7, 32, and 42)
nicotinic acetylcholine receptors (nAChRs)with highest affinity
for 7-nAChRs. The high resolution (1.5 A˚) crystal structure
revealed haditoxin to be a homodimer, like -neurotoxins,
which target neuronal 32- and 42-nAChRs. Interestingly
however, the monomeric subunits of haditoxin were composed
of a three-finger protein fold typical of curaremimetic short-
chain -neurotoxins. Biochemical studies confirmed that it
existed as a non-covalent dimer species in solution. Its struc-
tural similarity to short-chain-neurotoxins and-neurotoxins
notwithstanding, haditoxin exhibited unique blockade of
7-nAChRs (IC50 180 nM), which is recognized by neither short-
chain -neurotoxins nor -neurotoxins. This is the first report
of a dimeric short-chain -neurotoxin interacting with neuro-
nal 7-nAChRs as well as the first homodimeric three-finger
toxin to interact with muscle nAChRs.
Snake venoms are a rich source of pharmacologically active
proteins and polypeptides targeting a variety of receptors with
high affinity and specificity (1). Because of their high specificity,
some of these molecules have contributed significantly (a) to
the isolation and characterization of different receptors and
their subtypes in the field ofmolecular pharmacology and (b) as
lead compounds in the development of therapeutic agents (2,
3). For example, the discovery of -bungarotoxin, a postsynap-
tic neurotoxin from the venom of Bungarus multicinctus, led
to the identification of the nicotinic acetylcholine receptor
(nAChR),3 the first isolated receptor protein (4) as well as the
first one to be characterized electrophysiologically (5) and bio-
chemically (6, 7). Subsequently, it was also used to characterize
several other nAChRs (8–10).
Snake venom proteins can be broadly classified as enzymatic
and non-enzymatic proteins. Three-finger toxins (3FTxs) are
the largest group of non-enzymatic snake venom proteins (1,
11). They are most commonly found in the venoms of elapid
and hydrophiid snakes. Recently, our laboratory has also dem-
onstrated the presence of 3FTxs from colubrid venoms (12, 13),
and 3FTx transcripts have been found in the venom gland tran-
scriptome of viperid snakes (14, 15). The proteins in this family
of toxins share a common structural scaffold of three-sheeted
loops emerging from a central core (11, 16). Despite the overall
similarity in structure, these proteins have diverse functional
properties. Members of this family include neurotoxins target-
ing the cholinergic system (7, 11, 16), cytotoxins/cardiotoxins
interacting with the cell membranes (17), calciseptine and
related toxins that block the L-type Ca2 channels (18), den-
droaspins, which are antagonists of various cell adhesion pro-
cesses (19), and -cardiotoxin antagonizing the -adrenocep-
tors (20). The subtle variations in their structures, such as the
presence of extra disulfide bonds, differences in size and overall
conformation (twists and turns) of the loops, and longer C-ter-
minal and/orN-terminal extensions (21),may contribute to the
observed functional diversity as well as specificity of these tox-
ins (22).
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This family contains several types of neurotoxins that
interact with different subtypes of nicotinic and muscarinic
receptors involved in central and peripheral cholinergic
transmission. Depending on the target receptors, these neuro-
toxins can be broadly divided into various groups. Curaremi-
metic or-neurotoxins that targetmuscle ( or1 subtype)
nAChRs (7, 16, 23) belong to short-chain and long-chain neu-
rotoxins (classified based on size and number of disulfide
bridges (24)). Long-chain neurotoxins, but not short-chain
neurotoxins, also target neuronal 7-nAChRs associated with
neurotransmission in the brain (25). -Neurotoxins, such as
-bungarotoxin (B. multicinctus), show specificity for other
neuronal subtypes, 32- and 42-nAChRs (26, 27). Musca-
rinic 3FTxs, unlike many small molecule ligands, can distin-
guish between different types of muscarinic acetylcholine
receptors (mAChRs) (for review, see Ref. 28) and hence are
useful in the characterization of these receptor subtypes. Mus-
carinic toxin 1, isolated from the venom ofDendroaspis angus-
ticeps, interacts with mAChR subtype 1 (M1) (29), whereas
muscarinic toxin 3 (MT3), isolated from the same snake, inter-
acts with M4 mAChRs (30). In recent years, new 3FTxs with
distinct and novel receptor specificities have been character-
ized and added to this growing library (12, 13, 31–36), justifying
their usefulness as pharmacological tools to dissect the cholin-
ergic circuitry to understand the role of individual receptor
subtypes or offer clues to the rational design of specific
therapeutics.
All neurotoxins characterized to date exist as monomers
with the exception of -neurotoxins from Bungarus sp. (37,
38), which is a non-covalently linked homodimer that binds
neuronal (32 and 42) but not muscle () nAChRs.
More recently, we published the first report of a covalent het-
erodimeric neurotoxin, irditoxin from the venom of Boiga sp.,
which was a uniquely irreversible inhibitor of muscle ()
nAChRs (13). Here, we report the purification, pharmacologi-
cal characterization, and a high resolution crystal structure of a
novel non-covalent homodimeric neurotoxin from the venom
of Ophiophagus hannah (King cobra). Although its quaternary
structure is similar to -neurotoxins, it exhibited novel phar-
macology with potent blocking activity on muscle () as
well as neuronal (7, 32, and 42) nAChRs. Based on the
high resolution crystal structure (1.55 Å) we have explored its
structural similarities with other neurotoxins. This new toxin
was named haditoxin (O. hannah dimeric neurotoxin) and is
the first homodimeric three-finger neurotoxin interacting with
1-nAChRs.
EXPERIMENTAL PROCEDURES
Materials—Lyophilized O. hannah venom was obtained
from PT Venom Indo Persada (Jakarta, Indonesia) and Ken-
tucky Reptile Zoo (Slade, KY). Reagents for N-terminal se-
quencing by Edman degradation are from Applied Biosystems
(Foster City, CA). KCl, acetonitrile, and trifluoroacetic acid
were from Merck KGaA, Darmstadt, Germany. Precision Plus
protein standards, dual color (marker for SDS-PAGE), and
bis(sulfosuccinimidyl) suberate (BS3) were purchased from
Bio-Rad Laboratories and Pierce, respectively. Superdex 30
HiLoad (16/60) column and Jupiter C18 (5 , 300 Å, 4.6 150
mm) were purchased from GE Healthcare and Phenomenex
(Torrance, CA), respectively. Crystal screening solution and
accessories were obtained from Hampton Research (Aliso
Viejo, CA). All other chemicals including-bungarotoxin from
B. multicinctus were purchased from Sigma-Aldrich. All the
reagents were of the highest purity grade. Water was purified
using a MilliQ system (Millipore, Billerica, MA).
Animals—Animals (Swiss albino mice and Sprague-Dawley
rats) were acquired from the National University of Singapore
Laboratory Animal Center and acclimatized to theDepartment
Animal Holding Unit for at least 3 days before the experiments.
They were housed, four per cage, with food and water available
ad libitum in a light controlled room (12-h light/dark cycle,
light on at 7:00 a.m.) at 23 °C and 60% relative humidity.
Domestic chicks (Gallus gallus domesticus) were purchased
from Chew’s Agricultural Farm, Singapore, and delivered on
the day of experimentation. Animals were sacrificed by expo-
sure to 100% carbon dioxide. All experiments were conducted
according to the Protocol (021/07a) approved by the Institu-
tional Animal Care andUseCommittee of theNational Univer-
sity of Singapore.
Purification of the Protein—O. hannah crude venom (100
mg dissolved in 1 ml of MilliQ water and filtered) was loaded
onto a Superdex 30 gel filtration column, equilibrated with
50 mM Tris-HCl buffer; pH 7.4, and eluted with the same
buffer using an A¨KTA purifier system (GE Healthcare). Frac-
tions containing the toxin of interest were further subfraction-
ated by reverse phase-high performance liquid chromatogra-
phy (RP-HPLC) using a Jupiter C18 column, equilibrated with
0.1% (v/v) trifluoroacetic acid, and eluted with a linear gradient
of 80% (v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid. Elu-
tion was monitored at 280 and 215 nm. Fractions were directly
injected into an API-300 liquid chromatography-tandem MS
system (PerkinElmer Life Sciences) to determine the mass and
homogeneity of the protein as described previously (20). Ana-
lyte software (PerkinElmer Life Sciences) was used to analyze
and deconvolute the raw mass data. Fractions showing the
expected molecular mass were pooled and lyophilized.
Capillary Electrophoresis—Capillary electrophoresis was
performed on a BioFocus3000 system (Bio-Rad) to determine
the homogeneity of the protein after RP-HPLC. The native pro-
tein (1g/l) was injected to a 25m 17 cm coated capillary
using a pressure mode (5 p.s.i./s) and run in 0.1 M phosphate
buffer (pH 2.5) under 18 kV at 20 °C for 7 min. The migration
was monitored at 200 nm.
N-terminal Sequencing—N-terminal sequencing of the
native protein was performed by automated Edman degrada-
tion using a Procise 494 pulsed liquid-phase protein sequencer
(Applied Biosystems) with an on-line 785A phenylthiohydan-
toin derivative analyzer. The phenylthiohydantoin amino acids
were sequentially identified by mapping the respective separa-
tion profiles with the standard chromatogram.
CD Spectroscopy—Far-UV CD spectra (260–190 nm) were
recorded using a Jasco J-810 spectropolarimeter (Jasco Corp.,
Tokyo, Japan) as described previously (20). The protein sam-
ples (concentration range 0.25–1 mg/ml) were dissolved in
MilliQ water.
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In Vivo Toxicity Study—Native protein (200 l dissolved in
0.89% NaCl) was injected intraperitoneally using a 27-gauge
0.5-inch needle (BD Biosciences) into male Swiss albino mice
(15 2 g) at doses of 5, 10, and 25mg/kg (n 2). The symptoms
of envenomation were observed, and in the event of death, the
time of death was noted. The control group was injected with
200 l of 0.89% NaCl. Postmortem examinations were con-
ducted on all animals.
Ex Vivo Organ Bath Studies—Isolated tissue experiments
were performed as described previously (13, 31) using a con-
ventional organ bath (6 ml) containing Krebs solution of the
following composition (inmM): 118NaCl, 4.8 KCl, 1.2 KH2PO4,
2.5 CaCl2, 25 NaHCO3, 2.4 MgSO4, and 11 D-()glucose); pH
7.4, at 37 °C. This is continuously aerated with carbogen (5%
carbon dioxide in oxygen). The resting tension of the tissues
was maintained at 1–2 g, and the preparations were allowed to
equilibrate for 30–45 min. Electrical field stimulation was car-
ried out through platinum ring electrodes using a Grass stimu-
lator S88 (Grass Instruments, West Warwick, RI). The magni-
tude of the contractile response was measured in gram tension.
Data were continuously recorded on PowerLab/Chart 5 data
acquisition system via a force displacement transducer (Model
MLT0201) (AD Instruments, Bella Vista NSW, Australia).
Neuromuscular blockade produced by a toxin is expressed as a
percentage of the original twitch height in the absence of expo-
sure to toxin. Dose-response curves representing the percent
blockade after 30 min of exposure to the respective toxins were
plotted.
Chick Biventer Cervicis Muscle (CBCM) Preparations—The
CBCM nerve-skeletal muscle preparation (39) was isolated
from chicks (6 days old) and mounted in the organ bath cham-
ber under similar experimental conditions as described previ-
ously (12, 31). The effect of haditoxin (0.05–5 M; n  3) or
-bungarotoxin (0.01–1.0 M; n  3) on nerve-evoked twitch
responses of the CBCMwere studied. In separate experiments,
the recovery from complete neuromuscular blockade was
assessed bywashing out the toxinwithKrebs solution at 30-min
intervals (three cycles of 30-s on pulse, 30-s off pulse) over a
120-min period.
Rat HemidiaphragmMuscle (RHD) Preparations—The RHD
muscle associated with the phrenic nerve (40) was isolated and
mounted in a 5-ml organ bath chamber under similar condi-
tions as stated for CBCM, as described previously (13). The
effects of haditoxin (0.15–15 M; n  3) or -bungarotoxin
(0.01–1.0 M; n  3) on nerve-evoked twitch responses of the
RHD were investigated. Recovery of neuromuscular blockade
was assessed similarly as described above for CBCM.
Electrophysiology—Two-electrode voltage clamp experi-
mentswere done usingXenopus oocytes. The oocytes were pre-
pared and injected as described by Hogg et al. (41). Briefly, 2 ng
of cDNA encoding for human 42-, -, 7-, and 32-
nAChRs were injected into the oocytes. Two-electrode voltage
clamp measurements were done 2–3 days after injection. Dur-
ing recordings, the oocytes were perfused with OR2 (oocyte
ringer) containing (in mM): 82.5 NaCl, 2.5 KCl, 1 MgCl2, 2.5
Ca2Cl, 5 HEPES, and 20 g/ml bovine serum albumin; pH 7.4.
Atropine (0.5M) was added to all solutions to block activity of
endogenous muscarinic receptors. Just before use, acetylcho-
line (ACh) and haditoxin were dissolved the OR2 solution. All
recordings were performed with an automated two-electrode
voltage clamp robot. Oocytes were clamped at 100 mV, and
data were digitized and analyzed off-line using MATLAB
(Mathworks, Natick, MA).
Gel Filtration Chromatography—The oligomeric states of
the protein were examined by gel filtration chromatography on
a Superdex 75 column (1  30 cm) equilibrated with 50 mM
Tris-HCl buffer (pH 7.4) using an A¨KTA purifier system at a
flow rate of 0.6 ml/min. Calibration was done using bovine
serum albumin (66 kDa), carbonic anhydrase (29 kDa), cyto-
chrome c (12.4 kDa), aprotinin (6.5 kDa), and blue dextran (200
kDa) as molecular mass markers. Native protein (0.25–10 M)
as well as samples (0.25–10 M) treated with 0.6% SDS (2 h of
incubation at room temperature) (37) were loaded separately
onto the column, and respective elution profiles were recorded.
For the SDS-treated samples, the columnwas equilibrated with
the same buffer containing 0.1% SDS.
Electrophoresis—Tris-Tricine SDS-PAGE of the protein of
interest in the presence or absence of cross-linker BS3 (42) was
performed on a 12% gel, under reducing conditions, using the
Bio-Rad Mini-Protean II electrophoresis system. The concen-
tration of BS3 used was 5 mM. The protein bands were visual-
ized by Coomassie Blue staining.
Crystallization and Data Collection—Crystallization con-
ditions for the protein were screened with Hampton
Research screens using the hanging-drop vapor diffusion
method. Lyophilized protein was dissolved in 10 mM Tris-HCl
buffer, pH 7.4, with 100 mM NaCl. Crystallization experiments
were performed at room temperature 297 K (24 °C) with drops
containing equal volumes (1 l) of reservoir and protein solu-
tion. Small rod-shaped crystals were formed within 2–3 days
and grew to diffraction quality after 3 weeks. They were briefly
soaked in the reservoir solution supplemented with 10% glyc-
erol as cryo-protectant prior to the x-ray diffraction data col-
lection. Then these were flash-frozen in a nitrogen cold stream
at 100 K (173 °C). Diffraction up to 1.55 Åwas obtained using
a CCD detector (Platinum135) mounted on a BrukerMicrostar
Ultra rotating anode generator (Bruker AXS, Madison, WI). A
complete data set was collected, processed, and scaled using the
program HKL2000 (43).
RESULTS
Five novel 3FTxs were identified from the cDNA library of
the venom gland tissue of O. hannah, and one of them, named
-cardiotoxin, has been characterized previously (20). Here, we
describe the characterization of the second novel toxin, identi-
fied previously as an MTLP-3 homolog based on sequence
homology (20) (Fig. 1). The liquid chromatography/MS profile
of O. hannah venom (44) showed the presence of a 7,535.67
0.60 Da protein, similar to the expected molecular mass of the
protein being characterized. This protein was purified from the
crude venom using a two-step chromatographic approach.
Firstly, the venom components were separated based on their
sizes into five peaks using gel filtration chromatography (Fig.
2A). Subsequently, each peak was fractionated by RP-HPLC,
and the fractions were analyzed by ESI-MS to identify the pres-
ence of the protein of interest (Fig. 2A, black bar). Further, these
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fractionswere pooled and separated by RP-HPLC (Fig. 2B). The
ESI-MS of fraction 2a (Fig. 2C, black arrow) showed three peaks
with mass/charge (m/z) ratios ranging from 4 to6 charges
(Fig. 2C), and the final reconstructed mass spectrum showed a
molecular mass of 7,535.67 1.25 Da, which matched the cal-
culated mass of 7,534.42 Da (Fig. 2C, inset). The secondary
structural elements of haditoxin were analyzed using far-UV
CD spectroscopy. The spectrum shows maxima at 230 and
198–200 nm and a minimum at 215 nm (Fig. 2D). Thus, hadi-
toxin was found to be composed of -sheeted structure similar
to all other 3FTxs (11, 16). The presence of a single protein peak
in the electropherogram (Fig. 2E) indicates the homogeneity of
the protein, ensuring the absence of contaminants, especially
other -neurotoxin(s) and cytotoxins present in the venom.
Identificationwas further confirmed byN-terminal sequencing
of the first 36 residues, which matched the cDNA sequence of
the MTLP-3 homolog (20). This protein was found to be a
homodimer (see below) and hence was renamed as haditoxin
(O. hannah dimeric neurotoxin) following the nomenclature of
dimeric 3FTxs (12, 13).
Investigation of Haditoxin for Muscarinic Effects—As de-
tailed in Fig. 1, A and B, haditoxin showed high similarity
(80–83%) with muscarinic toxin homologs (MTLP and
MTLP-3) as well as similarity with muscarinic toxins (MT-,
MT7, andMT3) (51–52%). As such, we examined the effects of
haditoxin on in vitro smoothmuscle preparations, the rat ileum
and rat anococcygeus muscle, pharmacologically characterized
to represent M2 (45) and M3 mAChRs (46), respectively. In
both preparations, the protein had no effect on the contractile
response of the muscle to exogenously applied ACh or electri-
cal field stimulation, suggesting that haditoxin does not interact
withM2 andM3mAChRs (supplemental Fig. 1). Therefore, it is
likely that the observed sequence similarity with muscarinic
toxin homologs is probably coincidental due to either phylog-
eny or structure, including the presence of the core disulfide
bridges, and not the function. Thismerits further investigation,
including electrophysiological studies and/or binding assays on
other subtypes of mAChRs.
InVivoToxicity ofHaditoxin—Inpreliminary experiments to
observe the biological effects of haditoxin, allmice injectedwith
the toxin (5, 10, and 25 mg/kg) showed typical symptoms of
peripheral neurotoxicity, such as paralysis of hind limbs and
labored breathing, and finally died, presumably due to respira-
tory paralysis (47, 48). The time of death was recorded for each
animal, with the average calculated to be 94, 32.5, and 20 min,
respectively, for the 5, 10, and 25mg/kg doses. On postmortem,
no gross changes in the internal organs, notably hemorrhage,
were observed.
Ex Vivo Neurotoxic Effects of Haditoxin—The observed pe-
ripheral neurotoxic symptoms produced by haditoxin in vivo
warranted detailed pharmacological characterization on neu-
romuscular transmission using CBCM and RHD preparations.
Haditoxin (1.5 M) produced a reproducible time- and dose-
dependent neuromuscular blockade in both preparations (Fig.
3,A andC). In the CBCM, it completely inhibited the contract-
ile response to exogenous agonists (ACh and carbachol (CCh)),
whereas response to exogenous KCl and twitches evoked by
direct muscle stimulation were not inhibited, indicating a
postsynaptic neuromuscular blockade and an absence of direct
myotoxicity.
The IC50 of haditoxin on CBCM and RHD was 0.27  0.07
and 1.85 0.39 M, respectively (Fig. 3E) (considering the fact
FIGURE1.Multiple sequencealignmentofnovelproteins.A–C, sequencealignmentofhaditoxinwith themosthomologous sequences (A),muscarinic toxin
homologs (B), and short-chain-neurotoxins (C). Toxin names, species, and accessionnumbers are shown. Conserved residues in all sequences are highlighted
in black. Disulfide bridges and loop regions are also shown. At the end of each sequence, the numbers of amino acids are stated. The homology (sequence
identity and similarity (% Id(Sm))) of each protein is compared with haditoxin and shown at the end of each sequence. N. atra, Naja atra; N. kaouthia, Naja
kaouthia; D. polylepis, Dendroaspis polylepis; and L. semifasciata, Laticauda semifasciata.
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that the protein exists as dimer in solution; see below). When
compared with -bungarotoxin (IC50 on CBCM 12.1 5.4 nM
and RHD 100.5  22.5 nM) (Fig. 3E), haditoxin was about
50 times less potent on both avian (CBCM) and mammalian
(RHD) neuromuscular junctions.
Reversibility of the neuromuscular blockade was tested for
both preparations with intermittent washing (Fig. 3, D and F,
black arrows). Partial recovery of the contractile response (60%
recovery in 2 h) was observed in the CBCM (Fig. 3B) but not in
the RHD (Fig. 3D). These results indicate that unlike typical
-neurotoxins such as -bungarotoxin, haditoxin exhibits par-
tial reversibility in action, at least in the CBCM.
Effect of Haditoxin on Human nAChRs—Because haditoxin
blocked the muscle activity of the CBCM and RHD, we exam-
ined its activity on human -nAChRs. Haditoxin com-
pletely inhibited the ACh-induced  currents at a concen-
tration of 10 M (Fig. 4A) with an IC50 value of 550 nM (n 13)
(Fig. 4B). This inhibition was practically irreversible within 8
min of washout. This result is in good agreement with the find-
ings on ex vivo studies with RHD as discussed earlier. Next, we
tested the activity of haditoxin on 7- and 32-nAChRs. On
7-nAChRs, an irreversible block was observed at 10 M con-
centration of haditoxin (Fig. 4C) with an IC50 value was 180 nM
(n  4) (Fig. 4D). As shown in Fig. 4E, 10 M haditoxin fully
blocked the response of 32-nAChRs, with an IC50 value of
500 nM (n 4) (Fig. 4F). Notably, the blockade at 32 was fully
reversible, whereas long-lasting blockade was observed at
7-nAChRs. This suggests that theKOff value at the 7 receptor
is much smaller than at 32-nAChRs. As these two receptors
display about equivalent IC50 values, this indicates that their
respectiveKOn values are probably significantly different. How-
ever, the experimental protocol used herein prevents the
detailed analysis of the KOn and KOff values. An additional dif-
ference between these two receptors resides in their structural
composition. Although it is thought that 7-nAChRs display
five identical ligand binding sites, only two binding sites are
proposed for the 32-nAChRs. The difference in number of
binding sites and effects on competitive blockade was previ-
ously discussed for 7- and 42-nAChRs, showing significant
functional outcomes (49). Interestingly, haditoxin was almost
3-fold more potent to block ACh-induced responses mediated
by 7-nAChRs (IC50  180 nM, n  4) when compared with
FIGURE 2. Purification of haditoxin from the venomofO. hannah. A, gel filtration chromatogram of crude venom. Crude venom (100mg/ml) was fraction-
ated using a Superdex 30 HiLoad (16/60) column. The column was pre-equilibrated with 50 mM Tris-HCl buffer (pH 7.4). Proteins were eluted at a flow rate of
1 ml/min using the same buffer. A black bar at Peak 2 indicates the fractions containing haditoxin. B, RP-HPLC profile of the gel filtration fractions containing
haditoxin. Jupiter C18 (5, 300Å, 4.5 250mm) analytical columnwas equilibratedwith 0.1% (v/v) trifluoroacetic acid. Protein of interestwas eluted from the
columnwith a flow rate of 1ml/min with a gradient of 23–49% buffer B (80% acetonitrile in 0.1% trifluoroacetic acid). The dotted line indicates the gradient of
the buffer B. The downward arrow at Peak 2a indicates fractions containing haditoxin. C, ESI-MS profile of the RP-HPLC fraction containing haditoxin. The
spectrum shows a series of multiply charged ions, corresponding to a single, homogenous peptide with amolecular mass of 7,535.88 Da. Inset, reconstructed
mass spectrum of haditoxin; CPS  counts/s; amu  atomic mass units. D, far-UV CD spectrum of haditoxin. The protein was dissolved in MilliQ water (0.5
mg/ml), and theCDspectrawere recordedusinga0.1-cmpath length cuvette. E, electropherogramofhaditoxin. The samplewas injectedusingpressuremode
5 p.s.i./s, and electrophoresis runs were carried out using a coated capillary (17 cm 25 m) at 18 kV, with 0.1 M phosphate buffer (pH 2.5) at 20 °C for 7 min.
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- and 32-nAChRs. There was no recovery after applica-
tion of haditoxin. Finally, we tested the effect of haditoxin on
42-nAChRs. Application of 10 M haditoxin blocked only
70% of the current with partial reversibility (Fig. 4G). The IC50
value of the blockade is in themicromolar range (IC50 2.6M,
n  3) (Fig. 4H). However, further experiments will be neces-
sary to discriminate between the different mechanisms of
blockade and recovery. These results show that haditoxin had a
higher potency for7-nAChRs than for the other nAChRs. IC50
values for - and 32-nAChRs were in the same nanomo-
lar range, whereas for 42-nAChRs, it was in the micromolar
range.
Haditoxin Is a Dimer—During the gel filtration of the crude
venom, we observed that haditoxin eluted earlier when com-
pared with other 3FTxs (Fig. 2A, most of the 3FTxs elutes in
Peak 3). This led us to investigate the oligomeric states of this
protein. Thus, we carried out analytical gel filtration experi-
ments using a Superdex G-75 column. Protein, at concentra-
tions (0.25–10M) covering the IC50 inCBCM(0.27 0.07M)
and RHD (1.85  0.39 M) preparations, was loaded onto the
column. At all of these concentrations, the presence of a single
peak corresponding to a relative molecular mass of 16.25 kDa
was observed (Fig. 5A), supporting the existence of a dimeric
species. To observe the effect of SDS on dimerization, we
treated the protein (0.25–10M) with SDS and eluted using the
same column. It eluted as a single peak with a Mr of 8.16 kDa
(Fig. 5A), similar to the monomeric species.
The dimerization was further confirmed by Tris-Tricine
SDS-PAGE analysis in the presence and absence of a cross-
linker, BS3 (Fig. 5B). In the presence of BS3, both the dimeric
and the monomeric species were visualized (Fig. 5B, lane 1),
whereas only the monomeric species were observed in its
absence (Fig. 5B, lane 2). These results, together with MS data
(showing monomeric mass, Fig. 2C), indicate the existence of
FIGURE 3.Pharmacological profile of haditoxin.A–D, a segment of tracing showing the effect of haditoxin (1.5M) on CBCMpreparations (A), reversibility of
CBCMpreparation (B), RHDpreparations (C), and reversibility of RHDpreparation (D). ContractionswereproducedbyexogenousACh (300M), carbachol (CCh;
10M), and KCl (30mM). The black bar indicates the electrical field stimulation. The point of washing out the toxin with Krebs solution in reversibility studies is
indicated by the abbreviationW. E, dose-response curve of haditoxin and -bungarotoxin on CBCM and RHD. The block is calculated as a percentage of the
control twitch responses of the muscle to supramaximal nerve stimulation. Each data point is the mean S.E. of at least three experiments. F, comparative
reversibility profile of -bungarotoxin, haditoxin, and candoxin.
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haditoxin as a homodimer in solu-
tion at pharmacologically relevant
concentrations, and the dimeriza-
tion occurs through non-covalent
interactions. Further, as haditoxin
loses its -sheeted structure and
becomes random coil in the pres-
ence of SDS (as indicated by CD
studies; data not shown), its over-
all conformation may play a criti-
cal role in the dimerization.
Crystal Structure of Hadi-
toxin—To determine the three-di-
mensional structure of haditoxin,
we used the x-ray crystallographic
method. Diffraction quality crystals
of haditoxin were obtained with
0.1 M Tris, pH 8.5, 20% v/v ethanol
(Hampton Research crystal screen
2, condition 44). Diffraction up to
1.55 Å was observed, and the crys-
tals belonged to the space group P21
(Table 1).
Structure Determination and Re-
finement—The structure of hadi-
toxin was solved by the molecular
replacement method (Molrep) (50).
Initially, toxin-, isolated fromNaja
nigricollis venom, was used as a
search model (Protein Data Bank
(PDB) code 1IQ9; sequence identity
48%). The rotation and transla-
tion resulted in a correlation factor
of 0.07 and Rcryst of 0.57. Further
minimization in Refmac (51) re-
duced the R factor to 0.42. An excel-
lent quality electron density map
was calculated at this stage, which
allowed us to auto-build 90% of the
haditoxin model with ARP/wARP
(52). The resulting model with the
electron density map was examined
to manually build the rest of the
model using the Coot program (53).
After a few cycles of map fitting and
refinement, we obtained an R factor
of 0.194 (Rfree  0.225) for reflec-
tions I  I within 20-1.55 Å reso-
lution. Throughout the refinement
(Table 1), no noncrystallographic
symmetry restraint was employed.
All 65 residues (considering one
subunit) are well defined in the elec-
tron density map (Fig. 6A), and sta-
tistics for the Ramachandran plot
using PROCHECK (54) showed the
presence of 88.9% of non-glycine
residues in the most favored region.
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The coordinates and structure factors have been depositedwith
the Research Collaboratory for Structural Bioinformatics
(RCSB) PDB (55) with the code 3HH7. The asymmetric unit
consists of two monomers forming a tight dimer having an
approximate dimension of 25  13  4 Å (Fig. 6B). This crys-
tallographic dimer is consistent with the gel filtration and SDS-
PAGE observations (Fig. 5). Both monomers are related by a
two-fold symmetry, and their superposition yielded an r.m.s.d.
of 0.2 Å for 65 C atoms (Fig. 7A). Each monomer adopts the
common three-finger fold (11) consisting of three -sheeted
loops protruding from a central core, tightened by four highly
conserved disulfide bridges (Cys-3–Cys-24, Cys-17–Cys-41,
Cys-45–Cys-57, and Cys-58–Cys-63) (Fig. 6, B and C), and are
structurally similar to short-chain -neurotoxins such as tox-
in- and erabutoxins (Fig. 7B). Loop I forms a two-stranded
-sheet (Lys-2–Tyr-4 and Thr-14–Ile-16), whereas loops II
and III form a three-stranded -sheet (Glu-34–Thr-42, Phe-
23–Asp-31, and Lys-53–Cys-58). The antiparallel -strands of
the -sheet are stabilized by main chain-main chain hydrogen
bonding.
Dimeric Interface—The dimeric interface was analyzed using
the Protein Interfaces, Surfaces and Assemblies (PISA) server
(56). It is mainly formed by loop III of each subunit. Strands D,
C, E, E, C, and D form a six -pleated sheet with an overall
right-handed twist (Fig. 6B) in the dimer. Approximately 565
Å2 (or 12% of the total) surface areas and 17 residues of each
monomer contribute to the dimerization. The close contacts
between the monomers are maintained by 14 hydrogen bonds
(	3.2 Å) and extensive hydrophobic interactions (Table 2).
Six main chain-main chain hydrogen-bonding contacts exist
across the interface involving strand E of monomer A and E of
B (Table 2, Fig. 7C). Four are observed between the main chain
amide hydrogen and carbonyl oxygen of Val-55 and Cys-57
from monomer A and Val-55 and Cys-57 from monomer B,
and the remaining two exist between the carbonyl oxygen of
Lys-53 (and Lys-53) and the amide hydrogen of Arg-59 (and
Arg-59). In addition, there are another eight hydrogen-bond-
ing contacts mediated through the side chains of Thr-44, Cys-
45, Glu-47, Pro-50, and Arg-59 (Table 2, Fig. 7C). Two hydro-
phobic clusters further stabilize the dimeric structure. The side
chains of Phe-23 and Leu-48 from both monomers form one
cluster, whereas the disulfide bridge between Cys-45–Cys-57
and Val-55 of both monomers form the other. These observa-
tions strongly suggest the existence of haditoxin as non-cova-
lent homodimeric species.
DISCUSSION
Nonenzymatic neurotoxins from snake venom belonging to
the 3FTx family consist of closely related polypeptides with a
molecular mass range of 6,500–8,000 Da. Functionally, most
interfere with cholinergic neurotransmission and are highly
specific for different subtypes of muscarinic or nicotinic cho-
linergic receptors (for details, see the Introduction). This
underscores their immense potential as lead molecules in drug
discovery and as research tools in the characterization of recep-
tor subtypes.
Here, we have described the purification and characterization
of a novel neurotoxin, haditoxin, from the venomofO. hannah. It
is a non-covalent homodimer that produces potent postsynaptic
neuromuscular blockade of the mammalian muscle (IC50 
1.85 0.39M) and avianmuscle (IC50 0.27 0.07M) ()
FIGURE 4. Effect of haditoxin on humannACHRs expressed in Xenopus oocytes. A, C, E, andG, inhibition of ACh-induced currents in- (neuromuscular
junction) (A), 7- (C), 42- (E), and 32-nAChRs (G). Neuromuscular junction currents were activated by 10M ACh, whereas 200Mwas used to activate 7-,
42-, and32-nAChRs. The first three traces are controls, followedbya2-minexposure to several haditoxin concentrations ranging from10nM to10M. Each
experiment was terminated by a 8-min wash out. Little or no recovery was observed for - and 7-nAChRs, whereas partial to full recovery was observed
for42- and32-nAChRs. Inhibition curves of the fitted data, IC50, andHill coefficient (nH) for-nAChRs (B) were 0.55M and 0.7; for7-nAChRs (D), they
were 0.18 M and 0.8; for 32-nAChRs (F), they were 0.5 M and 1.1; and for 42-nAChRs (H), they were 2.6 M and 0.7. Error bars indicate S.E.
FIGURE 5. Dimerization of haditoxin. A, gel filtration profile of haditoxin
with (gray) andwithout (black) SDS. 1M haditoxin was loaded onto a Super-
dex 75 column (1 30 cm) equilibrated with 50 mM Tris-HCl buffer (pH 7.4).
The protein was eluted out with the 50 mM Tris-HCl buffer (pH 7.4) or 50 mM
Tris-HCl buffer (pH 7.4) containing 0.6% SDS at flow rate of 0.6ml/min. B, Tris-
Tricine SDS-PAGE analysis of haditoxinwith (lane 1) andwithout (lane 2) cross
linker (BS3).M is the marker lane. The concentration of BS3 is 5 mM.
TABLE 1
X-ray data collection and refinement statistics
Data collection
Cell parameters (Å) a 37.27, b 41.29,
c 40.98,  106.4°
Space group P21
Molecules/asymmetric unit 2




Completeness (%) 99.1 (92.9)
Rsym (%)a 0.093
I/ (I) 40.2 (6.0)
Refinement and quality
Resolution range (Å) 20–1.55
Rwork (%)b 19.4
Rfree (%)c 22.5
r.m.s.d. bond lengths (Å) 0.009
r.m.s.d. bond angles (deg) 1.274
Average B factors (Å2) 15.1
Number of protein atoms 1408
Number of waters 114
Ramachandran plot (%)
Most favored regions 88.9
Additional allowed regions 9.3
Generously allowed regions 1.9
Disallowed regions 0
aRsymIi
I/I, where Ii is the intensity of the ithmeasurement, and 
I is the
mean intensity for that reflection.
b Rwork  Fobs  Fcalc/Fobs, where Fcalc and Fobs are the calculated and
observed structure factor amplitudes, respectively.
c Rfree  as for Rwork, but for 10% of the total reflections chosen at random and
omitted from refinement.
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nAChRs (Fig. 3,A andC). In electrophysiological studies, it was an
antagonist of muscle () (IC50 0.55 M) as well as neuronal
7- (IC50 0.18 M), 32- (IC50 0.50 M), and 42- (IC50
2.60 M) nAChRs (Fig. 4). Interestingly, haditoxin exhibited a
novel pharmacology with combined blocking activity on muscle
() as well as neuronal (7, 32, and 42) nAChRs but with
thehighestpotencyon7-nAChRs,which is recognizedbyneither
short-chain -neurotoxins nor -neurotoxins.
FIGURE 6. Overall structure of haditoxin. A, stereo view of a portion of the final 2Fo  Fc map of haditoxin. The map was contoured at a level of 1.0 .
B, monomers A and B are shown in blue and red, respectively. Disulfide bonds are shown in yellow. N and C termini (N-term and C-term), -strands, and loops I,
II, and III are labeled. C, structure-based alignment of three-finger toxins. Color coding of conserved residues is provided by boxed red text, and color coding of
invariant residues is provided by red highlight. Accession numbers are shown on the left, and secondary structural elements of haditoxin are shown on top.
Numbering is shown for haditoxin only. Sequence alignment was done by Strap (82) and displayed with ESPript (83).
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The reversibility of this neuro-
muscular blockade was taxa-spe-
cific; it is partially reversible by
washing in the chick neuromuscu-
lar junction, whereas it was almost
irreversible in the rat neuromus-
cular junction. Earlier, we re-
ported taxa-specific neurotoxicity
of denmotoxin from Boiga den-
drophila (12) and irditoxin from
Boiga irregularis (13). Taxa specific-
ity manifests the natural targeting
of the venom toxins toward their
prey (13, 57–59). Snakes from the
Boiga sp. mainly feed on the non-
mammalian prey such as birds (12,
13, 60), whereas elapids, including
the king cobra, mainly prey on
snakes and rodents and only occa-
sionally and opportunistically on
birds (61, 62). Venom compositions
of snakes are known to be depen-
dent on prey specificity to ensure
efficiency in their capture and kill-
ing (58). Therefore, the taxa-specific
reversibility of the neuromuscular
blockade produced by haditoxin is
likely due to the natural species
specificity of the king cobra venom
and not because of low toxicity.
Structurally Important Residues
for Haditoxin—Haditoxin contains
all 8 conserved cysteine residues
that are essential for the three-fin-
ger folding (24, 63). They form
four disulfide bridges located in
the core region of the molecule. In
addition, this molecule possesses
several other structurally invari-
ant residues, responsible for the
stability of the three-finger fold.
For example, Tyr-25 (numbering
of the residues is according to
erabutoxin-a, unless stated other-
wise), the crucial residue stabilizing
the antiparallel -sheet structure
(64), is conserved in a similar three-
dimensional orientation. Similarly,
the structurally invariant Gly-40,
involved in the tight packing of the
three-dimensional fold by accom-
modating the bulky side chain of the
Tyr-25 (24), is also conserved. The 2
proline residues Pro-44 and Pro-48,
potentially associated with the for-
mation of the -turn (24), are con-
served in haditoxin as Pro-46 and
Pro-50. The salt bridge between the
Haditoxin, the First Dimeric-Neurotoxin
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N-terminal amino group and the carboxyl group of Glu-58 as
well as the C-terminal carboxyl group and the guanidinium
group of Arg-39 in erabutoxin-a (24) is maintained by the
N-terminal amino group and the carboxyl group of Asp-58 as
well as the C-terminal carboxyl group and the guanidinium
group of the Arg-39 in haditoxin. Thus, the presence of these
structurally invariant residues contributes to the stable three-
finger fold of haditoxin.
Functionally Important Residues for Haditoxin—Extensive
structure-function relationship studies on the short-chain
-neurotoxin, erabutoxin-a (24, 65, 66), and the long-chain
-neurotoxins, -cobratoxin (67, 68) and -bungarotoxin (69,
70), revealed the critical residues involved in the recognition of
nAChRs by snake neurotoxins. The crucial residues for -neu-
rotoxins to bind to muscle () nAChRs are Lys-27, Trp-29,
Asp-31, Phe-32, Arg-33, and Lys-47. Haditoxin possesses three
of them (Trp-29,Asp-31, andArg-33) in homologous positions.
Additionally, each type of toxin possesses specific residues that
recognize muscle or neuronal nAChRs. For muscle ()
nAChRs, these are His-6, Gln-7, Ser-8, Ser-9, and Gln-10 in
loop I andTyr-25, Gly-34, Ile-36, andGlu-38 in loop II of short-
chain -neurotoxins (65) and Arg-36 in loop II and Phe-65 in
the C terminus tail of long-chain -neurotoxins (67). His-6,
Gln-7, and Ser-8 in the loop I and Tyr-25, Gly-34, Ile-37, and
Glu-38 in the loop II are conserved in haditoxin as the muscle
subtype-specific determinants of short-chain -neurotoxins.
Moreover, Arg-36, muscle subtype-specific determinant of
long-chain -neurotoxins, is also conserved in haditoxin. The
presence of thesemultiple functional determinantsmay explain
the potent neurotoxicity exhibited by haditoxin onmammalian
and avian muscle () nAChR.
On the contrary, the specific determinants (Ala-28 and Lys-
35; -cobratoxin numbering) of long-chain -neurotoxins
toward the neuronal (7) nAChRs (71) are not conserved in
haditoxin. Significantly, haditoxin also lacks the fifth disulfide
bridge responsible for the cyclization of loop II, which is con-
sidered to be a hallmark determinant for the ability of neuro-
toxins such as -bungarotoxin and -bungarotoxins to interact
with their specific neuronal nAChR targets (67, 71–74). This is
somewhat surprising given the high affinity of haditoxin for 7-
(IC50 0.18 M), 32- (IC50 0.5 M), and 42- (IC50 2.6
M) nAChRs. Previously, candoxin, a non-conventional 3FTx
(31), was found to be an exception of a 3FTx that did not have
the fifth disulfide bridge in loop II (candoxin has a fifth disulfide
bridge in loop I) but still retained the ability to interact with
neuronal (7) nAChRs (75). It was suggested thus that candoxin
may likely interact with neuronal 7-nAChRs using alternate,
novel points of contact. Likewise, it is plausible that haditoxin
possesses unique combinations of determinants that enable its
interaction with 7-, as well as 32- and 42-nAChRs. A
detailed structure-function analysis to decipher these novel
determinants is beyond the scope of this report.
In the case of -neurotoxins, which interact with neuronal
32- and 42-nAChRs with high affinity (26, 27), the critical
functional residue was identified as Arg-34 (76). Haditoxin has
Arg-33 in a homologous position, whichmay contribute in part
to high affinity interaction with 32- (IC50  0.5 M) and
42- (IC50 2.6M) nAChRs.Mutagenesis studies on -bun-
garotoxin revealed that the replacement of Pro-36 to an amino
acid residue bearing a bulky, charged side chain, such as the Lys
found in-bungarotoxin, causes a 16-fold decrease in the efficacy
of the toxin to block neurotransmission in the chick ciliary gan-
glion assay (76). Haditoxin bears an equivalent glycine residue,
lacking a bulky, charged side chain, which can explain the high
affinityof this toxin toward theneuronal (32 and42)nAChRs.
Comparison of Haditoxin with Other Dimeric 3FTxs—Few
known examples of dimeric three-finger neurotoxins derived
from snake venoms exist (13, 37, 72). Among them, the most
well studied and characterized are the -neurotoxins, known to
be composed of two identical monomers held together by non-
covalent interactions (77, 78). The observed dimeric form of
haditoxin, with the characteristic six-pleated sheets, is similar
to that formed by -bungarotoxin (77). Superposition of both
molecules yielded an r.m.s.d. of 1.95 Å for 104 C atoms (Fig.
8A). The major deviations are located in the loops between the
antiparallel -strands. However, each monomer in -bungaro-
toxin is structurally homologous to long-chain -neurotoxins
unlike haditoxin, which resembles short-chain -neurotoxins
(Fig. 7C). The dimeric interface for both is maintained by six
main chain-main chain hydrogen bonds (77). In addition, hadi-
toxin has eight side chain hydrogen-bonding contacts between
the monomers, whereas only three similar contacts were
observed in-bungarotoxin (Fig. 7A) (77), suggesting that hadi-
toxin forms tighter dimers than-bungarotoxin. The side chain
interactions in -bungarotoxin are maintained by Phe-49, Leu-
57, and Ile-20, which are strictly conserved in all -neurotoxins
(77, 79).Mutagenesis studies have proven that replacing Phe-49
or Ile-20 with alanines renders a toxin with an apparent lack of
ability to fold into the native structure, even as amonomer (79).
FIGURE 7. Structural details of haditoxin. A, superimposition of both subunits of haditoxin. Subunits A and B are shown in blue and red, respectively.
B, superimposition subunit Aof haditoxinwith short-chain-neurotoxins. Subunit A is shown inblue, erabutoxin-a is shown inmagenta, erabutoxin-b is shown
in cyan, and toxin- is shown in green.C, stereo diagramof comparison of dimer interface of haditoxin (top) and-bungarotoxin (bottom). The residues to form
the hydrogen bonds are labeled. The main chain-main chain hydrogen bonds are shown in red, and the other hydrogen bonds are shown in yellow.
TABLE 2
Hydrogen bonds in the dimeric interface of the haditoxin
Hydrogen bonds Monomer A Monomer B Distance
Å
Main chain-main chain Cys-57 (O) Val-55 (N) 2.93
Val-55 (O) Cys-57 (N) 2.85
Cys-57 (N) Val-55 (O) 2.86
Val-55 (N) Cys-57 (O) 2.90
Lys-53 (O) Arg-59 (N) 3.10
Arg-59 (N) Lys-53 (O) 3.40
Side chain-side chain Glu-47 (OE1) Thr-44 (OG1) 2.63
Glu-47 (OE2) Cys-45 (N) 2.76
Pro-50 (O) Arg-59 (NE) 3.39
Thr-49 (O) Arg-59 (NH2) 3.37
Thr-44 (OG1) Glu-47 (OE1) 2.68
Cys-45 (N) Glu-47 (OE2) 2.81
Arg-59 (NH2) Thr-49 (O) 2.66
Arg-59 (NE) Gly-52 (O) 2.76
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The same result has been observed with deletion studies (dele-
tion of Arg-54) with an aim to generate a 65-residue-long pro-
tein, as found in the -neurotoxins, from the 66-residue-long
-bungarotoxin (79), whereas haditoxin being a 65-residue-
long protein lacks both Phe-49 and Ile-20 but still retains the
intact dimeric structure. The elec-
trostatic surface potentials for both
molecules were apparently similar
(Fig. 8B) except for the tip of loop II,
which revealed a strong positive
patch for haditoxin when compared
with -bungarotoxin (77).
Functionally, -neurotoxins inter-
actwith theneuronal (32 and42)
nAChRs with high affinity (26, 27),
whereas haditoxin interacts with
both muscle () and a variety of
neuronal (7, 32, and 42)
nAChRs. The crystal structure of
the -bungarotoxin dimer showed
that the guanidinium groups of the
essential arginine residues, situated
at the tip of the loop II, maintains
nearly identical distance (44 Å) (77),
like the acetylcholine binding sites
in the pentameric receptor (30–50
Å) (80, 81). The -bungarotoxin
dimer may both interact with the
acetylcholine binding sites on a
single neuronal receptor and physi-
cally block ion flow by spanning the
channel (77, 79). However, this
mode of interaction does not ex-
plain the inability of the -neuro-
toxins to block the muscle nAChRs.
Haditoxin maintains a distance of
52 Å between the guanidinium
groups of the critical arginine resi-
dues present in the turn region of
the second loop, which is almost
similar to the acetylcholine binding
sites in the pentameric receptor
mentioned above. However, unlike
the -neurotoxins, haditoxin inter-
acts with both muscle and neuronal
nAChRs. This supports the fact that
the dimeric toxins may have a
uniquemode of interaction with the
nAChRs, which demands further
investigation.
More recently, other heterodi-
meric 3FTxs from elapid venoms
have been reported, including
covalently (disulfide) linked ho-
modimers of a long-chain -neu-
rotoxin (-cobratoxin) and heterodi-
mers of -cobratoxin in combination
with a variety of three-finger cyto-
toxins (72). Unlike haditoxin, all of these dimers are formed
by covalent bonding (disulfide linkage) of the monomeric
units. Functionally, the -cobratoxin-cytotoxin het-
erodimers were able to block neuronal (7) nAChRs,
whereas the -cobratoxin homodimer exhibited blockade of
FIGURE8.Haditoxinversus-bungarotoxin.A, superimpositionof haditoxinwith-bungarotoxin. Haditoxin
and -bungarotoxin are shown in red and yellow, respectively. B, electrostatic surface of haditoxin (top) and
-bungarotoxin (bottom). The orientation is the same as in Fig. 6B. The locations of Arg-33 and Glu-34 of
haditoxin and Arg-34 of -bungarotoxin are indicated.
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both neuronal 7- and 32-nAChRs, unlike monomeric
-cobratoxin, which interacts with muscle () and neu-
ronal (7) nAChRs (72).
Our laboratory has also reported on a colubrid venom-de-
rived covalently linked heterodimeric 3FTx, irditoxin (13),
which was found to target muscle () nAChRs, in sharp
contrast to the reported function of elapid dimeric toxins (72).
Another distinguishing feature was that the subunits of irdi-
toxin structurally resemble non-conventional 3FTxs (13).
Haditoxin is both structurally and functionally distinct from
the -cobratoxin hetero/homodimers as well as irditoxin.
Structurally, haditoxin is a non-covalently linked homodimer
of the short-chain -neurotoxin type, and functionally, it has a
broad pharmacological profile with high affinity and selectivity
for muscle () and neuronal (7, 42, and 32) nAChRs.
Haditoxin exhibits a unique structural and functional profile
and is the first reported dimeric 3FTx interacting with themus-
cle () nAChR aswell as the first short-chain type of-neu-
rotoxin to interact with neuronal 7-nAChR with nanomolar
affinity.
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INTRODUCT ION
The coastline of peninsular India is bestowed with highly
productive estuarine areas. The Sundarbans, a deltaic
region of West Bengal, India, is the world’s largest
mangrove ecosystem, having a rich floral and faunal
diversity. The mollusc, Telescopium telescopium, is one of
the most dominant molluscan species found in the
Sundarban mangrove and it is found to reside mainly in
the estuarine environment. Telescopium has the ability to
survive in the typical mangrove environment, thereby
making them an attractive subject for scientific studies.
The molluscan species are known to produce potent
bioactive molecules and according to available reports,
some of these substances have been found to be useful in
both defence and predation. The bioactive components
identified so far in the molluscs indicate the presence of
neurotoxin, haemolysin, cardiotoxin and different bio-
genic amines [1,2]. It has also been observed that the
biological effects associated with molluscan tissue
extracts are either dependent on any one of these active
components or on the cumulative effect of these
substances.
On survey of the literature, it was observed that the
extracts from the spermathecal gland of Telescopium
telescopium produced potent antimicrobial [3] and
immunocontraceptive properties [4]. Moreover, two
endo-(1 linked to 3)-beta-D-glucanases have also been
isolated from this mollusc [5]. Moreover, a number of
reports are available indicating the presence of various
neuroactive components in different molluscan species
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ABSTRACT
The present study was carried out to evaluate the biological properties of the tissue
extract of a marine snail Telescopium telescopium, collected from the coastal regions of
West Bengal India. On extensive pharmacological screening, it was found that the
biological extract of T. telescopium (TTE) produced significant central nervous system
(CNS)-depressant activity as observed from the reduced spontaneous motility,
potentiation of pentobarbitone induced sleeping time, hypothermia and respiratory
depression with transient apnoea. The extract significantly decreased both residual
curiosity and also muscle coordination. The fraction, obtained following saturation
with 60–80% ammonium sulphate (80S), was also found to demonstrate predom-
inant CNS-depressant activity. It was observed that both TTE and the 80S fraction
significantly altered the brain noradrenaline and homovanillic acid levels without
affecting the brain gamma amino butyric acid (GABA) concentration. Based on the
present observations, it can be suggested that the CNS-depressant effects produced by
TTE and 80S could be attributable to modified catecholamine metabolism in the
brain.
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reports were available regarding its activity on the
central nervous system (CNS). In this study, an attempt
has been made to evaluate the neuropharmacological
profile of T. telescopium tissue extract (TTE) and of its
fraction(s).
MATER IALS AND METHODS
Collection and identification
Live molluscan species T. telescopium were collected from
the creeks of the river Matla in Jharkhali, Sundarban,
West Bengal, India. The molluscan specimens were
identified by Zoological Survey of India, New Alipore,
Kolkata, India.
Preparation of extract
On removal of the outer shell, the soft tissue portion was
homogenized with three volumes of 20 mM phosphate
buffer (pH 7.2) for 5 min, sonicated for 2 min and then
centrifuged at 14 000 g (Biofuge Stratos, Hanau,
Germany) at 4 C. The pooled extract was subsequently
defatted with dichloromethane (DCM) and concentrated
under reduced pressure. The concentrated fraction was
further subjected to successive precipitation with 30, 60
and 80% saturations of ammonium sulphate and then
the salts were removed by dialysis. The DCM cut extract
(TTE) and the precipitates thus obtained with 30 (30S),
60 (60S) and 80% (80S) were subsequently freeze dried
and stored at )20 C.
Protein estimation
Protein concentration was estimated following the
method described by Bradford [7] using standard Brad-
ford Kit (Genei, Bangalore, India) and all concentrations
of extract (unless otherwise specified) were expressed in
terms of protein equivalent.
Animals used
The pharmacological experiments were conducted using
adult Swiss albino mice (18–22 gm) and rats of Charles
Foster strain (120–180 gm). The animals were housed
in standard plastic cages and maintained on 12 h dark–
light cycle under regulated temperature (22 ± 2 C).
Animals were used after an acclimatization period of at
least 10 days in the laboratory environment and were
maintained on ad libitum food and water. Control
vehicle or test materials were administered intraperito-
neally unless otherwise specified. All experimental pro-
tocols were carried out according to the guidelines of the
Institutional Ethical Committee (constituted under Com-
mittee for the Purpose of Control and Supervision of
Experiments on Animals, India).
Acute toxicity study
Acute toxicity studies were carried out in male mice
(n = 20). The extract (TTE) and 80S were administered
(i.p.), in a dose range of 0.1–1.6 g/kg. The animals
were observed for signs and symptoms of toxicity and
number of mortality was recorded during a period of
24 h. The LD50 was determined according to the
method of Litchfield and Wilcoxon [8]. The animals
were also observed for any changes in the general
behaviour pattern following the administration of TTE
[9].
Spontaneous motility
Groups of mice (n = 10) were treated (i.p.) with either the
test samples (TTE, 100 and 200 mg/kg; 80S, 50 mg/kg)
or normal saline (0.1 mL/10 g). After 30 min of
treatment, the activity was measured in a photoacto-
meter (Techno, Lucknow, India) for 6 min and the
procedure was repeated at 30-min intervals up to a
period of 3 h [10].
Pentobarbitone-induced sleeping time
Groups (10 in each) of mice were treated with pento-
barbitone sodium (Sigma, St Louis, MO, USA) (40 mg/
kg, i.p.), 30 min after intraperitoneal administration of
TTE (100 and 200 mg/kg), 30S (100 mg/kg), 60S
(100 mg/kg), 80S (50 mg/kg), control vehicle (normal
saline) or chlorpromazine (Sigma) (4 mg/kg, i.p.). The
time interval between the loss and regaining of righting
reflex was measured as sleeping time [11].
Anticonvulsant activity
Pentylenetetrazole (PTZ) (HiMedia, Mumbai, India)
(80 mg/kg, i.p.) was injected into groups of mice (10
in each), 30 min after administration of TTE (100 and
200 mg/kg), 80S (50 mg/kg) or the control vehicle. The
animals were then carefully observed for the signs and
symptoms of convulsion [12]. Diazepam (East India
Pharmaceutical Works Ltd, Kolkata, India) (10 mg/kg,
i.p.) was used as the standard drug.
Body temperature
Rectal temperature was recorded at pre-determined time
intervals (up to 5 h) in groups of male mice (n = 10),
before and after the administration of TTE (100 and
200 mg/kg, i.p.), 80S (50 mg/kg, i.p.) or normal saline
[13,14].
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Rat respiration
The effect of TTE and 80S on abdominal respiration was
evaluated in male anaesthetized rats. TTE (100 and
200 mg/kg) and 80S (50 mg/kg) were administered
through the jugular vein [15]. Thereafter, one end of a
thread was tied to the skin at the lower end of the sternum
and the other end was carefully tied to a frontal writing
lever. The abdominal respiration was then recorded.
Studies on exploratory behaviour
Head-dip test
Telescopium telescopium tissue extract (100 and 200
mg/kg), 80S (50 mg/kg), normal saline (0.1 mL/kg) or
diazepam (10 mg/kg) were administered (i.p.) to groups
(n = 10) of pre-screened mice. The animals were then
placed singly on a wooden board (with 16 evenly spaced
holes) and the number of times, the animals dipped their
head inside the hole, during a period of 3 min was
recorded [16].
Y-maze test
Previously screened rats were divided into groups
(n = 10) and were treated with TTE (100 and
200 mg/kg), 80S (50 mg/kg) or the control vehicle. After
30 min, the rats were individually placed for 5 min in the
centre of a symmetrical Y-shaped runway (13 · 38 ·
33 cm) and the number of times, each rat (with all four
feet) entered the arms of the Y-maze were recorded [17].
Evasion test
Groups of mice (n = 10) were kept in a rectangular box,
having an inclined plane by which the mice could escape
from the box. Those mice, which escaped within 5 min,
were selected for further testing. Following administration
of control vehicle or test materials (TTE, 100 and 200 mg/
kg; 80S, 50 mg/kg), the animals were again placed in the
box and thereafter, the numbers of mice remaining in the
box, at the end of 5 min were recorded [18].
Studies on muscle relaxant activity
Rotarod test
The pre-screened mice (n = 10) were administered (i.p.)
with normal saline (0.1 mL/10 g), test material (TTE,
100 and 200 mg/kg; 80S, 50 mg/kg) or diazepam
(10 mg/kg). The animals were then placed (one at a
time) on a horizontal rod (30 mm diameter, rotating at
5 rpm) and were observed for 3 min. The numbers of
animals remaining on the rod were recorded and the
procedure was repeated at intervals of 30 min up to a
period of 2.5 h [19,20].
Chimney test
In a Pyrex glass tube (30 cm long and 2.8 cm diameter)
marked at a point 20 cm from its base, a mouse was
introduced at the end nearest to the mark. When the
mouse reached the bottom, the tube was reoriented
vertically, so that the mouse tried to climb backwards
immediately. The animals, which reached the mark
within 30 s, were selected for further testing. Thirty
minutes after administration (i.p.) of either the test
material (TTE, 100 and 200 mg/kg; 80S, 50 mg/kg),
diazepam (10 mg/kg) or normal saline (0.1 mL/kg), the
animals were placed individually in the glass tubes and
were then observed for their ability to climb backwards
during a time period of 30 s [21].
Traction test
Pre-screened albino mice (n = 10) were treated with the
control vehicle, test material (TTE, 100 and 200 mg/kg;
80S, 50 mg/kg) or diazepam (10 mg/kg). Each animal
was suspended through its forepaws on a metallic wire
(0.2 cm diameter) stretched horizontally at a height of
25 cm. The number of animals that failed to grasp the
wire (ataxia) with their hind paw within 10 s was
recorded [22].
Estimation of GABA content of brain in mice
The effect of TTE (100 and 200 mg/kg, i.p.), 80S
(50 mg/kg, i.p.) and the standard drug (diazepam,
10 mg/kg, i.p.) on the brain GABA (whole brain) content
was evaluated following the method of Lowe et al. [23].
The brain tissue homogenate (1 mL) was treated with
0.14 M ninhydrin solutions (0.5 M carbonate–bicarbon-
ate buffer, pH 9.95). The reaction mixture was then kept
in a water bath (60 C) for 30 min, cooled and treated
with 5.0 mL of copper tartarate reagent. After 10 min,
the fluorescence (377/451 nm) was measured in a
spectrofluorimeter (Shimadzu Rf-5000; Shimadzu Cor-
poration, Kyoto, Japan).
Effect on monoamine neurotransmitter
Biogenic amines in the different regions of the brain
were estimated by high performance liquid chromato-
graphy-electrochemical detector (HPLC-EC) according to
the modified method of Kim et al. [24]. The animals were
pretreated with either TTE (100 mg/kg) or 80S (50 mg/
kg). The animals were killed by decapitation and their
brains were rapidly removed and placed on chilled
containers. The striatum, hypothalamus, hippocampus
and cerebellum were dissected out as described by
Glowinski and Iversen [25]. The brain tissue samples
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were then homogenized in 0.17 M perchloric acid (with
dihydroxybenzylamine (DHBA) as internal standard in
the range of 25 ng/mL) by Polytron homogenizer
(Polytron, Littau-Lucerne, Switzerland). Homogenates
were then centrifuged at 33 000 g (Biofuge Stratos,
Hanau, Germany) at 4 C. Thereafter, 20 lL of super-
natant was injected via HPLC pump (Model 1525,
Binary Gradient Pump; Waters, Milford, MA, USA) into a
column (Spherisorb RP C18; Waters Corporation,
Milford, MA, USA) (5 lm particle size, 4.6 mm
i.d · 250 mm at 30 C) connected to an Electrochemical
detector (Model 2465; Waters) at a potential of +0.8 V
with glassy carbon working electrode vs. Ag/AgCl
reference electrode. Mobile phase consists of 32 mM
citric acid, 12.5 mM disodium hydrogen orthophos-
phate, 1.4 mM sodium octyl sulphonate, 0.05 mM
ethylenediamine tetra acetic acid (EDTA) and 16%
(v/v) methanol (pH 4.2) at a flow rate of 1.2 mL/min.
Amount of neurotransmitters were calculated from the
standard curve prepared with DA-DHBA, 5HT-DHBA,
DOPAC-DHBA, HVA-DHBA and 5HIAA-DHBA (Sigma).
Polyacrylamide gel electrophoresis (SDS–PAGE)
Sodium dodecyl sulphate–polyacrylamide gel electro-
phoresis (SDS–PAGE) was carried out according to
the method of Lammeli [26]. TTE and the various
ammonium sulphate precipitated fractions were loaded
(15 lg of protein in each lane) in a 10% polyacrylamide
gel (Sigma) containing 0.1% SDS and electrophoresis was
performed in a Minigel electrophoresis system (Amer-
sham Biosciences, Piscataway, NJ, USA). The broad
range molecular weight standards (205–6.5 kDa; Genei)
were run concurrently with the various samples.
Statistical analysis
Results were expressed as mean ± SE statistical analyses
were performed with one way analysis of variance
(ANOVA) followed by Student’s t-test and P < 0.05 was
considered to be statistically significant.
RESULTS
Acute toxicity
The LD50 of TTE (extract) and 80S (ammonium sul-
phate precipitated fraction) was found to be 800 and
1200 mg/kg (i.p. 24 h), respectively. It was also observed
that administration of the test substances (TTE and 80S,
i.p.) altered some behavioural responses in mice. The
animals became quiet, aggregated at corner of the cages
and also displayed reduced locomotor activity.
Spontaneous motility
In this experimental model, pretreatment with either TTE
or 80S produced significant reduction of spontaneous
motility. Moreover, the animals treated with the test
samples showed such reduced motility during the entire
duration (120 min) of the study (Figure 1).
Pentobarbitone-induced sleeping time
Prior administration of TTE (100 and 200 mg/kg, i.p.)
significantly potentiated pentobarbitone-induced sleep-
ing time in a dose-dependent manner. Among the
ammonium sulphate precipitated fractions, the 80S
fraction produced significant potentiation of pentobarbi-
tone-induced sleeping time (Figure 2).
Anticonvulsant activity
Pretreatment with either TTE or 80S could not protect
the experimental animals against PTZ-induced convul-
sion and mortality. However, both TTE and 80S
significantly delayed the onset of tremor and convulsion.
Diazepam pretreatment delayed the onset of tremor and
convulsion; moreover, no mortality was recorded
(Table I).
Body temperature
Administration of the TTE and 80S produced significant
lowering of normal body temperature, in a dose-depen-
dent manner. Maximum reduction in body temperature










































Figure 1 Effect of the Telescopium telescopium tissue extract (TTE)
and 80% ammonium sulphate saturated precipitate (80S) on
spontaneous motility in mice. TTE (100 and 200 mg/kg), 80S
(50 mg/kg) or control vehicle (normal saline; 0.1 mL/10 g) were
administered intraperitoneally. The spontaneous motility was
measured after 30 min following the administration of the test
substances. Values are expressed as mean ± SE (n = 10). P vs.
control, by t-test, *<0.005.
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was recorded after a period of 120 min and the normal
body temperature was found to be restored after a period
of about 4 h. (Figure 3).
Rat respiration
Intravenous administration of TTE (100 and 200 mg/kg)
and 80S (50 mg/kg) produced respiratory depression in
anaesthetized rats (Figure 4).
Exploratory behaviour patterns
Head-dip test
Pretreatment with different doses of TTE (100 mg/kg,
42%; 200 mg/kg, 65%), 80S (50 mg/kg, 78%) or
diazepam (10 mg/kg, 80%) produced significant reduc-
tion in head-dip responses when compared with the
control group of animals (Figure 5).
Y-maze test
Significant (dose-dependent) decrease in exploratory
behaviour pattern was observed in the different groups
of animals treated with TTE (100 mg/kg, 30%; 200
mg/kg, 39%), 80S (55%) or diazepam (10 mg/kg, 70%)
used as the standard drug (Figure 5).
Evasion test
Telescopium telescopium tissue extract (100 mg/kg, 60%;
200 mg/kg, 70%), 80S (50 mg/kg, 90%) and diazepam
(10 mg/kg, 100%) caused significant inhibition of resid-
ual curiosity in mice as observed in the evasion test
(Figure 5).
Muscle relaxant activity
Results of rotarod, chimney test and traction test
revealed significant loss in skeletal muscle co-ordination,
following administration of TTE and 80S (Figure 6). The
inhibitory activity of 80S fraction and diazepam (Diaz-
epam; 10 mg/kg) were found to be considerably higher
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Figure 2 Effect of TTE (100 and 200 mg/kg) and the ammonium
sulphate saturated precipitate (30S, 100 mg/kg; 60S, 100 mg/kg;
80S, 50 mg/kg), control vehicle (normal saline) and chlorproma-
zine (4 mg/kg) on Pentobarbitone sodium-induced sleeping time.
The test substances were administered (i.p.), 30 min before the
administration of pentobarbitone sodium. Values are expressed as
mean ± SE (n = 10). P vs. control, by t-test, *<0.005.













Control 4.2 ± 0.32 6.2 ± 0.46 5.3 ± 0.42 80
TTE (100 mg/kg) 5.4 ± 0.31* 8.0 ± 0.54* 4.4 ± 0.63 80
TTE (200 mg/kg) 8.1 ± 0.24* 10.4 ± 0.73* 4.0 ± 0.51 80
80S (50 mg/kg) 11.3 ± 0.34* 12.4 ± 0.85* 4.1 ± 0.67 70
Diazepam (10 mg/kg) 16.2 ± 0.34* – – Nil
TTE, Telescopium telescopium tissue extract; PTZ, pentylenetetrazole.
Values are expressed as mean ± SE (n = 10). P vs. control, by t-test, *<0.05 (first appearance of pilo-erection was considered as the onset of tremor response).



































Figure 3 Effect of TTE and 80S on normal body temperature. After
intraperitoneal administration of TTE (100 and 200 mg/kg), 80S
(50 mg/kg) or of normal saline as control vehicle, body temperature
was recorded at pre-determined intervals up to a period of 5 h.
Values are expressed as mean ± SE (n = 10). P vs. control, by t-test,
*<0.005.
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Effect on GABA content
Telescopium telescopium tissue extract as well as the 80S
fraction did not produce any significant change in the
brain GABA content. However, the standard drug
diazepam was found to increase the brain GABA content
significantly when compared with the control group of
animals.
Effect on brain biogenic amines
In this study, both TTE (100 and 200 mg/kg, i.p.) and
80S (50 mg/kg, i.p.) produced significant reduction of
noradrenaline (NA) content in different regions (cortex,
hippocampus and hypothalamus) of the brain, along
with elevation of homovanillic acid (HVA) in the cortex
and striatum. However, no significant changes in the
levels of 5-hydroxytryptamine (HT), dihydroxyphenyl-
60 60 60 T1 60 T2 44 3 38T
Figure 4 Effect of TTE and 80S on rat respiration. TTE (T1,
100 mg/kg; T2, 200 mg/kg) and 80S (T3, 50 mg/kg) were
administered to anaesthetized rats through the jugular vein, and
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Figure 5 Effect of TTE and 80S on exploratory behaviour pattern
using Head-dip, Y-maze and Evasion test models. TTE (100 and
200 mg/kg), 80S (50 mg/kg), control vehicle (normal saline) or
Diazepam (10 mg/kg) were administered (i.p.), 30 min prior to the
commencement of the experiments. Values are expressed as
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Figure 6 Effect of TTE, 80S and diazepam on motor coordination
(using Rotarod, Traction and Chimney models). The test substances
(TTE, 100 and 200 mg/kg; 80S, 50 mg/kg and Diazepam,
10 mg/kg) and the control vehicle were administered 30 min prior
to the commencement of the experiments. Values are expressed as
mean ± SE (n = 10). P vs. control, by t-test, *<0.005.
Table II Effect of TTE, ammonium sulphate saturated precipitate








NA CC 707 ± 44 529 ± 39* 476 ± 36* 354 ± 27*
HPC 486 ± 38 379 ± 32 343 ± 34* 326 ± 33*
HP 2098 ± 218 1894 ± 163 1695 ± 146* 1436 ± 125*
ST 488 ± 61 362 ± 43 327 ± 41 285 ± 32
DOPAC CC 226 ± 18 212 ± 24 202 ± 26 234 ± 24
HPC – – – –
HP – – – –
ST 452 ± 54 475 ± 64 426 ± 58 448 ± 49
5HIAA CC 867 ± 36 845 ± 41 823 ± 45 832 ± 42
HPC 946 ± 112 895 ± 116 999 ± 119 954 ± 114
HP 1326 ± 123 1233 ± 135 1239 ± 146 13351 ± 127
ST 1368 ± 86 1246 ± 96 1286 ± 114 1314 ± 129
DA CC 954 ± 76 965 ± 69 947 ± 82 1011 ± 114
HPC – – – –
HP 221 ± 11 257 ± 34 217 ± 28 247 ± 29
ST 1949 ± 124 1882 ± 118 2066 ± 221 2132 ± 234
HVA CC 31 ± 6 83 ± 13* 126 ± 23* 237 ± 19*
HPC – – – –
HP – – – –
ST 172 ± 14 286 ± 19* 298 ± 21* 387 ± 23*
5HT CC 495 ± 32 408 ± 26 386 ± 46 398 ± 33
HPC 404 ± 29 383 ± 26 401 ± 34 384 ± 30
HP 542 ± 36 567 ± 42 510 ± 39 533 ± 34
ST 513 ± 62 506 ± 46 499 ± 39 536 ± 35
TTE, Telescopium telescopium tissue extract; NA, noradrenaline;
DOPAC, 3,4-dihydroxyphenylacetic acid; HIAA, hydroxy indole acetic acid;
DA, dopamine; HT, hydroxytryptamine; CC, cortex; HPC, hippocampus;
HP, hypothalamus; ST, striatum.
P vs. control, by t-test, *<0.005.
Values are expressed as mean ± SE (n = 6) (concentrations of the biogenic
amines are expressed as ng/gm of brain tissue).
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alaine (DOPA) and hydroxy indole acetic acid (HIIA)
were observed following administration of TTE and 80S
(Table II).
Polyacrylamide gel electrophoresis (SDS–PAGE)
The band pattern of SDS–PAGE indicated that ammo-
nium sulphate precipitation produced distinct changes in
the protein profile of the different fractions (Figure 7).
The number of protein bands in the 80S fraction was
considerably decreased and some prominent bands were
observed at 104, 66 and 52 kD regions.
DISCUSS ION
Our study was aimed towards the evaluation of neuro-
pharmacological activity of T. telescopium. The initial
findings with the Telescopium extract indicated definite
alterations of general behaviour with reduced locomotor
activity. As evident from the results, both TTE and the
80S fraction produced significant reduction of
spontaneous motility, in a manner similar to that of
the CNS-depressants (barbiturates and benzodiazepines),
which are also known to produce identical effects in
rodents [27]. Significant potentiation of pentobarbitone-
induced sleeping time was also observed following
pretreatment with either TTE or 80S.
It is well established that prolongation of barbital
hypnosis is caused by sedative and/or hypnotic prop-
erty [28], attributed to either inhibition of pentobar-
bitone metabolism [29] or to some central mechanisms
involved in the regulation of sleep [30]. According to
some reports, there may be some correlation between
reduction in spontaneous motility and sedative activity
[31], generally attributed to a reduced CNS excitability
[32]. In this study, both TTE and the fraction 80S
lowered spontaneous motility, increased (dose-depen-
dently) pentobarbitone-induced sleeping time, reduced
normal body temperature and also produced respira-
tory depression (with transient apnoea), similar to that
of the benzodiazepines, which are also known to
produce similar pharmacological effects [15,27,33].
Moreover, intraperitoneal administration of TTE and
80S significantly delayed the onset of tremor and
convulsion induced by PTZ, even though no reduction
in mortality could be observed with the test sub-
stances. These findings indicate the probable CNS
depressant activity of the Telescopium products TTE
and 80S.
Furthermore, pretreatment with both TTE and 80S,
produced significant decrease in exploratory behaviour
pattern (evident from head-dip and Y-maze test models).
According to the published literature, such alteration of
exploratory behaviour can be attributed to the sedative
activity [34]. It was also observed that both TTE and the
fraction (80S) produced significant inhibition of residual
curiosity and these findings are in conformity with
various other CNS-depressant drugs [16,35].
In another study, both the test substances (TTE and
80S) produced significant motor in coordination (in the
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Figure 7 Polyacrylamide gel electropho-
resis (with SDS; 0.1%) of TTE and
different ammonium sulphate saturated
precipitate fractions (30S, 60S and 80S).
The separations were carried out with
10% polyacrylamide gel, and the bands
were visualized after staining with
Coomassie blue. Lanes: (1) TTE; (2) 60S;
(3) 80S; (4) 30S; (5) standard molecular
weight marker.
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observations with the test samples were found to be
similar to the standard drug diazepam [13,16], which is
also known to produce generalized muscle relaxation
[36].
The CNS-depressant effects of barbiturates and benzo-
diazepines have been reported to be mediated through
GABAA receptors [37]. Moreover, many researchers
have correlated CNS depressant activity with elevation
of brain GABA levels [38]. However, in our studies
neither TTE nor 80S produced any significant alteration
of brain GABA levels.
In this context, it may be mentioned that besides
GABA, catecholamines have also been found to promote
wakefulness by inhibiting the sleep-active neurons [39].
According to the published reports, substances causing
catecholamine deficiency are known to influence sleep.
Amongst the different catecholamines, depletion of NA
(reserpine, alpha methyl-P-tyrosine, 6-hydroxydop-
amine), often leads to depression [40,41] and has also
been observed that mice with NA deficiency tend to fall
asleep faster and are also difficult to awake, indicating
the stimulating effect of NA on wakefulness [42]. NA is
known to be a predominant target for different anti-
depressant drugs (with varying specificity towards the
adrenergic system), which are known to influence the
level of NA, thereby improving adrenergic signalling
during depression [43]. Therefore, further studies were
carried out to evaluate the role of TTE and 80S on
catecholamine concentration in the different regions of
the brain. From this study, it was evident that both TTE
and 80S significantly diminished the concentration of
NA in the cortex, hippocampus, hypothalamus and
striatum, whereas the concentration of HVA was found
to be increased in the cortex and striatum. However, the
levels of dopamine and 5HT, in the different regions of
the brain, remained unaltered. Hence, from the present
findings, it is evident that intraperitoneal administration
of the molluscan product(s), produced significant alter-
ation of catecholamine metabolism, resembling certain
CNS-depressant compounds [44,45] and centrally acting
muscle relaxants.
From SDS–PAGE analysis of the test substances, it was
observed that ammonium sulphate precipitation (80S
fraction) caused a marked change in the protein band
pattern as compared with the crude extract (TTE).
Moreover, on the basis of the experimental findings, it
may also be noted that the CNS-depressant activity of
80S fraction was found to be more pronounced in
comparison with the crude sample (TTE). Thus, from the
results of the current investigation, it was evident that
both TTE and the fraction possess definite CNS-depres-
sant activity. Further studies are presently being carried
out to purify and characterize the bioactive peptide(s)
present in the 80S fraction.
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a b s t r a c t
Acanthus ilicifolius Linn, is a perennial herb (Acanthaceae) widely found in the Sundarban mangroves and
is popularly used for its wound healing effects. In the present study an attempt was made to evaluate the
anti-inﬂammatory activity of the Acanthus ilicifolius leaves. The methanolic fraction of Acanthus ilicifolius
leaf extract produced signiﬁcant inhibition of rat paw oedema, when administered both prior to and
after carrageenan administration, in a manner similar to BW755C a synthetic cyclooxygenase (COX) and
lipoxygenase (LOX) inhibitor. The extract decreased protein exudation and leukocyte migration in the
peritoneal ﬂuid, thereby indicating its effectiveness towards inhibiting peritoneal inﬂammation. It also
produced signiﬁcant inhibition of COX (1 and 2) and 5-LOX activity. Preincubation of the extract inhibited
the production of proinﬂammatory cytokines (TNF and IL-6) in lipopolysaccharide (LPS)-stimulated
peripheral blood mononuclear cells (PBMCs). The methanolic fraction of the extract was also found toytokines possess signiﬁcant free radical (DPPH, ABTS, superoxide and hydroxyl radical) scavenging activity. The
extract on intraperitoneal administration augmented the endogenous antioxidant status, as evident from















Mangroves are salt tolerant vegetations, widely found in the
ropical and subtropical intertidal regions. The ecosystems com-
rises of heterogeneous habitats with the ﬂora and fauna adapted
o the difﬁcult environmental conditions. The Sundarban ecosys-
em is one of the most biologically productive and taxonomically
iverse ecosystems of the South-east Asia (Mann, 2000).
Acanthus ilicifolius Linn. (Acanthaceae) is an evergreen spinus
erb, widely found in the Sunderban region, popularly used for its
ound healing ability by the coastal inhabitants of West Bengal.
n survey of ethnomedical literature it was found that the leaves
f Acanthus ilicifolius are used for the treatment of rheumatism,
nakebite, paralysis and asthma in different parts of the world
Babu et al., 2001). The whole plant extract has been reported to
ossess analgesic and anti-inﬂammatory activities (Agshikar et al.,
979), while no such report has been published in reference to the
eaves of Acanthus ilicifolius. Methanolic extract of the leaves has
∗ Corresponding author at: Department of Pharmaceutical Technology, Jadavpur
niversity, Kolkata 700 032, West Bengal, India. Tel.: +91 33 24146666.
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een reported to exhibit hepatoprotective (Babu et al., 2001) and
umor reducing activities (Babu et al., 2002). Leishmanicidal activ-
ty of 2-benzoxazolinone, isolated from the leaves of this plant has
lso been documented (Kapil et al., 1994). Phytochemical studies
ith the plant revealed the presence of lignans (Kanchapoom et
l., 2001) and megastigmane glycosides (Wu et al., 2003).
According to various medical literatures, several adverse
eactions are known to be associated with the conventional non-
teroidal anti-inﬂammatory drugs (NSAIDs), thereby limiting the
idespread application of these agents. Development of newer
nti-inﬂammatory compounds possessing fewer side effects still
emains a challenge to the scientiﬁc community. Accordingly, our
aboratoryhadbeenactively engaged in studies related to screening
f Indian medicinal plants, both mangrove and also local varieties,
or novel anti-inﬂammatory molecules. During the course of such
nvestigations we had been able to identify some local plants like
luchea indica (coastalmangrove region) (Sen et al., 1993), Bryophy-
um pinatum (Pal and Nag Chaudhuri, 1991) and Calotropis procera
Sen et al., 1998), possessing simultaneous anti-inﬂammatory and
ntiulcer activity, attributed to probable blockade of COX and LOX
nzyme systems.
In the present study an attempt has been made to evaluate the
nti-inﬂammatoryproﬁle ofAcanthus ilicifoliuswith a view towards
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lucidation of the probable mechanism of action, using various in
itro and in vivo experimental models.
. Materials and methods
.1. Plant material and preparation of the methanolic fraction
The leaves of Acanthus ilicifolius (Acanthaceae) were from the
anning region of West Bengal. The plant material was taxonomi-
ally identiﬁed and authenticated by the Botanical Survey of India
ndavoucher specimen (AC/2004/1)hasbeenpreserved for further
tilization. The leaveswere shadedried, slicedandpulverizedusing
mechanical grinder. The powdered leaves (3.5 kg) were defatted
y maceration with petroleum ether (at room temperature; 48h).
his processwas repeated (three times) for complete removal of the
atty materials. It was then dried in air and subsequently subjected
o extraction with chloroform as above. Thereafter, the extraction
as carried out with methanol. After exhaustive extraction, the
ethanolic extract was collected and concentrated under reduced
ressure at 45–50 ◦C. A greenish brown concentrated methanolic
xtract (AC-M) was obtained (yield 0.45%, w/w with respect to the
ried starting material). The ﬁnal product was then stored at 4 ◦C.
.2. Animals used
Adult male Charles Foster rats (weighing 120–150g), and male
wiss albino mice (weighing 20–25g) were used for the study. The
nimalswere housed in polypropylene cages at 25±2 ◦C (with 12h
ight and dark cycle). All the animals were acclimatized to labora-
ory environment for a week before the experiment. The animals
ere provided free access to standard pellet diet and water ad
ibitum. The care and use of laboratory animals were strictly in
ccordance to the guidelines prescribed by the Institutional Eth-
cal Committee (constituted under the guidelines Committee for
he Purpose of Control and Supervision of Experiments on Animals,
ndia).
.3. Drugs and chemicals
Carrageenan ( 80% and  20%); 1,1-diphenyl-2-picryl hydrazyl
ydrate (DPPH) and lipopolysaccharide (LPS, E.coli: B4) were
urchased from Sigma–Aldrich (St. Louis, MO, USA). Tripyridyltri-
zine (TPTZ) was purchased from Fluka chemical company (Buchs,
witzerland). All other unlabelled chemicals and reagents were of
nalytical grade (SRL Mumbai, E.Merck India).
.4. Determination of total phenolic compounds
The content of phenolic compounds was determined accord-
ng to the method of Singleton and Rossi (1965). Samples (150l)
ere mixed with 750l of Folin–Ciocalteu’s reagent and 600l of
odium carbonate (7.5%). The tubes were then incubated at 50 ◦C
or 10min and the absorption was measured at 760nm. The total
henolic content was expressed as quercetin equivalents (QE).
.5. Carrageenan induced rat paw oedema (pre- and
ost-treatment)
The control vehicle (isotonic saline 0.9%, w/v), test and standard
rugs were administered 30min prior to the administration of car-
ageenan (SigmaType I; 0.1mlof 1%,w/v solution) in the subplantar
issue of the hind paw. The paw volumes were measured using
lethysmometer (Model No 7141; UGO Basile, Italy), immediately
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f carrageenan (Chattopadhyay et al., 2004; Nag Chaudhuri et al.,
005).
In the post-treatment study, the same procedure was repeated
here the test drugs were administered (intraperitoneally), 2 h
fter the administration of carrageenan (Boughton-Smith et al.,
993).
.6. Exudative inﬂammation
Acanthus ilicifolius (200 and 400mg/kg; i.p.), acetylsalicylic acid
100mg/kg; i.p.) and the control vehicle (normal saline; i.p.) were
dministered to different groups of animal. The leukocyte count
nd the protein content (using Bradford reagent) in the peritoneal
xudate was determined 3h following the intraperitoneal admin-
stration of 0.05N acetic acid (Nag Chaudhuri et al., 2005).
.7. Effect on PGE2 production by COX-2 (whole blood assay)
Freshly collected blood (heparinised) was incubated with
cetylsalicylic acid (12g/ml) for 6h, followed by incubation at
7 ◦C for 1h with different concentrations of Acanthus ilicifolius or
he standarddrug. Thereafter, 10l of LPSwas added to the reaction
ixture, and then the tubes were again incubated at 37 ◦C for 24h.
inally, the plasma was separated by centrifugation (at 2000 rpm
or 10min) and was used for the determination of PGE2 content
ELISA kit; GE Healthcare).
.8. Effect on cyclooxygenase (COX-1 and 2) using Amplex
ed-based ﬂuorimetric assay
The assay was performed using COX assay kit (ELISA). Brieﬂy,
he test and the standard drugs were incubated with the appro-
riate COX enzymes (COX-1, 1.5U/well and COX-2, 2.5U/well), in a
eaction buffer (0.1M Tris–HCl buffer, pH 8.0; 5mM EDTA; 2mM
henol and 2.5mM hematin) for a period of 15min at 37 ◦C. Then
0Mamplex redwasadded to themixture followedbyadditionof
rachidonic acid (100M/well), thereafter the ﬂuorescence (exci-
ation 544nm and emission 590nm) was measured up to a period
f 30min.
.9. Effects on production of cytokines [interleukin-6 (IL-6) and
umour necrosis factor-˛ (TNF-˛)]
Human peripheral blood mononuclear cells were prepared
ccording to Yaqoob et al. (1998). The cells were suspended in cul-
ure medium (HEPES-buffered RPMI containing 2mM glutamine
nd antibiotics) and were incubated with either methanolic frac-
ion of acanthus or the standard drug (6h at 37 ◦C) followed by
timulation with bacterial lipopolysaccharide. At the end of the
ncubation, themediumwas collected and cytokineswere analysed
y ELISA kit according to the manufacturers instruction.
.10. Effect on 5-lipoxygenase (LOX) enzyme
The assay mixture (3ml) consisted of 5nM of 5-LOX enzyme
Soybean; Sigma-type V, 108 KD) in Tris–HCl buffer (pH 9.0). This
nzymemixture was incubatedwith the test substances for 15min
t room temperature. After the incubation period freshly prepared
0M arachidonic acid in 50mM Tris–HCl buffer (pH 9.0) was
dded to the mixture. Finally, the enzyme inhibition was mea-
ured as decrease in absorbance of the reaction mixture at 234nm
or 180 s using Hitachi U 2000 Spectrophotometer (Kulkarni et al.,
990).
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.11. 2,2-Diphenyl-1-picryl hydrazine hydrate (DPPH) scavenging
ctivity
Different concentrations of the test substances (Acanthus ilici-
olius, vitamin C and quercetin) were incubated (in darkness) with
PPH (0.3mM in methanol). After 30min of incubation at room
emperature, the absorbance was measured at 518nm (Mensor et
l., 2001).
.12. 2,2′-Azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS)
adical decolorization assay
ABTS solution (diluted to an absorbance of 0.745) was mixed
ith different concentrations of the test or standard drugs. The
ecrease in absorbance of the reaction mixture (incubated in dark
or 5min) was measured at 734nm (Re et al., 1998).
.13. Measurements of reductive ability
Samples in 3.5ml phosphate buffer (0.2M; pH 6.6) were mixed
ith K3Fe(CN)6 (1.0%, w/v) solution and was incubated at 50 ◦C for
0min. Thereafter, 2.5ml of trichloroacetic acid (TCA)was added to
hemixture and centrifuged at 3000 rpm (10min). The supernatant
2.5ml) was mixed with 0.5ml of freshly prepared FeCl3 solu-
ion (0.1%, w/v) and then the absorbance was recorded at 700nm
Oyaizu, 1986).
.14. Superoxide anion scavenging activity
The reaction mixture containing nitro blue tetrazolium (NBT;
.156M)andNADH (468M; in100mMphosphate buffer pH7.4)
ere mixed with different concentrations of the test samples, fol-
owed by the addition of phenazine methosulphate (PMS) (60 (M;
n 100mM phosphate buffer, pH 7.4). The reaction mixture was
hen incubated at 25 ◦C (5min) and the absorbance was recorded
t 560nm (Nishimiki and Rao, 1972).
.15. Hydroxyl radical scavenging
The reaction mixture containing 2-deoxy-d-ribose (1mM),
henyl hydrazine (0.2mM), (in phosphate buffer, pH 7.4) and
ifferent concentration of the test samples were incubated for
h at 37 ◦C. The reaction was stopped by the addition of 2.8 %
w/v) trichloroacetic acid solution, followed by centrifugation at
000 rpm (10min). The supernatant was mixed with aqueous 1%
w/v) thiobarbituric acid (TBA). The TBA reactive product thus
ormed was directly measured at 532nm (Halliwell et al., 1987).
.16. Effect on ferric reducing ability of plasma (FRAP)
Acanthus ilicifolius, quercetin, vitamin C and vitamin E were
dministered (i.p.) to different groups of animals. After 2h,
lood samples were withdrawn and the plasma was separated
or the determination of FRAP. Then 300l of freshly prepared
RAP reagent (10mM tripyridyltriazine, 20mM ferric chloride and
00mM acetate buffer) was mixed with 10l of plasma and the
bsorbance was measured at 593nm (Benzie and Strain, 1996).
.17. Total peroxyl radical trapping ability: TRAP assayAcanthus ilicifolius, quercetin and vitamin C were adminis-
ered (i.p.) to different groups of animals. One hour later, blood
amples were withdrawn and the plasma was separated for the
etermination of TRAP. Ten microliters of plasma was diluted




gig. 1. Effect of Acanthus ilicifolius, indomethacin and BW 755C on carrageenan
nduced paw edema (values are mean± S.E.; n=6). P-value (versus control):
P<0.05, **P<0.01 and ***P<0.001.
′,7′-dichloroﬂouroscien diacetate (DCFH-DA) in a ﬁnal concen-
ration of 14mol/l. The reaction was initiated by the addition
f 2,2′-diazobis (2amidinopropane) dihydrochloride (56mmol/L).
he absorbance was measured at 504nm using Hitachi U 2000
pectrophotometer (Valkonen and Kuusi, 1997).
.18. Statistical analysis
Results were expressed as mean± S.E. (n=6). Statistical analy-
es were performed with one-way analysis of variance (ANOVA)
ollowed by post hoc Dunnett’s test using prism software. “P” value
ess than 0.05 were considered to be statistically signiﬁcant.
. Results
.1. Total polyphenol composition
The amount of total phenolic compounds present in the
ethanolic fraction of Acanthus ilicifolius leaf extract was found to
e 310±3mg (expressed as quercetin equivalents per g of extract).
.2. Carrageenan-induced rat paw oedema
Methanolic fraction of Acanthus ilicifolius signiﬁcantly inhib-
ted (ED50 =146.2mg/kg; 95% CL=69.38–286.2), both the early and
ate phases of carrageenan-induced paw oedema (Fig. 1). In the
ost-treatment model (drug administration after 2h), the extract
ED50 =194.1mg/kg; 95%CL=135.8–301.4) andBW755C (COX–LOX
nhibitor) signiﬁcantly decreased the carrageenan induced rat paw
edema, however, indomethacin was found to produce no signiﬁ-
ant inhibitory activity (Fig. 1).
.3. Exudative inﬂammation
Pretreatment with the test drug (200 and 400mg/kg; i.p.)
roduced signiﬁcant inhibition of peritoneal protein exudation
Table 1) and also caused signiﬁcant reduction of total leukocyte
ount in the peritoneal exudate when compared with the control
roup of animals.
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Table 1
Effect of the methanolic fraction of Acanthus ilicifolius and acetyl salicylic acid on peritoneal inﬂammation (values are mean± S.E.; n=6)
Drug Dose (mg/kg) Acetic acid induced peritoneal inﬂammation
Leukocytes/ml of exudate Inhibition (%) Protein (mg/ml) Inhibition (%)
Saline control – 2780 ± 24 – 14.30 ± 0.27 –
Acanthus ilicifolius 200 1440 ± 21 48* 10.20 ± 0.24 29*
Acanthus ilicifolius 400 640 ± 36 77* 7.37 ± 0.53 49*
A 83* 5.83 ± 0.29 59*






























Fig. 2. Reductive ability of the methanolic fraction of Acanthus ilicifolius (values are
mean± S.E.; n=4). P-value (versus control): **P<0.01.
Fig. 3. Effect of Acanthus ilicifolius (methanolic fraction) and the standard antiox-












Scetylsalicylic acid 200 487 ± 11
nimals were pre-treated with the drugs and peritoneal inﬂammation was produce
* p<0.01
.4. Effect on PGE2 release
The methanolic fraction of Acanthus ilicifolius leaf extract
1g/ml, 11%; 10g/ml, 46%) and the standard drug etoricoxib
1g/ml, 47%; 10g/ml, 98%) signiﬁcantly inhibited COX 2 depen-
ent PGE2 generation in LPS-stimulated whole blood assay.
.5. Effect of Acanthus ilicifolius on in vitro COX assay
Themethanolic fractionofAcanthus ilicifolius signiﬁcantly inhib-
ted both COX 1(1 (g/ml; 99%) and COX 2 (1 (g/ml; 87%) enzymes.
owever, acetylsalicylic acid (18 (g/ml) produced 97% inhibition of
OX 1 and that of rofecoxib (3.14 (g/ml) was found to be 95% for
OX 2.
.6. Effect on pro-inﬂammatory cytokines (IL-6 and TNF˛)
The methanolic fraction of Acanthus ilicifolius signiﬁcantly
nhibited the secretion of the pro-inﬂammatory cytokines in LPS-
timulated mononuclear cells. Acanthus ilicifolius exhibited an IC50
f 88.64±6.3 (g/ml (IL-6) and 1.24±0.28 (g/ml (TNF), respec-
ively. As evident fromthe IC50 values, dexamethasonewas found to
e more effective (IL-6, 39.41±2.8 (g/ml; TNF, 0.18±0.02 (g/ml).
.7. Effect of Acanthus ilicifolius on soybean 5-lipoxygenase
The methanolic fraction of Acanthus ilicifolius (1 (g/ml) demon-
trated 79% inhibition of enzyme activity, which was found to be
igher in case of BW 755C (91%) and quercetin (84%), at identical
oncentration.
.8. Free radical scavenging activity of Acanthus ilicifolius
Signiﬁcant DPPH free radical scavenging activity was observed
ith the test drug (Table 2). However, the IC50 values of quercetin
5.82 (g/ml) and vitamin C (6.62 (g/ml) were moderately less than
hat of the Acanthus ilicifolius (8.4 (g/ml).
The methanolic fraction of Acanthus ilicifolius leaf extract pro-
uced a concentration dependent scavenging of ABTS.+ radical
IC50 of 10.34 (g/ml). Quercetin (IC50 3.6 (g/ml) and vitamin C (IC50
.86 (g/ml) were found to be more effective in comparison to
he test drug (Table 2). The methanolic fraction and the standard






cavenging activity of Acanthus ilicifolius against DPPH, ABTS, superoxide and hydroxyl ra
rugs Inhibitory concentration (IC50) (g/ml
DPPH radical ABTS rad
canthus 8.40 ± 0.06 10.34 ± 0
uercetin 5.28 ± 0.08 3.60 ± 0
itamin C 6.62 ± 0.05 4.86 ± 0
odium metabisulphite – –ntraperitoneal administration (values are mean± S.E.; n=6). P-value (versus con-
rol): *P<0.05, and **P<0.01.
.9. Reductive ability
The methanolic fraction of Acanthus ilicifolius leaf extract
emonstrated signiﬁcant reductive ability, which was also found
o be concentration dependent (Fig. 2).
.10. Effect on FRAPFerric reducing ability of the plasma (FRAP) was signiﬁcantly
levated following intraperitoneal administration of Acanthus ilici-
olius (Fig. 3).
dicals (values are expressed as mean± S.E.; n=4)
ical Superoxide radical Hydroxyl radical
.02 78.12 ± 2.51 24.60 ± 1.10
.03 30.19 ± 1.32 14.32 ± 0.52
.03 52.18 ± 3.14 21.08 ± 0.34
– 11.3 ± 0.22


































































































sig. 4. Effect of Acanthus ilicifolius (methanolic fraction) and quercetin on total per-
xyl radical trapping ability (TRAP) (values are mean± S.E.; n=6). P-value (versus
ontrol): *P<0.05, **P<0.01, and ***P<0.001.
.11. Effect on TRAP
Pretreatment with Acanthus ilicifolius produced signiﬁcant as
ell as dose dependent elevation of the total peroxyl radical trap-
ing ability of plasma (Fig. 4).
. Discussion
Conventional NSAIDs are themost commonly prescribed agents
sed for the management of inﬂammation and pain, however,
oxic manifestation associated with these agents is a matter of
oncern. As a result, several new approaches are now considered
or design and development of superior anti-inﬂammatory com-
ounds, showing fewer side effects. In the present study, we have
valuated the anti-inﬂammatory activity of Acanthus ilicifolius. The
ethanolic fractionof theAcanthus ilicifoliuswhenadministeredup
o a dose of 1200mg/kg, produced no visible side effects or death,
nd the dose range was found to be well tolerated in the treated
roups.
Carrageenan induced rat paw oedema, is a well-accepted and
opular model for evaluating anti-inﬂammatory activity. Car-
ageenan is known to produce a biphasic response (Vinegar et al.,
969), where the early phase is related to the production of his-
amine, leukotrienes’, PAF and possibly cyclooxygenase products,
hile the delayed phase is linked to the neutrophil inﬁltration,
icosanoid release, production of free radicals and also release of
ther neutrophil derived mediators (Cuzzocrea et al., 1998). Inter-
stingly NSAIDs may not be effective in reducing the inﬂammation
n the later phase of such oedema formation, (Boughton-Smith
t al., 1993). In the present study, Acanthus ilicifolius leaf extract
roduced signiﬁcant and also dose dependent inhibition of car-
ageenan induced paw oedema. Moreover, during post-treatment
i.e., drug administered after 2h following carrageenan injection),
he methanolic fraction was again found to be effective against
arrageenan induced paw oedema. Our ﬁndings were found to be
imilar to that of BW755C (aCOXandLOX inhibitor),whichwas also
ound tobehighlyeffective, particularly in thepost-treatment stud-
es (administered after the induction of oedema), when compared
o the popular NSAIDs (Boughton-Smith et al., 1993).
Intraperitoneal administration of acetic acid produces a sus-
ained increase in capillary permeability, thereby leading to
ncreased cellular inﬁltration coupled with protein exudation, ulti-
ately leading to severe inﬂammatory conditions. The present
ndings indicate the effectiveness of the methanolic fraction of
canthus ilicifolius leaf extract against acetic acid induced peri-
oneal inﬂammation in a manner similar to that of the NSAIDs
Northover, 1963; Whittle, 1964). It was also observed that the
ethanolic fraction (at 1g/ml) produced signiﬁcant inhibition of
yclooxygenase (1 and2), however, the extract didnotproduce such
quivalent effectiveness (46% at 10g/ml) towards LPS induced
GE2 release in peripheral blood mononuclear cells. Moreover, the
R
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ethanolic fraction was also found to possess signiﬁcant 5-LOX
nhibitory activities, comparable to that of phenidoneandBW755C.
During inﬂammation, the leukocytes and macrophages migrat-
ng to the site of injury are known to produce the superoxide
adicalO2−,which in turn lead to the generationof hydrogenperox-
de. Furthermore, in the presence of suitable transitional elements,
ydrogen peroxide may be transformed to the highly reactive
ydroxyl radical. These radicals can also act as second messengers,
hereby activating the production of other inﬂammatorymediators
Garcia et al., 1996).
Antioxidant activity of various test compounds can be rapidly
valuated with in vitro test systems employing DPPH, ABTS+ rad-
cals. In the present study the methanolic fraction of Acanthus
licifolius and standard drug quercetin signiﬁcantly scavenged both
PPH and ABTS radicals in a concentration dependent manner
nd also demonstrated signiﬁcant reductive ability. Moreover,
he methanolic fraction of Acanthus ilicifolius signiﬁcantly scav-
nged both superoxide (generated from the PMS-NADH system)
nd hydroxyl radicals (derived from deoxy-d-ribose and phenyl
ydrazine).
Acanthus ilicifolius leaf extract also improved the endogenous
ntioxidant status as was evident from the increased levels of
RAP, a sensitive index for understanding the reducing capacity of
iological ﬂuid during oxidative stress (Benzie and Strain, 1996).
ntraperitoneal administrationofAcanthus ilicifoliusproduceda sig-
iﬁcant (concentration dependent) elevation of TRAP.
According to reports, anti-inﬂammatory agents like synthetic
yrazoline derivatives (phenidone, BW 755C; inhibitor of COX and
OX) and some plant polyphenolics are also potent antioxidants,
nd such antioxidant activity probably contribute towards their
OX–LOX inhibitory effects (Charlier and Michaux, 2003).
Reactive oxygen species are known to activate anumber of intra-
ellular signaling pathways such as NFB, which in turn activates
he transcription of various pro-inﬂammatory cytokines (inter-
eukins and TNF), cell adhesionmolecules and also COX 2 (Pavlick
t al., 2002). It has also been observed that TNF production in the
PS-stimulatedcells isdependenton5-LOXactivity,whichhasbeen
onﬁrmed with the use of 5-LOX inhibitors like L656, 224 but not
ith acetylsalicylic acid (MacIntyre and Pope, 1991). In conformity
ith these ﬁndings, our studywith Acanthus ilicifolius revealed sig-
iﬁcant inhibition of IL-6 and TNF in human PBMC (stimulated
ith LPS), and the IC50 value were found to be 88.64±6.3 and
9.41±2.84, respectively.
Thus on the basis of the present ﬁndings we can suggest that
he observed anti-inﬂammatory activity of Acanthus ilicifolius may
e attributed to its inhibitory effect on the COX–LOX enzymes,
robably inﬂuenced in turn by the superior free radical trapping
ctivity of the components present in the extract. Further, studies
re being conducted to identify and characterize the compound(s)
esponsible for the observed inhibition of COX and LOX.
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